
<html lang="en"     class="pb-page"  data-request-id="c7431622-ea32-4bd0-8a8f-077869c392de"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2016.59.issue-3;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01550;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors" /></meta><meta name="dc.Creator" content="Guanglin  Luo" /></meta><meta name="dc.Creator" content="Ling  Chen" /></meta><meta name="dc.Creator" content="Catherine R.  Burton" /></meta><meta name="dc.Creator" content="Hong  Xiao" /></meta><meta name="dc.Creator" content="Prasanna  Sivaprakasam" /></meta><meta name="dc.Creator" content="Carol M.  Krause" /></meta><meta name="dc.Creator" content="Yang  Cao" /></meta><meta name="dc.Creator" content="Nengyin  Liu" /></meta><meta name="dc.Creator" content="Jonathan  Lippy" /></meta><meta name="dc.Creator" content="Wendy J.  Clarke" /></meta><meta name="dc.Creator" content="Kimberly  Snow" /></meta><meta name="dc.Creator" content="Joseph  Raybon" /></meta><meta name="dc.Creator" content="Vinod  Arora" /></meta><meta name="dc.Creator" content="Matt  Pokross" /></meta><meta name="dc.Creator" content="Kevin  Kish" /></meta><meta name="dc.Creator" content="Hal A.  Lewis" /></meta><meta name="dc.Creator" content="David R.  Langley" /></meta><meta name="dc.Creator" content="John E.  Macor" /></meta><meta name="dc.Creator" content="Gene M.  Dubowchik" /></meta><meta name="dc.Description" content="GSK-3 is a serine/threonine kinase that has numerous substrates. Many of these proteins are involved in the regulation of diverse cellular functions, including metabolism, differentiation, prolifer..." /></meta><meta name="Description" content="GSK-3 is a serine/threonine kinase that has numerous substrates. Many of these proteins are involved in the regulation of diverse cellular functions, including metabolism, differentiation, prolifer..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 22, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01550" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01550" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01550" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01550" /></link>
        
    
    

<title>Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01550" /></meta><meta property="og:title" content="Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0001.jpeg" /></meta><meta property="og:description" content="GSK-3 is a serine/threonine kinase that has numerous substrates. Many of these proteins are involved in the regulation of diverse cellular functions, including metabolism, differentiation, proliferation, and apoptosis. Inhibition of GSK-3 may be useful in treating a number of diseases including Alzheimer’s disease (AD), type II diabetes, mood disorders, and some cancers, but the approach poses significant challenges. Here, we present a class of isonicotinamides that are potent, highly kinase-selective GSK-3 inhibitors, the members of which demonstrated oral activity in a triple-transgenic mouse model of AD. The remarkably high kinase selectivity and straightforward synthesis of these compounds bode well for their further exploration as tool compounds and therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01550"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01550">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01550&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01550&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01550&amp;href=/doi/10.1021/acs.jmedchem.5b01550" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1041-1051</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01534" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01559" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guanglin++Luo">Guanglin Luo</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ling++Chen">Ling Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine+R.++Burton">Catherine R. Burton</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Xiao">Hong Xiao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prasanna++Sivaprakasam">Prasanna Sivaprakasam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carol+M.++Krause">Carol M. Krause</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Cao">Yang Cao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nengyin++Liu">Nengyin Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Lippy">Jonathan Lippy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy+J.++Clarke">Wendy J. Clarke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Snow">Kimberly Snow</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Raybon">Joseph Raybon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod++Arora">Vinod Arora</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matt++Pokross">Matt Pokross</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Kish">Kevin Kish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hal+A.++Lewis">Hal A. Lewis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Langley">David R. Langley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+E.++Macor">John E. Macor</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gene+M.++Dubowchik">Gene M. Dubowchik</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Bristol-Myers Squibb Research & Development, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#335446525d545f5a5d1d5f465c73515e401d505c5e"><span class="__cf_email__" data-cfemail="2b4c5e4a454c47424505475e446b49465805484446">[email protected]</span></a>. Phone: 203-677-6640. Fax: 203-677-7702.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01550&amp;href=/doi/10.1021%2Facs.jmedchem.5b01550" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1041–1051</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 11, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 October 2015</li><li><span class="item_label"><b>Published</b> online</span>22 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01550</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1041%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuanglin%2BLuo%252C%2BLing%2BChen%252C%2BCatherine%2BR.%2BBurton%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D3%26contentID%3Dacs.jmedchem.5b01550%26title%3DDiscovery%2Bof%2BIsonicotinamides%2Bas%2BHighly%2BSelective%252C%2BBrain%2BPenetrable%252C%2Band%2BOrally%2BActive%2BGlycogen%2BSynthase%2BKinase-3%2BInhibitors%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1051%26publicationDate%3DFebruary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01550"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2492</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01550" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guanglin&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Ling&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;R. Burton&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Prasanna&quot;,&quot;last_name&quot;:&quot;Sivaprakasam&quot;},{&quot;first_name&quot;:&quot;Carol&quot;,&quot;last_name&quot;:&quot;M. Krause&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Nengyin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Lippy&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;J. Clarke&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Snow&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Raybon&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;Arora&quot;},{&quot;first_name&quot;:&quot;Matt&quot;,&quot;last_name&quot;:&quot;Pokross&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Kish&quot;},{&quot;first_name&quot;:&quot;Hal&quot;,&quot;last_name&quot;:&quot;A. Lewis&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Langley&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;E. Macor&quot;},{&quot;first_name&quot;:&quot;Gene&quot;,&quot;last_name&quot;:&quot;M. Dubowchik&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;1041-1051&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01550&quot;},&quot;abstract&quot;:&quot;GSK-3 is a serine/threonine kinase that has numerous substrates. Many of these proteins are involved in the regulation of diverse cellular functions, including metabolism, differentiation, proliferation, and apoptosis. Inhibition of GSK-3 may be useful in treating a number of diseases including Alzheimer’s disease (AD), type II diabetes, mood disorders, and some cancers, but the approach poses significant challenges. Here, we present a class of isonicotinamides that are potent, highly kinase-selective GSK-3 inhibitors, the members of which demonstrated oral activity in a triple-transgenic mouse model of AD. The remarkably high kinase selectivity and straightforward synthesis of these compounds bode well for their further exploration as tool compounds and therapeutics.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01550&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01550" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01550&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01550" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01550&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01550" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01550&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01550&amp;href=/doi/10.1021/acs.jmedchem.5b01550" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01550" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01550" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01550%26sid%3Dliteratum%253Aachs%26pmid%3D26751161%26genre%3Darticle%26aulast%3DLuo%26date%3D2016%26atitle%3DDiscovery%2Bof%2BIsonicotinamides%2Bas%2BHighly%2BSelective%252C%2BBrain%2BPenetrable%252C%2Band%2BOrally%2BActive%2BGlycogen%2BSynthase%2BKinase-3%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D3%26spage%3D1041%26epage%3D1051%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/jmcmar.2016.59.issue-3/20160211/jmcmar.2016.59.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">GSK-3 is a serine/threonine kinase that has numerous substrates. Many of these proteins are involved in the regulation of diverse cellular functions, including metabolism, differentiation, proliferation, and apoptosis. Inhibition of GSK-3 may be useful in treating a number of diseases including Alzheimer’s disease (AD), type II diabetes, mood disorders, and some cancers, but the approach poses significant challenges. Here, we present a class of isonicotinamides that are potent, highly kinase-selective GSK-3 inhibitors, the members of which demonstrated oral activity in a triple-transgenic mouse model of AD. The remarkably high kinase selectivity and straightforward synthesis of these compounds bode well for their further exploration as tool compounds and therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia and affects over 30 million people worldwide. An estimated 5.2 million Americans have AD, and it is the fifth leading cause of death in Americans age 65 or older.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD is histopathologically defined by neuronal loss, the presence of intracellular neurofibrillary tangles (NFTs), the formation of extracellular senile plaques, and the occurrence of cerebral amyloid angiopathy.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> There is currently no disease-modifying treatment available. While extensive preclinical and clinical efforts have focused on beta-amyloid (Aβ)-related intervention, a related hypothesis is that hyperphosphorylation of tau protein leads to the destabilization of microtubules, which then aggregate to form NFTs.</div><div class="NLM_p">Glycogen synthase kinase-3 (GSK-3) is a proline-directed serine/threonine kinase that is involved in the regulation of various physiological functions, such as metabolism, proliferation, and apoptosis, by carrying out the phosphorylation of multiple protein substrates.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> GSK-3 exists in two isoforms, GSK-3α (51 kDa) and GSK-3β (47 kDa), that share 84% overall identity and 98% identity within their respective catalytic domains.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Both primary isoforms are ubiquitously expressed, with high levels observed in the brain.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> In most brain areas, GSK-3β is the predominant isoform.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> There is evidence to suggest that the GSK-3β isoform is the key kinase required for hyperphosphorylation of tau.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> However, some studies suggest that GKS-3α and GSK-3β share very similar, if not entirely redundant, functions in a number of cellular processes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> GSK-3 is one of a small number of kinases that are constitutively active, and its activity generally results in a reduction of substrate function. The substrates on which it functions are numerous, with at least 50 being well-defined, but there are perhaps as many as 100 or more in total.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Given its central role in cellular differentiation and metabolism, acting on a large number of substrates, it is not surprising that GSK-3 is highly regulated. This is enforced by multiple mechanisms including substrate priming, activating phosphorylation, physical sequestration, and, most prominently, inhibitory phosphorylation. The activity of GSK-3β is significantly reduced by phosphorylation at Ser-9 in the N-terminal domain, most notably by protein kinase B (PKB or AKT).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This inhibitory pathway has been proposed to result in neuroprotection, neurogenesis, and favorable outcomes following pharmacological treatment in various mood disorders. Hyperphosphorylation of tau by GSK-3 has been demonstrated both in cell culture and in <i>in vivo</i> studies.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Hyperphosphorylated tau disengages from microtubules, resulting in destabilization of these filaments with concomitant negative effects on intracellular structures and transport mechanisms.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition, the uncomplexed, hyperphosphorylated tau assembles into paired helical filaments (PHFs) that aggregate to produce the stereotypic intracellular NFTs associated with AD.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Other potential pathological consequences of overactivation of GSK-3 include neuroinflammation and apoptosis.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Furthermore, GSK-3 has been demonstrated to be involved in mechanisms underlying memory and learning, and dysregulation of GSK-3 may explain some of the early cognitive deficits observed in AD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These results and observations suggest that inhibition of GSK-3 activity may be useful in the treatment of both the neuropathologic and symptomatic aspects of AD, as well as other neurodegenerative diseases. Recently, a non-ATP-competitive, irreversible GSK-3 inhibitor, Tideglusib, was tested in Phase II studies for AD.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">GSK-3 inhibitors have also been studied as potential agents for the treatment of mood disorders<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and metabolic diseases, such as type II diabetes<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and bone density improvement.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Looming over these attractive opportunities for therapeutic intervention has been the perceived risk of hyperplasia resulting from interference in one of GSK-3’s most prominent roles: phosphorylation of beta-catenin, leading to its eventual destruction in the proteasome.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, over 50 years of clinical experience with lithium for treating bipolar disorder, which is now believed to work through GSK-3 inhibition, firmly establishes that these patients do not have increased cancer risks. Interestingly, several studies have shown an anticancer effect of GSK-3 inhibition, potentiating the effect of standard chemotherapy against a number of tumor types including pancreatic cancer and leukemias.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Initial phase I clinical data has recently been reported for a combination of Pemetrexed with a GSK-3 inhibitor, LY2090314.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Over the past 2 decades, a number of highly diverse classes of GSK-3 inhibitors have been discovered.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Representative GSK-3 inhibitors are shown in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. SB-216763 (<b>1</b>) was an early maleimide derivative that showed reduction of tau hyperphosphorylation in rat brain.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Another maleimide derivative, BIP-135 (<b>2</b>), has recently shown activity in models of bipolar disorder and spinal muscular atrophy.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>3</b> showed a good brain/plasma (b/p) ratio and reduced tau hyperphosphorylation <i>in vivo</i>.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Compound <b>4</b> was disclosed in 2009 as a potent and selective GSK-3 inhibitor that inhibited tau phosphorylation in rat primary neuronal cells and mouse brain tissue.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compounds <b>5</b>–<b>7</b> were recently disclosed to be brain-penetrable, but no efficacy data has so far been reported.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> Unfortunately, most GSK-3 inhibitors that are claimed to be selective have only been tested against a limited set of kinases. We believe that when targeting such a critical regulatory enzyme such as GSK-3, especially for a nononcology indication, kinase selectivity may be of paramount importance.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected GSK-3 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a recent publication, we disclosed a series of GSK-3 inhibitors, exemplified by compound <b>8</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Modeling and X-ray structural studies showed that the left-side aminopyridine bound to the hinge region of GSK-3 and the right-side amide carbonyl made a hydrogen bond with Lys-85 (K85). We were interested in replacing the lactam with pyridine, in which the pyridyl nitrogen would act as the H-bond acceptor, which might improve CNS penetration. To further simplify the synthesis and to give the rigid tricyclic scaffold a bit more flexibility, we also replaced the pyrrole portion with an amide group (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the 3-pyridinyl isonicotinamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The proposed isonicotinamides were synthesized by two general strategies (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). In the initial approach, commercial isonicotinic acid dichloride was reacted with various 3-aminopyridines to generate the 2-chloroisonicotinamide intermediates, which were then subjected to Buchwald amidation without purification<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> to afford the desired products. For broader structural diversity or larger scale reactions, we developed a second, more convergent approach. Starting with 2-amino isonicotinic acid or its methyl ester, monoacylation of the amino group was not feasible (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Instead, double acylation and the formation of the mixed anhydride always occurred. To solve this issue, methyl 2-amino isonicotinate was treated with excess acyl chloride (2.1 equiv) to afford the bis-acylated intermediate <b>9</b>. Subsequent treatment with 4 equiv of aqueous LiOH achieved complete conversion to the monoacylated acid <b>10</b>, which upon neutralization with 4 equiv of aqueous HCl precipitated out as a white solid. The acid could directly react with many 3-aminopyridines under various amide formation conditions or be converted to the acyl chloride to react with more electron-deficient 3-aminopyridines.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Pyridinyl Isonicotinamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, rt, 18 h; (b) cyclopropanecarboxyamide, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Xantphos, dioxane, 150 °C, 2 h; (c) cyclopropanecarbonyl chloride (2.1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, 0 °C, 1 h (88%); (d) LiOH (4 equiv), THF–MeOH (10:1), rt, 18 h (79%); (e) 3-aminopyridine, HATU, DMF, rt (or 85 °C), <i>i</i>-Pr<sub>2</sub>NEt, 18–48 h; (f) oxalyl chloride (1.2 equiv), DMF (cat.), rt, 30 min, then 3-aminopyridine, Et<sub>3</sub>N, rt, 2 h.</p></p></figure><div class="NLM_p">Compounds were initially tested in GSK-3β/α competition assays (GSK-3β/α IC<sub>50</sub>) with a fluorescently labeled small molecule at its <i>K</i><sub>d</sub> as well as in a cellular phosphorylated Tau (pTau) lowering assay (pTau IC<sub>50</sub>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> While a modest level of isoform selectivity was often seen with particular compounds in the enzyme assay, none of the compounds described herein could be described as truly selective in this respect. We also developed a similar assay in a vinblastine-resistant carcinoma (KBV) cell line that overexpresses human tau protein. Testing compounds with or without the P-glycoprotein (Pgp) inhibitor tariquidar allowed us to assess Pgp-related efflux. A resulting KBV ratio > 2 would suggest a low chance of significant brain penetration.</div><div class="NLM_p">Data for an initial set of isonicotinamides is shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. To our delight, the unsubstituted pyridine <b>11</b> showed good enzymatic inhibition of GSK-3. Various substitutions at the 4-position were well-tolerated and usually improved enzyme inhibition and cell potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GSK-3β/α Affinity and pTau for Compounds <b>11</b>–<b>18</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GSK-3β/α<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pTau IC<sub>50</sub>(nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">KBV ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">24(±3.0)/3.9</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">37(±9.4)/34</td><td class="colsep0 rowsep0" align="left">1600</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">2-OH</td><td class="colsep0 rowsep0" align="left">490(±100)/210</td><td class="colsep0 rowsep0" align="left">10 000</td><td class="colsep0 rowsep0" align="left">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="left">51(±18)/43</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">3.4(±0.42)/4.5</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">11(±2.1)/4.5</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">19(±2.5)/6.3</td><td class="colsep0 rowsep0" align="left">960</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">4-Ph</td><td class="colsep0 rowsep0" align="left">9.8(±3.6)/5.5</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">1.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are means of at least three experiments, but data for GSK-3α was not repeated.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Values are means of at least two experiments.</p></div></div></div><div class="NLM_p">The proposed binding model for this series of compounds was confirmed by solving the X-ray co-crystal structures of select inhibitors with GSK-3β.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> shows the details of key interactions observed with compound <b>15</b> binding in the active site, with respect to ADP.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The 2-aminopyridine makes hydrogen bonds with the hinge V135 backbone amide, and the 3-aminopyridine sp<sup>2</sup> nitrogen forms a key hydrogen bond with the K85 amine. Comparison with bound ADP suggested the 4-position of the 3-aminopyridine as a suitable vector to target the sugar pocket to optimize the potency and PK properties of this class of compounds. The bound structures also indicated that positions 4- and possibly 5- of the 3-aminopyridine should be more accessible for substitution than the more sterically crowded 2- and 6-positions. Two conserved structural water molecules observed in the back pocket were found to effectively bridge compound <b>15</b> through the central carbonyl oxygen.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of compound <b>15</b> in the kinase domain of GSK-3β overlaid onto the X-ray structure of ADP bound GSK-3β complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1C">1J1C</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The ligands are rendered as a stick model in green carbons for ADP and magenta carbons for compound <b>15</b>. Image was prepared using PyMOL.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 4-methyl ether compound <b>15</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) significantly increased GSK-3 inhibition and cellular pTau lowering. We then further explored the SAR with regard to the alkoxy group. Various 4-alkoxy-3-pyridylamine intermediates were prepared as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. While direct substitution of the chloride by primary alcohols or phenol was straightforward, secondary alcohols such as <i>i</i>-PrOH failed. On the other hand, Mitsunobu coupling worked smoothly with 2-propanol followed by reduction of the nitro group via hydrogenation to afford the intermediate for compound <b>20</b>. The final compounds were prepared following the general sequence described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Alkoxy-pyridin-3-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alcohol/phenol, DMF, K<sub>2</sub>CO<sub>3</sub>, 65 °C, 18 h; (b) Pd/C/hydrogen (1 atm), MeOH; (c) <i>i</i>-PrOH, Ph<sub>3</sub>P, DIAD, rt, 5 h.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, all ether derivatives demonstrated single-digit nanomolar binding affinity toward GSK-3. In particular, the neopentyl ether <b>23</b> showed subnanomolar inhibition and very potent cellular pTau lowering (IC<sub>50</sub> = 36 nM). Unfortunately, the two most potent compounds in the cell assay, <b>23</b> and <b>24</b>, had poor metabolic stability, particularly in rodent liver microsomes (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The hydroxyethyl ether <b>25</b> had good potency and metabolic stability, but it had a high KBV efflux ratio (3.8). Data for compounds <b>15</b>, <b>19</b>, <b>21</b>, and <b>22</b> supported further profiling.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Data for Compounds <b>15</b> and <b>19</b>–<b>25</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0015.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GSK-3β/α<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pTau IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">KBV ratio</th><th class="colsep0 rowsep0" align="center">met. stab. (M/R/H)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">3.4(±0.42)/4.5</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">59/82/92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.5(±0.98)/2.2</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">57/90/100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">O<sup><i>i</i></sup>Pr</td><td class="colsep0 rowsep0" align="left">1.9(±0.81)/1.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0/23/65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">4.0(±1.3)/2.7</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">13/65/89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">OPh</td><td class="colsep0 rowsep0" align="left">4.2(±1.1)/1.1</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">15/69/97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">1.0(±1.1)/0.74</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">0/1/29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>-Cyclopropyl</td><td class="colsep0 rowsep0" align="left">2.4(±0.86)/1.8</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0/35/81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">4.2(±0.55)/3.2</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">50/80/88</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values are means of at least three experiments, but data for GSK-3α was not repeated.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Values are means of at least two experiments.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Values are percentage remaining after 10 min with 0.5 μM compound incubated in liver microsomes.</p></div></div></div><div class="NLM_p">Since we were targeting some level of chronic inhibition of GSK-3, a master regulatory kinase, we considered a high degree of selectivity over off-target kinases to be highly desirable. For broad kinase screening, we utilized the Ambit panel of almost 400 kinases, where selected compounds were tested at 1 μM.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> As represented by the Ambit radial graphs shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the pyrrolopyridinone <b>8</b> had very poor kinase selectivity, whereas the isonicotinamide methyl ether <b>15</b> was dramatically improved. These results were in agreement with IC<sub>50</sub> data from a smaller in-house panel of 30 kinases, which were generally greater than the concentrations tested at 2 or 50 μM.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ambit radial graphs of compounds <b>8</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and <b>15</b>. This is a single-point assay panel with a control for each kinase. Each line represents remaining activity of a single kinase in the presence of 1 μM test compound. Starting from the center, the circles denote 83, 33, and 0% of control binding remaining.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The kinases are grouped into families differing by line color. As shown for <b>15</b>, the two teal lines at nearly 0% represent GSK-3α and β.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We decided to explore SAR around the phenyl group of compound <b>18</b>. These analogues were prepared by Suzuki coupling with a common iodide intermediate <b>26</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), which was prepared from the carboxylic acid <b>10</b>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>27</b>–<b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride (1.2 equiv), DMF (cat.), 0 °C, 2 h, then 4-iodopyridin-3-amine, Et<sub>3</sub>N, 0 °C to rt; (b) aryl boronic acid, Na<sub>2</sub>CO<sub>3</sub> (2.0 M), Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 110 °C (microwave), 30 min.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, a single fluorine was well-tolerated at the 4-position (<b>29</b>) but less so at the 2- and 3-positions (<b>27</b> and <b>28</b>). Other 4-substituted analogues (<b>29</b>–<b>36</b>) showed good enzyme and cell potencies with the exception of the <i>t</i>-butyl compound (<b>36</b>). Generally poor rodent metabolic stability was seen for most examples, but several showed promising human stability. Nitrile <b>32</b> looked good with respect to metabolic stability; however, as with other examples such as <b>25</b> in which polarity was introduced in this region, it was a strong Pgp substrate. The 2-CF<sub>3</sub> and 2-Cl derivatives, as well as various 2,4-disubstituted analogues (<b>37</b>–<b>43</b>), showed improved GSK-3 activities but had very poor metabolic stability. No advantage was seen with 2,5- or 2,3-difluoro substitution (<b>44</b> and <b>45</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Data for Compounds <b>18</b> and <b>27</b>–<b>45</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0016.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GSK-3β/α<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pTau IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">KBV ratio</th><th class="colsep0 rowsep0" align="center">met. stab. (M/R/H)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.8(±3.6)/5.5</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">50/88/93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">13(±4.2)/3.3</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">33/85/86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">16(±11)/–</td><td class="colsep0 rowsep0" align="left">480</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">40/76/75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">5.2(±2.2)/1.7</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">61/85/72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">2.1(±0.95)/0.45</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">14/64/51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">4-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">11(±3.5)/6.9</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">36/74/44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">4.7(±1.3)/1.9</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">69/90/88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">5.9(±2.7)/2.0</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">64/89/76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">4-OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">5.9(±2.3)/3.1</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">39/75/0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">4.7(±1.6)/1.1</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">3/33/25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">4-<i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">19(±8.9)/19</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">0/15/1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.0(±0.69)/0.66</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0/4/7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3.7(±1.1)/0.88</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1/27/16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">2,4-F<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1.9(±1.2)/0.34</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">48/87/66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2.2(±1.2)/2.1</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">8/41/22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">2-Cl-4-F</td><td class="colsep0 rowsep0" align="left">1.2(±1.1)/0.28</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">2/32/34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>-4-F</td><td class="colsep0 rowsep0" align="left">0.87(±1.2)/0.17</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0/11/13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">2-F-4-Cl</td><td class="colsep0 rowsep0" align="left">2.8(±0.91)/1.2</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">0.91</td><td class="colsep0 rowsep0" align="left">36/80/63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">2,5-F<sub>2</sub></td><td class="colsep0 rowsep0" align="left">20(±5.4)/15</td><td class="colsep0 rowsep0" align="left">770</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">30/63/82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">2,3-F<sub>2</sub></td><td class="colsep0 rowsep0" align="left">10(±4.8)/6.4</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">29/62/52</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are means of at least three experiments, but data for GSK-3α was not repeated.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Values are means of at least two experiments.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Values are percentage remaining after 10 min with 0.5 μM compound incubated in liver microsomes.</p></div></div></div><div class="NLM_p">Ambit screening with almost 400 kinases of the phenyl compounds, <b>18</b>, <b>29</b>, and <b>33</b>, showed them to have excellent kinase selectivity (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> These compounds showed appreciable inhibitory activity, at least in these assays, only to the two GSK-3 isoforms.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ambit radial graphs for compounds <b>18</b>, <b>29</b>, and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It appears that a combination of the central amide linker, which participates in water-mediated hydrogen bonding in the rear of the ATP pocket, and the strongly tilted 4-phenyl group occupying the large sugar pocket in GSK-3β are primarily responsible for the high degree of kinase selectivity observed. Notably, the back pocket region of kinases varies in size and shape partly due to the nonconserved nature of the gate keeper residue. Also, the hydrophilic sugar pocket has been used to achieve selectivity,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> as the residues that make up this pocket are also not highly conserved. A surface representation of <b>18</b> bound in the GSK-3β kinase domain (2.9 Å) is shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. The modeled water-mediated hydrogen bond network proposed for this class of compounds is also shown in the inset.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Surface representation of compound <b>18</b> bound to the ATP-binding site of GSK-3β showing the 4-phenyl group of the 3-aminopyridine occupying the sugar pocket. The two conserved structural water molecules that were not detected in the X-ray structure of GSK-3β–compound <b>18</b> complex most likely due to the low resolution (3.0 Å) were modeled and are shown in the inset.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with their favorable cellular KBV ratios, compounds <b>18</b> and <b>33</b>, had very good Caco-2 permeabilities with no observed active efflux (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In addition, both compounds showed excellent inherent bilayer permeability in the PAMPA assay.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Permeability Data for Compounds <b>18</b> and <b>33</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Caco-2 <i>P</i><sub>c</sub> A–B, nm/s</th><th class="colsep0 rowsep0" align="center">Caco-2 <i>P</i><sub>c</sub> B–A, nm/s</th><th class="colsep0 rowsep0" align="center">efflux ratio</th><th class="colsep0 rowsep0" align="center">PAMPA <i>P</i><sub>c</sub> (pH 7.4), nm/s</th><th class="colsep0 rowsep0" align="center">PAMPA <i>P</i><sub>c</sub> (pH 5.5), nm/s</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">319</td><td class="colsep0 rowsep0" align="left">301</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">483</td><td class="colsep0 rowsep0" align="left">526</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">354</td><td class="colsep0 rowsep0" align="left">279</td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="left">1260</td><td class="colsep0 rowsep0" align="left">904</td></tr></tbody></table></div></div><div class="NLM_p">We tested selected compounds in a triple-transgenic mouse AD model.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> These mice show elevated pTau levels and develop mild functional deficits, plaques, and tangles that are hallmarks of AD. It is important to note that, when tested, these compounds showed very high clearance in mice (for compound <b>29</b>, Cl = 133 mL/min/kg, or >100% of hepatic blood flow), primarily due to facile hydrolysis of the pyridyl-2-aminocarboxamide and pyridyl N-oxidation of the 3-aminopyridine. When incubated in mouse serum at 37 °C, 24% amide cleavage from compound <b>18</b> was observed over 3 h, whereas only trace levels were detected in human serum. No degradants from cleavage of the core amide were seen. Less rapid <i>in vivo</i> clearance was seen for compound <b>18</b> in rat (24 mL/min/kg) and dog (9.6 mL/min/kg). We believe that this rapid clearance in mice resulted in a high degree of variability seen in plasma and brain exposures of compounds dosed po in these studies<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and limits the extent of PK/PD interpretation possible in this species. In addition, compound <b>18</b> had IC<sub>50</sub>’s all higher than 20 μM in the CYP panel and higher than 80 μM in the hERG flux assay.</div><div class="NLM_p">Compound <b>18</b> showed significant activity at 30 mg/kg po in two independent studies in this model (results for one study are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The effect was comparable to the maximal pTau reduction achievable with LiCl at its MTD (250 mg/kg) and persisted to 24 h (pTau levels shown are normalized to total Tau). It is important to note that the maximal pTau reduction achievable with GSK-3 inhibition in this model is 50%, presumably due to the action of other kinases. Only a trend toward activity was seen at 3 and 10 mg/kg. Similar results were obtained with compound <b>29</b> (data not shown). In the same model, the alkoxyphenyl compounds, <b>15</b>, <b>19</b>, <b>21</b>, and <b>22</b>, were inactive at 30 mg/kg po. Subsequent studies showed <b>18</b> to have somewhat robust but variable brain exposures (440 ± 362 nM at 2 h) and a b/p ratio of 0.2–0.3.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The alkoxy analogues, on the other hand, demonstrated poor oral exposures and no detectable brain levels (e.g., compound <b>21</b> had plasma exposure of 47 nM at 30 mg/kg, po).</div><div class="NLM_p">In two separate time-course/dose–response studies, compound <b>33</b> showed significant activity at 10 and 30 mg/kg, po, at various time points (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). At 1 and 3 mg/kg, significant activity was also seen at 2 h. Brain-to-plasma levels were higher in comparison with those for <b>18</b> (≥0.5), but interanimal variability was large, complicating interpretation.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response (3, 10 mg/kg at 5 h) and time course (30 mg/kg) of <b>18</b> in the triple-transgenic mouse AD model.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The blue bar represents vehicle only, and the red bar shows maximum pTau reduction by LiCl (250 mg/kg ip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response of <b>33</b> at 1, 3, 10, and 30 mg/kg po and time course at both 10 and 30 mg/kg po in the mouse AD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have discovered a novel class of potent GSK-3 inhibitors such as <b>18</b>, <b>29</b>, and <b>33</b> that show remarkable kinase selectivity in broad panel screening. Despite high <i>in vivo</i> clearance, these compounds showed good <i>in vivo</i> activity, lowering pTau levels in a triple-transgenic AD mouse model. With their very high level of kinase selectivity, radiolabeled versions of these molecules would be useful tools in further studies. These and further SAR studies around this chemotype will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Chemistry Details</h3><div class="NLM_p">All commercially available reagents and solvents were used without further purification unless otherwise stated. All reactions were carried out under an inert atmosphere of dry nitrogen in oven- or flame-dried glassware unless otherwise stated. Flash column chromatography was performed using 40–60 μm silica gel 60 (EMD Chemicals, Inc.) as the stationary phase or prepacked columns from ISCO Inco., Biotage, or Thomson Instrument Co. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 or 500 MHz machine with tetramethylsilane or residual protiated solvent used as a reference. <sup>13</sup>C NMR were recorded on a Bruker DRX-500 instrument operating at 125 MHz with residual <sup>12</sup>C solvent used as a reference. Low-resolution mass spectra were recorded using a Waters Micromass ZQ with electrospray ionization. High-resolution mass spectra were recorded using a Waters Micromass LCT time-of-flight mass spectrometer with electrospray ionization. The purity of all compounds was determined by either liquid chromatography–mass spectrometry (LCMS) or analytical HPLC and was confirmed to be greater than 95%.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2-Chloro-<i>N</i>-(pyridin-3-yl)isonicotinamide (<b>11i</b>)</h4><div class="NLM_p last">In a 10 mL round-bottomed flask was dissolved 2-chloroisonicotinoyl chloride (227.3 mg, 1.291 mmol) in methylene chloride to give a colorless solution. Pyridin-3-amine (134 mg, 1.42 mmol) was added, and a precipitate formed. Hunig’s base (0.248 mL, 1.421 mmol) was added, and all solids were dissolved. The mixture was stirred at rt for 18 h. The mixture was purified by flash column chromatography using silica gel and eluting with a gradient up to 8% methanol/methylene chloride, affording the desired product (248.4 mg, 82%) as a white solid: MS (ESI) (<i>m</i>/<i>z</i>): 234 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (d, <i>J</i> = 2.5 Hz, 1H), 8.62 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 8.47 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H), 8.30 (d, <i>J</i> = 7.5 Hz, 1H), 8.20 (s, 1H), 7.85–7.79 (m, 1H), 7.69 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.40 (dd, <i>J</i> = 8.3, 4.8 Hz, 1H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2-Chloro-<i>N</i>-(4-methoxypyridin-3-yl)isonicotinamide (<b>15i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 264 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.41 (s, 1H), 8.58 (s, 1H), 8.52 (d, <i>J</i> = 5.1 Hz, 1H), 8.29 (d, <i>J</i> = 5.6 Hz, 1H), 7.75 (s, 1H), 7.63 (dd, <i>J</i> = 5.1, 1.4 Hz, 1H), 6.86 (d, <i>J</i> = 5.6 Hz, 1H), 3.97 (s, 3H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-Chloro-<i>N</i>-(4-phenylpyridin-3-yl)isonicotinamide (<b>18i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 310 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-Chloro-<i>N</i>-(4-(2,2,2-trifluoroethoxy)pyridin-3-yl)isonicotinamide (<b>19i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 332 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-Chloro-<i>N</i>-(4-isopropoxypyridin-3-yl)isonicotinamide (<b>20i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 292 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.33 (s, 1H), 8.64 (s, 1H), 8.47 (dd, <i>J</i> = 5.1, 0.5 Hz, 1H), 8.20 (d, <i>J</i> = 5.6 Hz, 1H), 7.70 (d, <i>J</i> = 0.7 Hz, 1H), 7.56 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 6.80 (d, <i>J</i> = 5.7 Hz, 1H), 4.70 (hept, <i>J</i> = 6.1 Hz, 1H), 1.37 (d, <i>J</i> = 6.1 Hz, 6H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-Chloro-<i>N</i>-(4-ethoxypyridin-3-yl)isonicotinamide (<b>21i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 278 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.51 (s, 1H), 8.61–8.55 (m, 1H), 8.41 (br. s., 1H), 8.32 (d, <i>J</i> = 5.5 Hz, 1H), 7.80–7.75 (m, 1H), 7.62 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 6.86 (d, <i>J</i> = 5.5 Hz, 1H), 4.25 (q, <i>J</i> = 7.0 Hz, 2H), 1.53 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-Chloro-<i>N</i>-(4-(cyclopropylmethoxy)pyridin-3-yl)isonicotinamide (<b>24i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 304 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.39 (s, 1H), 8.65 (s, 1H), 8.51 (dd, <i>J</i> = 5.1, 0.5 Hz, 1H), 8.24 (d, <i>J</i> = 5.6 Hz, 1H), 7.74 (d, <i>J</i> = 0.7 Hz, 1H), 7.60 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 6.80 (d, <i>J</i> = 5.6 Hz, 1H), 3.96 (d, <i>J</i> = 7.1 Hz, 2H), 1.38–1.23 (m, 1H), 0.72–0.63 (m, 2H), 0.40–0.33 (m, 2H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-Chloro-<i>N</i>-(4-(2-hydroxyethoxy)pyridin-3-yl)isonicotinamide (<b>25i</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 294 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, MeOD) δ 9.06 (s, 1H), 8.57 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 8.29 (d, <i>J</i> = 5.8 Hz, 1H), 7.95 (d, <i>J</i> = 0.7 Hz, 1H), 7.84 (dd, <i>J</i> = 5.2, 1.5 Hz, 1H), 7.15 (d, <i>J</i> = 5.8 Hz, 1H), 4.30–4.24 (m, 2H), 4.01–3.94 (m, 2H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(pyridin-3-yl)isonicotinamide (<b>11</b>)</h4><div class="NLM_p last">To a 5 mL microwave tube under a nitrogen atmosphere were added <b>11i</b> (50.5 mg, 0.216 mmol), cyclopropanecarboxamide (55.2 mg, 0.648 mmol), and potassium carbonate (44.8 mg, 0.324 mmol) in dioxane (2 mL) (degassed) to give a colorless suspension. Pd(OAc)<sub>2</sub> (7.28 mg, 0.032 mmol) and Xantphos (37.5 mg, 0.065 mmol) were added. The vial was sealed and heated at 150 °C for 2 h. Volatile components were removed <i>in vacuo</i>. The residue was suspended in 3 mL of dimethylformamide and filtered. The solution was purified by prep-HPLC to afford the desired product (5 mg, 8%): MS (ESI) (<i>m</i>/<i>z</i>): 283 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.06 (s, 1H), 10.74 (s, 1H), 8.92 (d, <i>J</i> = 2.4 Hz, 1H), 8.55 (s, 1H), 8.53 (d, <i>J</i> = 5.0 Hz, 1H), 8.36 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 8.19 (ddd, <i>J</i> = 8.3, 2.5, 1.5 Hz, 1H), 7.57 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.43 (ddd, <i>J</i> = 8.3, 4.7, 0.6 Hz, 1H), 2.14–1.99 (m, 1H), 0.93–0.81 (m, 4H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-methoxypyridin-3-yl)isonicotinamide (<b>15</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 313 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 10.07 (s, 1H), 8.57 (s, 1H), 8.54 (s, 1H), 8.50 (d, <i>J</i> = 5.0 Hz, 1H), 8.38 (d, <i>J</i> = 5.6 Hz, 1H), 7.57 (d, <i>J</i> = 4.5 Hz, 1H), 7.19 (d, <i>J</i> = 5.7 Hz, 1H), 3.90 (s, 3H), 2.05 (tt, <i>J</i> = 6.9, 5.5 Hz, 1H), 0.92–0.80 (m, 4H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-phenylpyridin-3-yl)isonicotinamide (<b>18</b>)</h4><div class="NLM_p last">HRMS (ESI) (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>19</sub>O<sub>2</sub>N<sub>4</sub>, 359.1503 (M + H)<sup>+</sup>; found, 359.1492; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.46 (s, 1H), 8.63 (s, 1H), 8.58 (d, <i>J</i> = 5.0 Hz, 1H), 8.46 (d, <i>J</i> = 4.5 Hz, 2H), 7.55–7.48 (m, 3H), 7.48–7.43 (m, 2H), 7.40 (tt, <i>J</i> = 6.2, 1.4 Hz, 2H), 2.04 (tt, <i>J</i> = 7.1, 5.3 Hz, 1H), 0.90–0.80 (m, 4H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2,2,2-trifluoroethoxy)pyridin-3-yl)isonicotinamide (<b>19</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 381 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, MeOD) δ 11.83 (s, 1H), 11.01 (s, 1H), 9.34 (s, 2H), 9.32 (d, <i>J</i> = 5.2 Hz, 1H), 9.25 (d, <i>J</i> = 5.7 Hz, 1H), 8.33 (d, <i>J</i> = 4.3 Hz, 1H), 8.13 (d, <i>J</i> = 5.7 Hz, 1H), 5.76 (q, <i>J</i> = 8.7 Hz, 2H), 2.85 (dq, <i>J</i> = 6.6, 5.7 Hz, 1H), 1.69–1.64 (m, 4H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-isopropoxypyridin-3-yl)isonicotinamide (<b>20</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 341 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.03 (s, 1H), 9.86 (s, 1H), 8.60 (s, 1H), 8.55 (s, 1H), 8.51 (d, <i>J</i> = 5.1 Hz, 1H), 8.32 (d, <i>J</i> = 5.6 Hz, 1H), 7.54 (s, 1H), 7.18 (d, <i>J</i> = 5.8 Hz, 1H), 4.80 (dt, <i>J</i> = 12.1, 6.0 Hz, 1H), 2.10–2.01 (m, 1H), 1.31 (d, <i>J</i> = 6.0 Hz, 6H), 0.90–0.84 (m, 4H).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-ethoxypyridin-3-yl)isonicotinamide (<b>21</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 327 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.58 (s, 1H), 8.70 (s, 1H), 8.50–8.41 (m, 3H), 8.35 (d, <i>J</i> = 5.5 Hz, 1H), 7.59 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 6.87 (d, <i>J</i> = 5.5 Hz, 1H), 4.24 (q, <i>J</i> = 7.0 Hz, 2H), 1.67–1.60 (m, 1H), 1.59–1.54 (m, 3H), 1.17–1.12 (m, 2H), 0.99–0.94 (m, 2H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(cyclopropylmethoxy)pyridin-3-yl)isonicotinamide (<b>24</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 353 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.03 (s, 1H), 9.98 (s, 1H), 8.57 (s, 2H), 8.51 (d, <i>J</i> = 5.1 Hz, 1H), 8.34 (d, <i>J</i> = 5.7 Hz, 1H), 7.56 (d, <i>J</i> = 5.0 Hz, 1H), 7.16 (d, <i>J</i> = 5.7 Hz, 1H), 4.01 (d, <i>J</i> = 6.8 Hz, 2H), 2.10–1.98 (m, 1H), 1.27–1.23 (m, 1H), 0.86 (d, <i>J</i> = 6.1 Hz, 4H), 0.59–0.51 (m, 2H), 0.42–0.32 (m, 2H).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2-hydroxyethoxy)pyridin-3-yl)isonicotinamide (<b>25</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 343 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.04 (s, 1H), 8.75 (s, 1H), 8.54 (s, 1H), 8.51 (d, <i>J</i> = 5.0 Hz, 1H), 8.32 (d, <i>J</i> = 5.6 Hz, 1H), 7.55 (d, <i>J</i> = 4.4 Hz, 1H), 7.19 (d, <i>J</i> = 5.7 Hz, 1H), 4.16 (t, <i>J</i> = 4.8 Hz, 2H), 3.78–3.71 (m, 2H), 2.06 (s, 1H), 0.91–0.85 (m, 4H).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-(<i>N</i>-(Cyclopropanecarbonyl)cyclopropanecarboxamido)isonicotinate (<b>9</b>)</h4><div class="NLM_p last">Cyclopropanecarbonyl chloride (3.79 mL, 41.4 mmol) was added to a solution of methyl 2-aminoisonicotinamide (3.0 g, 19.72 mmol) and Hünig’s base (7.23 mL, 41.4 mmol) in methylene chloride (150 mL) at 0 °C. The reaction was stirred at 0 °C for 1 h before quenching with water. The mixture was diluted with methylene chloride and washed with NaHCO<sub>3</sub> (sat.) and water. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Flash column chromatography, eluting with ethyl acetate in hexane (0–50%), afforded the desired product (4.99 g, 88%) as a white solid: MS (ESI) (<i>m</i>/<i>z</i>): 311 (M + Na)<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(Cyclopropanecarboxamido)isonicotinic Acid (<b>10</b>)</h4><div class="NLM_p last">A mixture of LiOH (8.65 mL, 69.2 mmol, 8 M in water) and <b>9</b> (4.99 g, 17.31 mmol) in tetrahydrofuran (20 mL) and methanol (2 mL) was stirred at room temperature for 18 h. The volatile components were removed <i>in vacuo</i>, and the residue was acidified by adding 1 N HCl. The solid was filtered and washed with water. The white solid was used without further purification after drying under high vacuum for several hours (2.81 g, 79%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 8.56 (s, 1H), 8.48 (dd, <i>J</i> = 5.3, 0.8 Hz, 1H), 7.51 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 2.06–1.98 (m, 1H), 0.88–0.81 (m, 4H).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-phenoxypyridin-3-yl)isonicotinamide (<b>22</b>)</h4><div class="NLM_p last">To a 5 mL round-bottomed flask was added <b>10</b> (34 mg, 0.165 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) to give a white suspension. DMF (2.55 μL, 0.033 mmol) (one drop) and oxalyl chloride (0.017 mL, 0.198 mmol) were added. The mixture was stirred at rt for 30 min. 4-Phenoxypyridin-3-amine (30.7 mg, 0.165 mmol) and Et<sub>3</sub>N (0.069 mL, 0.495 mmol) were added. The mixture was stirred at rt overnight. The reaction mixture was concentrated, redissolved in 1.5 mL of MeOH, and purified by prep-HPLC to afford the desired product (21.3 mg, 35%): MS (ESI) (<i>m</i>/<i>z</i>): 375 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 10.41 (s, 1H), 8.71 (s, 1H), 8.55 (s, 1H), 8.52–8.43 (m, 1H), 8.34 (d, <i>J</i> = 5.6 Hz, 1H), 7.54–7.50 (m, 1H), 7.50–7.45 (m, 2H), 7.31–7.25 (m, 1H), 7.20–7.15 (m, 2H), 6.79 (d, <i>J</i> = 5.6 Hz, 1H), 2.09–1.99 (m, 1H), 0.88–0.79 (m, 4H).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(trifluoromethyl)pyridin-3-yl)isonicotinamide (<b>17</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 351 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.04 (s, 1H), 10.80–10.64 (s,br, 1H), 8.85 (s, 1H), 8.78 (d, <i>J</i> = 4.9 Hz, 1H), 8.59 (s, 1H), 8.53 (d, <i>J</i> = 5.2 Hz, 1H), 7.85 (d, <i>J</i> = 4.9 Hz, 1H), 7.56 (dd, <i>J</i> = 5.0, 1.4 Hz, 1H), 2.12–2.01 (m, 1H), 0.92–0.82 (m, 4H).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(neopentyloxy)pyridin-3-yl)isonicotinamide (<b>23</b>)</h4><div class="NLM_p last">To a 5 mL vial were added 4-(neopentyloxy)pyridin-3-amine (24 mg, 0.133 mmol) and <b>10</b> (27.5 mg, 0.133 mmol) in DMF (1 mL) to give a tan solution. HATU (101 mg, 0.266 mmol) and Hunig’s base (0.047 mL, 0.266 mmol) were added, and the mixture was stirred at rt for 18 h. The reaction mixture was purified by prep-HPLC to afford the desired product (32 mg, 65%): MS (ESI) (<i>m</i>/<i>z</i>): 369 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, 1H), 9.97 (s, 1H), 8.56 (s, 1H), 8.51 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 8.49 (s, 1H), 8.36 (d, <i>J</i> = 5.6 Hz, 1H), 7.53 (dd, <i>J</i> = 5.1, 1.4 Hz, 1H), 7.16 (d, <i>J</i> = 5.7 Hz, 1H), 3.77 (s, 2H), 2.12–1.99 (m, 1H), 0.96 (s, 9H), 0.90–0.83 (m, 4H).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(2-fluoropyridin-3-yl)isonicotinamide (<b>12</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 301 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.06 (s, 1H), 10.61 (s, 1H), 8.57 (d, <i>J</i> = 0.5 Hz, 1H), 8.53 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 8.20 (ddd, <i>J</i> = 9.6, 7.8, 1.7 Hz, 1H), 8.15–8.09 (m, 1H), 7.56 (dd, <i>J</i> = 5.1, 1.6 Hz, 1H), 7.48–7.40 (m, 1H), 2.11–2.00 (m, 1H), 0.92–0.81 (m, 4H).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(2-hydroxypyridin-3-yl)isonicotinamide (<b>13</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 299 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.18 (s, 1H), 11.08 (s, 1H), 9.44 (s, 1H), 8.61–8.44 (m, 2H), 8.30 (dd, <i>J</i> = 7.3, 1.8 Hz, 1H), 7.51 (dd, <i>J</i> = 5.1, 1.6 Hz, 1H), 7.23 (dd, <i>J</i> = 6.6, 1.8 Hz, 1H), 6.42–6.22 (m, 1H), 2.05 (dq, <i>J</i> = 7.5, 5.0 Hz, 1H), 0.93–0.81 (m, 4H).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(2-cyanopyridin-3-yl)isonicotinamide (<b>14</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 308 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 8.62 (s, 1H), 8.51 (d, <i>J</i> = 4.9 Hz, 2H), 8.21 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 7.73 (dd, <i>J</i> = 8.4, 4.6 Hz, 1H), 7.64 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 2.09–1.99 (m, 1H), 0.91–0.81 (m, 4H).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-iodopyridin-3-yl)isonicotinamide (<b>26</b>)</h4><div class="NLM_p last">To a 250 mL round-bottomed flask was added <b>10</b> (776.5 mg, 3.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) to give a white suspension. After cooling to 0 °C, DMF (0.029 mL, 0.377 mmol) and oxalyl chloride (0.363 mL, 4.14 mmol) were added. The mixture was stirred at 0 °C for 2 h. LCMS showed the desired chloride (as methyl ester form). 4-Iodopyridin-3-amine (829 mg, 3.77 mmol) was added at 0 °C, followed by Et<sub>3</sub>N (2.1 mL, 15.06 mmol). The mixture became clear to a tan solution. It was concentrated to a tan oil. The residue was purified by FCC up to 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> (contains 1% AcOH). The product peak was pooled and concentrated to a tan solid (100%), which was used without further characterization.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(4-Chloropyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>16</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 317 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.60 (s, 1H), 8.76 (s, 1H), 8.71 (d, <i>J</i> = 0.7 Hz, 1H), 8.49 (dd, <i>J</i> = 5.1, 0.7 Hz, 1H), 8.42 (s, 1H), 8.38 (d, <i>J</i> = 5.3 Hz, 1H), 7.59 (dd, <i>J</i> = 5.1, 1.6 Hz, 1H), 7.42 (d, <i>J</i> = 5.2 Hz, 1H), 1.69–1.58 (m, 1H), 1.20–1.13 (m, 2H), 1.00–0.93 (m, 2H).</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2-fluorophenyl)pyridin-3-yl)isonicotinamide (<b>27</b>)</h4><div class="NLM_p last">To a 5 mL microwave tube were added <b>26</b> (36.6 mg, 0.090 mmol), (2-fluorophenyl)boronic acid (20.07 mg, 0.143 mmol), and Na<sub>2</sub>CO<sub>3</sub> (0.134 mL, 0.269 mmol) in dioxane (0.8 mL) to give a tan suspension under nitrogen. 1,1′-Bis(diphenylphosphino)ferrocenepalladium(II) dichloride, toluene (3.69 mg, 4.48 μmol) was added under nitrogen. The vial was sealed and heated at 140 °C for 45 min. It was filtered and purified by prep-HPLC to afford the desired product (7.2 mg, 21%): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, 1H), 10.41 (s, 1H), 8.70 (s, 1H), 8.58 (d, <i>J</i> = 5.0 Hz, 1H), 8.43 (d, <i>J</i> = 5.2 Hz, 1H), 8.40 (s, 1H), 7.49 (d, <i>J</i> = 5.0 Hz, 1H), 7.47–7.38 (m, 2H), 7.35–7.22 (m, 3H), 2.03 (dq, <i>J</i> = 7.1, 5.4 Hz, 1H), 0.89–0.81 (m, 4H).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(3-fluorophenyl)pyridin-3-yl)isonicotinamide (<b>28</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 377 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.47 (s, 1H), 8.66 (s, 1H), 8.59 (d, <i>J</i> = 5.0 Hz, 1H), 8.49–8.43 (m, 2H), 7.52 (d, <i>J</i> = 5.0 Hz, 1H), 7.51–7.44 (m, 1H), 7.40 (d, <i>J</i> = 4.9 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 2H), 7.27–7.21 (m, 1H), 2.08–1.99 (m, 1H), 0.89–0.81 (m, 4H).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-fluorophenyl)pyridin-3-yl)isonicotinamide (<b>29</b>)</h4><div class="NLM_p last">HRMS (ESI) (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>18</sub>O<sub>2</sub>N<sub>4</sub>F, 377.1408 (M + H)<sup>+</sup>; found, 377.1398; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.42 (s, 1H), 8.65 (s, 1H), 8.57 (d, <i>J</i> = 5.0 Hz, 1H), 8.50–8.41 (m, 2H), 7.56 (dd, <i>J</i> = 8.7, 5.5 Hz, 2H), 7.49 (d, <i>J</i> = 5.0 Hz, 1H), 7.40 (d, <i>J</i> = 4.7 Hz, 1H), 7.35–7.24 (m, 2H), 2.10–1.98 (m, 1H), 0.88–0.82 (m, 4H).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-methoxyphenyl)pyridin-3-yl)isonicotinamide (<b>30</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 389 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 10.38 (s, 1H), 8.60 (s, 1H), 8.54 (d, <i>J</i> = 5.0 Hz, 1H), 8.47 (d, <i>J</i> = 5.0 Hz, 2H), 7.47 (dd, <i>J</i> = 9.8, 6.9 Hz, 3H), 7.43 (d, <i>J</i> = 6.2 Hz, 1H), 7.05–7.01 (m, 2H), 3.79 (s, 3H), 2.10–1.96 (m, 1H), 0.91–0.79 (m, 4H).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)isonicotinamide (<b>31</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 443 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 10.46 (s, 1H), 8.71 (s, 1H), 8.61 (d, <i>J</i> = 5.1 Hz, 1H), 8.46 (d, <i>J</i> = 5.2 Hz, 1H), 8.44 (s, 1H), 7.66 (s, 1H), 7.64 (s, 1H), 7.55 (d, <i>J</i> = 5.0 Hz, 1H), 7.48 (s, 1H), 7.46 (s, 1H), 7.38 (d, <i>J</i> = 5.0 Hz, 1H), 2.10–1.98 (m, 1H), 0.92–0.79 (m, 4H).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(4-(4-Cyanophenyl)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>32</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 384 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 10.50 (s, 1H), 8.72 (s, 1H), 8.61 (d, <i>J</i> = 5.0 Hz, 1H), 8.46 (d, <i>J</i> = 5.1 Hz, 1H), 8.40 (s, 1H), 7.95–7.90 (m, 2H), 7.70 (d, <i>J</i> = 8.4 Hz, 2H), 7.53 (d, <i>J</i> = 5.1 Hz, 1H), 7.39 (d, <i>J</i> = 4.0 Hz, 1H), 2.09–1.99 (m, 1H), 0.86 (dtd, <i>J</i> = 8.0, 5.0, 3.1 Hz, 4H).</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(4-(4-Chlorophenyl)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>33</b>)</h4><div class="NLM_p last">HRMS (ESI) (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>18</sub>O<sub>2</sub>N<sub>4</sub>Cl, 393.1113 (M + H)<sup>+</sup>; found,: 393.1104; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 10.44 (s, 1H), 8.67 (s, 1H), 8.58 (d, <i>J</i> = 5.0 Hz, 1H), 8.52–8.40 (m, 2H), 7.56–7.51 (m, 4H), 7.50 (d, <i>J</i> = 5.1 Hz, 1H), 7.41 (d, <i>J</i> = 4.0 Hz, 1H), 2.04 (dq, <i>J</i> = 7.5, 5.0 Hz, 1H), 0.92–0.80 (m, 4H).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-(difluoromethoxy)phenyl)pyridin-3-yl)isonicotinamide (<b>34</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 425 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.42 (s, 1H), 8.66 (s, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.46 (d, <i>J</i> = 5.2 Hz, 1H), 8.43 (s, 1H), 7.59 (d, <i>J</i> = 8.5 Hz, 2H), 7.49 (d, <i>J</i> = 4.9 Hz, 1H), 7.41 (d, <i>J</i> = 5.2 Hz, 1H), 7.31–7.25 (m, 3H), 2.08–1.99 (m, 1H), 0.88–0.82 (m, 4H).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-(methyl)phenyl)pyridin-3-yl)isonicotinamide (<b>35</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 373 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.38 (s, 1H), 8.62 (s, 1H), 8.56 (d, <i>J</i> = 5.0 Hz, 1H), 8.51–8.42 (m, 2H), 7.47 (d, <i>J</i> = 5.0 Hz, 1H), 7.42 (d, <i>J</i> = 7.8 Hz, 3H), 7.27 (d, <i>J</i> = 7.9 Hz, 2H), 2.32 (s, 3H), 2.10–1.99 (m, 1H), 0.90–0.80 (m, 4H).</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(4-(4-(<i>tert</i>-Butyl)phenyl)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>36</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 415 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.38 (s, 1H), 8.65 (s, 1H), 8.55 (d, <i>J</i> = 5.2 Hz, 1H), 8.49–8.43 (m, 2H), 7.54–7.46 (m, 5H), 7.41 (d, <i>J</i> = 4.6 Hz, 1H), 2.08–1.99 (m, 1H), 1.30 (s, 9H), 0.87–0.82 (m, 4H).</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2-(trifluoromethyl)phenyl)pyridin-3-yl)isonicotinamide (<b>37</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 427 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 10.19 (s, 1H), 8.72 (s, 1H), 8.56 (d, <i>J</i> = 4.9 Hz, 1H), 8.39 (d, <i>J</i> = 5.2 Hz, 1H), 8.31 (s, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 7.73–7.67 (m, 1H), 7.65–7.59 (m, 1H), 7.40 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (d, <i>J</i> = 5.2 Hz, 1H), 7.20 (dd, <i>J</i> = 5.0, 1.4 Hz, 1H), 2.05–1.98 (m, 1H), 0.86–0.81 (m, 4H).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2-chlorophenyl)pyridin-3-yl)isonicotinamide (<b>38</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 393 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 10.58 (s, 1H), 8.94 (s, 1H), 8.72 (d, <i>J</i> = 5.2 Hz, 1H), 8.44 (d, <i>J</i> = 5.2 Hz, 1H), 8.37 (s, 1H), 7.71 (d, <i>J</i> = 5.5 Hz, 1H), 7.60–7.56 (m, 1H), 7.48–7.40 (m, 3H), 7.30 (dd, <i>J</i> = 5.2, 1.2 Hz, 1H), 2.03 (quin, <i>J</i> = 6.2 Hz, 1H), 0.86–0.83 (m, 4H).</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2,4-difluorophenyl)pyridin-3-yl)isonicotinamide (<b>39</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 395 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (s, 1H), 10.40 (br. s., 1H), 8.73 (s, 1H), 8.58 (d, <i>J</i> = 4.9 Hz, 1H), 8.45 (d, <i>J</i> = 4.9 Hz, 1H), 8.39 (s, 1H), 7.51–7.43 (m, 2H), 7.39–7.29 (m, 2H), 7.18 (td, <i>J</i> = 8.5, 2.4 Hz, 1H), 2.09–2.00 (m, 1H), 0.89–0.80 (m, 4H).</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2,4-dichlorophenyl)pyridin-3-yl)isonicotinamide (<b>40</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 427 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, 1H), 10.34 (br. s., 1H), 8.77 (s, 1H), 8.58 (d, <i>J</i> = 5.2 Hz, 1H), 8.44 (d, <i>J</i> = 4.9 Hz, 1H), 8.35 (s, 1H), 7.73 (d, <i>J</i> = 1.8 Hz, 1H), 7.51 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.43 (d, <i>J</i> = 5.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.2 Hz, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 1H), 2.06–1.99 (m, 1H), 0.89–0.82 (m, 4H).</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(4-(2-Chloro-4-fluorophenyl)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>41</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 393 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, 1H), 10.32 (br. s., 1H), 8.75 (s, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.43 (d, <i>J</i> = 5.2 Hz, 1H), 8.35 (s, 1H), 7.55 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.45–7.39 (m, 2H), 7.34–7.27 (m, 2H), 2.05–1.99 (m, 1H), 0.87–0.83 (m, 4H).</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(4-fluoro-2-(trifluoromethyl)phenyl)pyridin-3-yl)isonicotinamide (<b>42</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 445 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 10.17 (br. s., 1H), 8.77 (s, 1H), 8.55 (d, <i>J</i> = 5.2 Hz, 1H), 8.41 (d, <i>J</i> = 4.9 Hz, 1H), 8.28 (s, 1H), 7.75 (dd, <i>J</i> = 9.3, 2.6 Hz, 1H), 7.60 (td, <i>J</i> = 8.5, 2.6 Hz, 1H), 7.46 (dd, <i>J</i> = 8.7, 5.6 Hz, 1H), 7.36 (d, <i>J</i> = 4.9 Hz, 1H), 7.23 (dd, <i>J</i> = 5.2, 1.2 Hz, 1H), 2.06–1.96 (m, 1H), 0.87–0.81 (m, 4H).</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(4-(4-Chloro-2-fluorophenyl)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide (<b>43</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 411 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 10.42 (br. s., 1H), 8.75 (s, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.45 (d, <i>J</i> = 5.2 Hz, 1H), 8.39 (s, 1H), 7.55 (dd, <i>J</i> = 10.1, 2.1 Hz, 1H), 7.50–7.43 (m, 2H), 7.41–7.32 (m, 2H), 2.08–1.99 (m, 1H), 0.90–0.82 (m, 4H).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2,5-difluorophenyl)pyridin-3-yl)isonicotinamide (<b>44</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 395 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (s, 1H), 10.46 (br. s., 1H), 8.72 (s, 1H), 8.60 (d, <i>J</i> = 4.9 Hz, 1H), 8.45 (d, <i>J</i> = 5.2 Hz, 1H), 8.40 (s, 1H), 7.51 (d, <i>J</i> = 5.2 Hz, 1H), 7.40–7.25 (m, 4H), 2.07–1.98 (m, 1H), 0.87–0.82 (m, 4H).</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(Cyclopropanecarboxamido)-<i>N</i>-(4-(2,3-difluorophenyl)pyridin-3-yl)isonicotinamide (<b>45</b>)</h4><div class="NLM_p last">MS (ESI) (<i>m</i>/<i>z</i>): 395 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.97 (s, 1H), 8.75 (s, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.43 (d, <i>J</i> = 5.2 Hz, 1H), 8.39 (s, 1H), 7.51 (d, <i>J</i> = 4.9 Hz, 1H), 7.46 (q, <i>J</i> = 8.5 Hz, 1H), 7.34 (d, <i>J</i> = 4.6 Hz, 1H), 7.30–7.19 (m, 2H), 2.07–1.99 (m, 1H), 0.87–0.81 (m, 4H).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> GSK-3β/3α Kinase Assay</h3><div class="NLM_p last">Inhibitors were evaluated in a competitive binding assay for their ability to bind to GSK-3α and GSK-3β. Test compound was incubated in assay buffer (20 mM Hepes, pH 7.4, 10 mM MgCl<sub>2</sub>, 0.015% Brij-35, 4 mM DTT, 0.05 mg/mL BSA) in the presence of 1 nM GST-GSK-3α or GST-GSK-3β, a fluorescently labeled small molecule at <i>K</i><sub>d</sub> (GSK-3α = 15 nM; GSK-3β = 6 nM), and 0.2 nM anti-GST labeled detection antibody. After a 1 h incubation at room temperature, homogeneous time-resolved florescence (HTRF) was monitored on a Envision plate reader (Ex 340 nm; Em 520/615 nm). Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. Dose–response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC<sub>50</sub>).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Triple-Transgenic Mouse Model<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></h3><div class="NLM_p last">Mice were handled strictly according to Bristol-Myers Squibb (BMS) Animal Care and Use Committee guidelines. 3×Tg mice were obtained from Dr. Frank LaFerla at the University of California, Irvine. The mice were bred onto the C57BL/6 background by Dr. Mark Mattson (National Institute on Aging), and breeders from those congenic mice were obtained by BMS, where they were bred as homozygotes. Mice were housed with a 6 am–6 pm light/dark cycle and allowed free access to food and water. Animals were used for study between the ages of 5 to 7 months. Test compounds were dosed at 30 mg/kg as a nanosuspension in 2% HPC-SSL/0.15% SLS/97.85% water by oral gavage. LiCl was administered at 250 mg/kg by ip injection in water. Animals were euthanized by guillotine 5 h postdose. Brains were dissected into hemispheres, flash frozen in liquid nitrogen, and stored at −80 °C until processing. Each hemisphere was homogenized in T-PER tissue protein extraction buffer (Thermo Scientific, Rockford, IL) supplemented with phosphatase inhibitor cocktail sets I and II (Sigma-Aldrich, St. Louis, MO), complete protease inhibitor EDTA-free (Roche, Indianapolis, IN), 7 μM pepstatin (Sigma-Aldrich, St. Louis, MO), and 1 mM PMSF (Sigma, St. Louis, MO) using a Potter-Elvehjem homogenizer. Homogenate was centrifuged at 100 000<i>g</i> for 30 min at 4 °C. Cleared homogenate was frozen and stored at −80 °C. Commercial total tau human (KHB0041) and tau[S396] human (KHB7031) ELISA kits (Invitrogen, Grand Island, NY) were used as directed to determine total and S396 phosphorylated human tau levels in the cleared homogenates, respectively. Each sample was tested in triplicate, and compound-treated animal groups were compared to vehicle-treated animal groups with statistical analysis using Student’s <i>t</i> test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01550">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01550" class="ext-link">10.1021/acs.jmedchem.5b01550</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES strings and GSK-3β/α and pTau IC<sub>50</sub> data for <b>11</b>–<b>45</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Synthesis and characterization of the aminopyridine intermediates from <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>; X-ray crystal studies of <b>15</b> and <b>18</b> bound to GSK-3β; biological assays; and related Ambit graphs (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv">jm5b01550_si_001.csv (2.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf">jm5b01550_si_002.pdf (1.28 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01550" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guanglin Luo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#284f5d49464f44414606445d47684a455b064b4745"><span class="__cf_email__" data-cfemail="553220343b32393c3b7b39203a153738267b363a38">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling Chen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine R. Burton</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Xiao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prasanna Sivaprakasam</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carol M. Krause</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Cao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nengyin Liu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Lippy</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy J. Clarke</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Snow</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Raybon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod Arora</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matt Pokross</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Kish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hal A. Lewis</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Langley</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John E. Macor</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gene M. Dubowchik</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research
& Development, Bristol-Myers Squibb
Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d88e3833-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Spectrix chemists for all of the final compound purification and characterizations.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">GSK-3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase-3</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">beta-amyloid</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">PKB (AKT)</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">PHFs</td><td class="NLM_def"><p class="first last">paired helical filaments</p></td></tr><tr><td class="NLM_term">b/p ratio</td><td class="NLM_def"><p class="first last">brain/plasma ratio</p></td></tr><tr><td class="NLM_term">pTau</td><td class="NLM_def"><p class="first last">phosphorylated Tau</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">muclear magnetic resonance</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">taken orally</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Facts and Figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.jalz.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.jalz.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=23507120" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=208-245&author=Alzheimer%E2%80%99s+Association&title=Alzheimer%E2%80%99s+Disease+Facts+and+Figures&doi=10.1016%2Fj.jalz.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D208%26epage%3D245%26doi%3D10.1016%2Fj.jalz.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=16914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=151-153&author=J.+Hardy&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis%3A+an+update+and+reappraisal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">151-153</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Here I recap the scientific and personal background of the delineation of the amyloid cascade hypothesis for Alzheimer's disease that I wrote with Gerry Higgins and the events leading to the writing of that influential review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9h63kZgivLVg90H21EOLACvtfcHk0ljVoHSj6n1oDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D&md5=9c91d6b0cf34cfdffbd2b0bb4b9429d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%253A%2520an%2520update%2520and%2520reappraisal%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D151%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zaghi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inayathullah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lossinsky, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoumi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avagyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa-Jeffrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiala, M.</span><span> </span><span class="NLM_article-title">Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1007/s00401-008-0481-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1007%2Fs00401-008-0481-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19139910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2009&pages=111-124&author=J.+Zaghiauthor=B.+Goldensonauthor=M.+Inayathullahauthor=A.+S.+Lossinskyauthor=A.+Masoumiauthor=H.+Avagyanauthor=M.+Mahanianauthor=M.+Bernasauthor=M.+Weinandauthor=M.+J.+Rosenthalauthor=A.+Espinosa-Jeffreyauthor=J.+de+Vellisauthor=D.+B.+Teplowauthor=M.+Fiala&title=Alzheimer+disease+macrophages+shuttle+amyloid-beta+from+neurons+to+vessels%2C+contributing+to+amyloid+angiopathy&doi=10.1007%2Fs00401-008-0481-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy</span></div><div class="casAuthors">Zaghi, Justin; Goldenson, Ben; Inayathullah, Mohammed; Lossinsky, Albert S.; Masoumi, Ava; Avagyan, Hripsime; Mahanian, Michelle; Bernas, Michael; Weinand, Martin; Rosenthal, Mark J.; Espinosa-Jeffrey, Araceli; Vellis, Jean; Teplow, David B.; Fiala, Milan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-124</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuronal accumulation of oligomeric amyloid-β (Αβ) is considered the proximal cause of neuronal demise in Alzheimer disease (AD) patients.  Blood-borne macrophages might reduce Aβ stress to neurons by immigration into the brain and phagocytosis of Αβ.  We tested migration and export across a blood-brain barrier model, and phagocytosis and clearance of Αβ by AD and normal subjects' macrophages.  Both AD and normal macrophages were inhibited in Αβ export across the blood-brain barrier due to adherence of Aβ-engorged macrophages to the endothelial layer.  In comparison to normal subjects' macrophages, AD macrophages ingested and cleared less Αβ, and underwent apoptosis upon exposure to sol., protofibrillar, or fibrillar Αβ.  Confocal microscopy of stained AD brain sections revealed oligomeric Aβ in neurons and apoptotic macrophages, which surrounded and infiltrated congophilic microvessels, and fibrillar Aβ in plaques and microvessel walls.  After incubation with AD brain sections, normal subjects' monocytes intruded into neurons and uploaded oligomeric Aβ.  In conclusion, in patients with AD, macrophages appear to shuttle Aβ from neurons to vessels where their apoptosis may release fibrillar Aβ, contributing to cerebral amyloid angiopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS6yLUNEq7Y7Vg90H21EOLACvtfcHk0ljVoHSj6n1oDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCltLk%253D&md5=db05736bca63e06a146188bd8f876631</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00401-008-0481-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-008-0481-0%26sid%3Dliteratum%253Aachs%26aulast%3DZaghi%26aufirst%3DJ.%26aulast%3DGoldenson%26aufirst%3DB.%26aulast%3DInayathullah%26aufirst%3DM.%26aulast%3DLossinsky%26aufirst%3DA.%2BS.%26aulast%3DMasoumi%26aufirst%3DA.%26aulast%3DAvagyan%26aufirst%3DH.%26aulast%3DMahanian%26aufirst%3DM.%26aulast%3DBernas%26aufirst%3DM.%26aulast%3DWeinand%26aufirst%3DM.%26aulast%3DRosenthal%26aufirst%3DM.%2BJ.%26aulast%3DEspinosa-Jeffrey%26aufirst%3DA.%26aulast%3Dde%2BVellis%26aufirst%3DJ.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DFiala%26aufirst%3DM.%26atitle%3DAlzheimer%2520disease%2520macrophages%2520shuttle%2520amyloid-beta%2520from%2520neurons%2520to%2520vessels%252C%2520contributing%2520to%2520amyloid%2520angiopathy%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D117%26spage%3D111%26epage%3D124%26doi%3D10.1007%2Fs00401-008-0481-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Grimes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">The multifaceted roles of glycogen synthase kinase 3β in cellular signaling</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/S0301-0082(01)00011-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0301-0082%2801%2900011-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=11527574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1yjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=391-426&author=C.+A.+Grimesauthor=R.+S.+Jope&title=The+multifaceted+roles+of+glycogen+synthase+kinase+3%CE%B2+in+cellular+signaling&doi=10.1016%2FS0301-0082%2801%2900011-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The multifaceted roles of glycogen synthase kinase 3β in cellular signaling</span></div><div class="casAuthors">Grimes, C. A.; Jope, R. S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-426</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Glycogen synthase kinase-3β (GSK3β) is a fascinating enzyme with an astoundingly diverse no. of actions in intracellular signaling systems.  GSK3β activity is regulated by serine (inhibitory) and tyrosine (stimulatory) phosphorylation, by protein complex formation, and by its intracellular localization.  GSK3β phosphorylates and thereby regulates the functions of many metabolic, signaling, and structural proteins.  Notable among the signaling proteins regulated by GSK3β are the many transcription factors, including activator protein-1, cAMP response element binding protein, heat shock factor-1, nuclear factor of activated T cells, Myc, β-catenin, CCAAT/enhancer binding protein, and NFκB.  Lithium, the primary therapeutic agent for bipolar mood disorder, is a selective inhibitor of GSK3β.  This raises the possibility that dysregulation of GSK3β and its inhibition by lithium may contribute to the disorder and its treatment, resp.  GSK3β has been linked to all of the primary abnormalities assocd. with Alzheimer's disease.  These include interactions between GSK3β and components of the plaque-producing amyloid system, the participation of GSK3β in phosphorylating the microtubule-binding protein tau that may contribute to the formation of neurofibrillary tangles, and interactions of GSK3β with presenilin and other Alzheimer's disease-assocd. proteins.  GSK3β also regulates cell survival, as it facilitates a variety of apoptotic mechanisms, and lithium provides protection from many insults.  Thus, GSK3β has a central role regulating neuronal plasticity, gene expression, and cell survival, and may be a key component of certain psychiatric and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFqZD3ZTv7LVg90H21EOLACvtfcHk0li3R8eu_rFemg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1yjt7Y%253D&md5=1bcb96a552a0307c1be6e079b5b1bec0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2801%2900011-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252801%252900011-9%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BA.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DThe%2520multifaceted%2520roles%2520of%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520in%2520cellular%2520signaling%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D391%26epage%3D426%26doi%3D10.1016%2FS0301-0082%2801%2900011-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Molecular cloning and expression of glycogen synthase kinase-3/factor A</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2431</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1002%2Fj.1460-2075.1990.tb07419.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=2164470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK3MXis1Gr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1990&pages=2431-2438&author=J.+R.+Woodgett&title=Molecular+cloning+and+expression+of+glycogen+synthase+kinase-3%2Ffactor+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of glycogen synthase kinase-3/factor A</span></div><div class="casAuthors">Woodgett, James Robert</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2431-8</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a protein-serine kinase implicated in the hormonal control of several regulatory proteins, including glycogen synthase and transcription factor c-jun.  Two classes of rat brain cDNA for this enzyme were isolated (GSK-3α and GSK-3β).  The α-type encoded a 51-kDa polypeptide, the sequence of which included all of the tryptic peptides detd. by protein sequence anal. of purified skeletal muscle GSK-3.  The novel β-type cDNA had the potential to encode a 47-kDA protein with 85% amino acid identity to GSK-3α.  The 2 types of cDNA were the products of distinct genes as detd. by genomic organization and nucleic acid sequence anal.  Both α and β clones exhibited kinase activity when expressed in COS-1 cells and type-specific antibodies to GSK-3 α and β detect proteins of 51 and 47 kDa, resp., in a variety of rat tissue exts., with highest levels of both in brain.  Partial purifn. of GSK-3 activity from bovine resulted in the isolation of active α and β proteins.  The physiol. importance of these 2 proteins in cellular signal transduction is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm736N83asgLVg90H21EOLACvtfcHk0li3R8eu_rFemg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXis1Gr&md5=3bacbf348b8ba673831fe9b9ca5cfde6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1990.tb07419.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1990.tb07419.x%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520cloning%2520and%2520expression%2520of%2520glycogen%2520synthase%2520kinase-3%252Ffactor%2520A%26jtitle%3DEMBO%2520J.%26date%3D1990%26volume%3D9%26spage%3D2431%26epage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span> </span><span class="NLM_article-title">Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1097/00005072-199701000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1097%2F00005072-199701000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=8990130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADyaK2s7ksVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=70-78&author=J.+J.+Peiauthor=T.+Tanakaauthor=Y.+C.+Tungauthor=E.+Braakauthor=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Distribution%2C+levels%2C+and+activity+of+glycogen+synthase+kinase-3+in+the+Alzheimer+disease+brain&doi=10.1097%2F00005072-199701000-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain</span></div><div class="casAuthors">Pei J J; Tanaka T; Tung Y C; Braak E; Iqbal K; Grundke-Iqbal I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">A number of studies have implicated a proline-directed protein kinase, glycogen synthase kinase-3 (GSK-3) in the hyperphosphorylation of tau in Alzheimer's disease (AD).  Toward understanding the role of GSK-3 in the abnormal hyperphosphorylation of tau in AD we have found that GSK-3 is prominently present in neuronal cell bodies and their processes and co-localizes with neurofibrillary changes in AD brain.  Furthermore, the levels of GSK-3 as determined by indirect ELISA are approximately 50% increased in the postsynaptosomal supernatant from AD brains as compared to the controls.  However, no increase in GSK-3 enzyme activity was detected.  In AD brain, with its reduced phosphatase activity, even normal levels of GSK-3 activity might be sufficient for the hyperphosphorylation of tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmu8m1y1XLJ0EgZCMqtRBifW6udTcc2ebHfb-f8bp-ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7ksVelsQ%253D%253D&md5=18b0957c0a36ecb25875aaa4e8c6bc91</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F00005072-199701000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199701000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DBraak%26aufirst%3DE.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DDistribution%252C%2520levels%252C%2520and%2520activity%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520the%2520Alzheimer%2520disease%2520brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1997%26volume%3D56%26spage%3D70%26epage%3D78%26doi%3D10.1097%2F00005072-199701000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1097/00005072-199909000-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1097%2F00005072-199909000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10499443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=1010-1019&author=J.+J.+Peiauthor=E.+Braakauthor=H.+Braakauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Distribution+of+active+glycogen+synthase+kinase+3beta+%28GSK-3beta%29+in+brains+staged+for+Alzheimer+disease+neurofibrillary+changes&doi=10.1097%2F00005072-199909000-00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes</span></div><div class="casAuthors">Pei, Jin-Jing; Braak, Eva; Braak, Heiko; Grundke-Iqbal, Inge; Iqbal, Khalid; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1010-1019</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">Accumulation of paired helical filaments (PHFs) in neurofibrillary tangles, neuropil threads, and dystrophic neurites is one of the major neuropathol. hallmarks of Alzheimer disease (AD).  The principal protein subunit of PHFs is the abnormally hyperphosphorylated tau.  Glycogen synthase kinase 3β (GSK-3β) is one of the candidate kinases involved in PHF-tau formation.  To play a role in PHF-tau formation, it would be expected that GSK-3β is active in tangle bearing neurons.  In the present study, the authors investigated the regional and intracellular distributions of active and inactive forms of GSK-3β in brains staged for neurofibrillary changes.  The authors found that neurons with tangle-like inclusions pos. for active, but not inactive, GSK-3β appear initially in the Pre-α layer of the entorhinal cortex and extend to other brain regions, coincident with the sequence of the development of neurofibrillary changes.  Active, but not inactive, GSK-3β was found to initially accumulate in the cytoplasm of pretangle neurons.  These data provide direct in situ evidence that is consistent with the involvement of GSK-3β in PHF-tau formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphCsw1UpeBWLVg90H21EOLACvtfcHk0liB3jB_BIr2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOlsL4%253D&md5=3671085e971d742792dbf7f376c7d24f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00005072-199909000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199909000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DBraak%26aufirst%3DE.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DDistribution%2520of%2520active%2520glycogen%2520synthase%2520kinase%25203beta%2520%2528GSK-3beta%2529%2520in%2520brains%2520staged%2520for%2520Alzheimer%2520disease%2520neurofibrillary%2520changes%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1999%26volume%3D58%26spage%3D1010%26epage%3D1019%26doi%3D10.1097%2F00005072-199909000-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Leroy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J.-P.</span><span> </span><span class="NLM_article-title">Developmental expression and localization of glycogen synthase kinase-3β in rat brain</span> <span class="citation_source-journal">J. Chem. Neuroanat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/S0891-0618(99)00012-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0891-0618%2899%2900012-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10450875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVaht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=279-293&author=K.+Leroyauthor=J.-P.+Brion&title=Developmental+expression+and+localization+of+glycogen+synthase+kinase-3%CE%B2+in+rat+brain&doi=10.1016%2FS0891-0618%2899%2900012-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental expression and localization of glycogen synthase kinase-3β in rat brain</span></div><div class="casAuthors">Leroy, Karelle; Brion, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Neuroanatomy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">JCNAEE</span>;
        ISSN:<span class="NLM_cas:issn">0891-0618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase (GSK)-3β is a protein kinase in the wingless/wnt pathway and as such is involved in the regulation of growth and development of the neural tissue in Drosophila and in vertebrates.  GSK-3β is also abundantly expressed in mammalian adult brain, where it might play a role in the regulation of several substrates.  Here, the expression and the neuroanatomical distribution of GSK-3β immunoreactivity in the rat brain from embryonic up to adult stages was studied.  GSK-3β was expressed in the developing brain with the highest expression obsd. from 18 days of embryonic life up to 10 days of postnatal life.  Its expression decreased thereafter and was lowest in the adult.  GSK-3β was strongly expressed in developing neurons but only weakly expressed in layers contg. neuroblasts.  In the adult and during development, GSK-3β was detected in the perikarya and proximal part of dendrites.  In the embryo, an intense GSK-3β immunoreactivity was also obsd. in axonal tracts.  This axonal immunoreactivity had markedly decreased by 10 days of postnatal life and was absent at 20 days of postnatal life and in the adult.  No GSK-3β immunoreactivity was detected in astrocytes.  The GSK-3β immunoreactivity was found in most brain regions, although significant local variations of GSK-3β expression were obsd.  The developmental evolution of GSK-3β compartmentalization in neurons paralleled that of phosphorylated tau, a protein considered to be a physiol. substrate for the kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVvQKSfzSAdrVg90H21EOLACvtfcHk0liB3jB_BIr2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVaht78%253D&md5=b15a111e176deefc04f86e51aed214fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0891-0618%2899%2900012-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-0618%252899%252900012-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DK.%26aulast%3DBrion%26aufirst%3DJ.-P.%26atitle%3DDevelopmental%2520expression%2520and%2520localization%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Chem.%2520Neuroanat.%26date%3D1999%26volume%3D16%26spage%3D279%26epage%3D293%26doi%3D10.1016%2FS0891-0618%2899%2900012-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sereno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Isla, T.</span><span> </span><span class="NLM_article-title">A novel GSK-3β inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1016/j.nbd.2009.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.nbd.2009.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19523516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=359-367&author=L.+Serenoauthor=M.+Comaauthor=M.+Rodriguezauthor=P.+Sanchez-Ferrerauthor=M.+B.+Sanchezauthor=I.+Gichauthor=J.+M.+Agulloauthor=M.+Perezauthor=J.+Avilaauthor=C.+Guardia-Laguartaauthor=J.+Clarimonauthor=A.+Lleoauthor=T.+G%C3%B3mez-Isla&title=A+novel+GSK-3%CE%B2+inhibitor+reduces+Alzheimer%E2%80%99s+pathology+and+rescues+neuronal+loss+in+vivo&doi=10.1016%2Fj.nbd.2009.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo</span></div><div class="casAuthors">Sereno, L.; Coma, M.; Rodriguez, M.; Sanchez-Ferrer, P.; Sanchez, M. B.; Gich, I.; Agullo, J. M.; Perez, M.; Avila, J.; Guardia-Laguarta, C.; Clarimon, J.; Lleo, A.; Gomez-Isla, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid deposits, neurofibrillary tangles, and neuronal cell death in selectively vulnerable brain regions are the chief hallmarks in Alzheimer's (AD) brains.  Glycogen synthase kinase-3 (GSK-3) is one of the key kinases required for AD-type abnormal hyperphosphorylation of tau, which is believed to be a crit. event in neurofibrillary tangle formation.  GSK-3 has also been recently implicated in amyloid precursor protein (APP) processing/Aβ prodn., apoptotic cell death, and learning and memory.  Thus, GSK-3 inhibition represents a very attractive drug target in AD and other neurodegenerative disorders.  To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non-ATP competitive GSK-3β inhibitor, NP12.  Treatment with this thiadiazolidinone compd. resulted in lower levels of tau phosphorylation, decreased amyloid deposition and plaque-assocd. astrocytic proliferation, protection of neurons in the entorhinal cortex and CA1 hippocampal subfield against cell death, and prevention of memory deficits in this transgenic mouse model.  These results show that this novel GSK-3 inhibitor has a dual impact on amyloid and tau alterations and, perhaps even more important, on neuronal survival in vivo further suggesting that GSK-3 is a relevant therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDbLMUp5zF7Vg90H21EOLACvtfcHk0lh6sFzP5KfsdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D&md5=b3d6145f5662c989f22113bef022656e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSereno%26aufirst%3DL.%26aulast%3DComa%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSanchez-Ferrer%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DM.%2BB.%26aulast%3DGich%26aufirst%3DI.%26aulast%3DAgullo%26aufirst%3DJ.%2BM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DClarimon%26aufirst%3DJ.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Isla%26aufirst%3DT.%26atitle%3DA%2520novel%2520GSK-3%25CE%25B2%2520inhibitor%2520reduces%2520Alzheimer%25E2%2580%2599s%2520pathology%2520and%2520rescues%2520neuronal%2520loss%2520in%2520vivo%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26spage%3D359%26epage%3D367%26doi%3D10.1016%2Fj.nbd.2009.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Drug development targeting the glycogen synthase kinase-3β(GSK-3β)-mediated signal transduction pathway: role of GSK-3β in adult brain</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1254/jphs.08R29FM</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1254%2Fjphs.08R29FM" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19179803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFemtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=174-178&author=A.+Takashima&title=Drug+development+targeting+the+glycogen+synthase+kinase-3%CE%B2%28GSK-3%CE%B2%29-mediated+signal+transduction+pathway%3A+role+of+GSK-3%CE%B2+in+adult+brain&doi=10.1254%2Fjphs.08R29FM"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: role of GSK-3β in adult brain</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-178</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase.  Since its activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains, GSK-3β may be inhibited under normal conditions but activated under pathol. conditions.  Given its link to NFT formation, we sought to det. whether GSK-3β exists in the brain as a "pathol. time bomb" that promotes disease development.  To address this hypothesis, we analyzed GSK-3β heterozygote (GSK+/-) mice, which express GSK-3β at 50% wild-type levels.  When tested in the Morris water maze test, GSK+/- mice surprisingly exhibited retrograde amnesia.  Further anal. indicated that GSK+/- mice had impaired memory reconsolidation but normal memory consolidation.  Therefore, we concluded that GSK-3β activation is required for memory reconsolidation in the adult brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAd0ZTQ3NKLVg90H21EOLACvtfcHk0lh6sFzP5KfsdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFemtLs%253D&md5=4102ddb90f55d8cdcbe63b510047d137</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1254%2Fjphs.08R29FM&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.08R29FM%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DDrug%2520development%2520targeting%2520the%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2528GSK-3%25CE%25B2%2529-mediated%2520signal%2520transduction%2520pathway%253A%2520role%2520of%2520GSK-3%25CE%25B2%2520in%2520adult%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D109%26spage%3D174%26epage%3D178%26doi%3D10.1254%2Fjphs.08R29FM" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Doble, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kockeritz, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.1016/j.devcel.2007.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.devcel.2007.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=957-971&author=B.+W.+Dobleauthor=S.+Patelauthor=G.+A.+Woodauthor=L.+K.+Kockeritzauthor=J.+R.+Woodgett&title=Functional+redundancy+of+GSK-3alpha+and+GSK-3beta+in+Wnt%2Fbeta-catenin+signaling+shown+by+using+an+allelic+series+of+embryonic+stem+cell+lines&doi=10.1016%2Fj.devcel.2007.04.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2007.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2007.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DG.%2BA.%26aulast%3DKockeritz%26aufirst%3DL.%2BK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DFunctional%2520redundancy%2520of%2520GSK-3alpha%2520and%2520GSK-3beta%2520in%2520Wnt%252Fbeta-catenin%2520signaling%2520shown%2520by%2520using%2520an%2520allelic%2520series%2520of%2520embryonic%2520stem%2520cell%2520lines%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D12%26spage%3D957%26epage%3D971%26doi%3D10.1016%2Fj.devcel.2007.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sutherland, C.</span><span> </span><span class="NLM_article-title">What Are the bona fide GSK3 Substrates?</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">505607</span><span class="refDoi"> DOI: 10.4061/2011/505607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.4061%2F2011%2F505607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21629754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADC%252BC3MrntVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=505607&author=C.+Sutherland&title=What+Are+the+bona+fide+GSK3+Substrates%3F&doi=10.4061%2F2011%2F505607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">What Are the bona fide GSK3 Substrates?</span></div><div class="casAuthors">Sutherland Calum</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">505607</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body.  However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo.  Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells.  In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQII8bXRBJjgDUE-swuRqsHfW6udTcc2eZj_0xjc5rl87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrntVKqsA%253D%253D&md5=1539d25659573451e6d6f343ff03aa5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4061%2F2011%2F505607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F505607%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DWhat%2520Are%2520the%2520bona%2520fide%2520GSK3%2520Substrates%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D505607%26doi%3D10.4061%2F2011%2F505607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andjelkovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/378785a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2F378785a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=8524413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK28XltFWj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=785-789&author=D.+A.+Crossauthor=D.+R.+Alessiauthor=P.+Cohenauthor=M.+Andjelkovichauthor=B.+A.+Hemmings&title=Inhibition+of+glycogen+synthase+kinase-3+by+insulin+mediated+by+protein+kinase+B&doi=10.1038%2F378785a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B</span></div><div class="casAuthors">Cross, Darren A. E.; Alessi, Dario R.; Cohen, Philip; Andjelkovich, Mirjana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6559</span>),
    <span class="NLM_cas:pages">785-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Agents which prevent the activation of both MAP kinase-activated protein kinase-1 and p70S6k by insulin in vivo do not block the phosphorylation and inhibition of glycogen synthase kinase-3 (GSK3) in L6 myotubes.  Another insulin-stimulated protein kinase inactivates GSK3 under these conditions, and the authors demonstrate that it is the product of the proto-oncogene protein kinase B (PKB, also known as Akt/RAC).  Like the inhibition of GSK3, the activation of PKB is prevented by inhibitors of phosphatidylinositol 3-kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKh6GNVgGhFbVg90H21EOLACvtfcHk0lidLyMkyNFhPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFWj&md5=56723cab1f5412b4e55aca875989d1fa</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F378785a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378785a0%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAndjelkovich%26aufirst%3DM.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520by%2520insulin%2520mediated%2520by%2520protein%2520kinase%2520B%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D785%26epage%3D789%26doi%3D10.1038%2F378785a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NobLE, W.</span><span> </span><span class="NLM_article-title">Functional implications of glycogen synthase kinase-3-mediated Tau phosphorylation</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4061/2011/352805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.4061%2F2011%2F352805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=1-11&author=D.+P.+Hangerauthor=W.+NobLE&title=Functional+implications+of+glycogen+synthase+kinase-3-mediated+Tau+phosphorylation&doi=10.4061%2F2011%2F352805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4061%2F2011%2F352805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F352805%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DNobLE%26aufirst%3DW.%26atitle%3DFunctional%2520implications%2520of%2520glycogen%2520synthase%2520kinase-3-mediated%2520Tau%2520phosphorylation%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D1%26epage%3D11%26doi%3D10.4061%2F2011%2F352805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Stebbings, H.</span><span> </span><span class="NLM_article-title">Microtubule-based intracellular transport of organelles</span> <span class="citation_source-journal">Cytoskeleton</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/S1874-6020(06)80017-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS1874-6020%2806%2980017-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=113-140&author=H.+Stebbings&title=Microtubule-based+intracellular+transport+of+organelles&doi=10.1016%2FS1874-6020%2806%2980017-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1874-6020%2806%2980017-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1874-6020%252806%252980017-0%26sid%3Dliteratum%253Aachs%26aulast%3DStebbings%26aufirst%3DH.%26atitle%3DMicrotubule-based%2520intracellular%2520transport%2520of%2520organelles%26jtitle%3DCytoskeleton%26date%3D1995%26volume%3D2%26spage%3D113%26epage%3D140%26doi%3D10.1016%2FS1874-6020%2806%2980017-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau. A component of Alzheimer paired helical filaments</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">6084</span><span class="NLM_x">–</span> <span class="NLM_lpage">6089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=3084478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaL28XitVCqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=6084-6089&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=M.+Quinlanauthor=Y.+C.+Tungauthor=M.+S.+Zaidiauthor=H.+M.+Wisniewski&title=Microtubule-associated+protein+tau.+A+component+of+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-associated protein tau.  A component of Alzheimer paired helical filaments</span></div><div class="casAuthors">Grundke-Iqbal, Inge; Iqbal, Khalid; Quinlan, Maureen; Tung, Yunn Chyn; Zaidi, Masooma S.; Wisniewski, Henryk M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6084-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Microtubule-assocd. protein tau was purified from bovine brain microtubules by either (1) phosphocellulose chromatog., (2) heat treatment at pH 6.4 (3) heat treatment at pH 2.7, (4) heat treatment at pH 2.7 followed by extn. with perchloric acid and pptn. with glycerol, or (5) by pptn. with (NH4)2SO4 followed by extn. with perchloric acid.  All of these tau prepns. reacted specifically with antibodies to Alzheimer paired helical filaments.  Affinity purified antibodies to tau labeled both Alzheimer neurofibrillary tangles and plaque neurites but not amyloid in Alzheimer brain tissue sections and labeled paired helical filament polypeptides on Western blots.  Human brain tau and paired helical filament polypeptides comigrated on SDS-polyacrylamide gels.  Apparently, tau is a major component of Alzheimer paired helical filaments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6BKwstlhNy7Vg90H21EOLACvtfcHk0lgIbYIIa50MJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVCqsb0%253D&md5=61cc3c14ac3cb3b7663d1ed7b6ffbf5c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DZaidi%26aufirst%3DM.%2BS.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26atitle%3DMicrotubule-associated%2520protein%2520tau.%2520A%2520component%2520of%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D6084%26epage%3D6089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4913</span><span class="NLM_x">–</span> <span class="NLM_lpage">4917</span><span class="refDoi"> DOI: 10.1073/pnas.83.13.4913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1073%2Fpnas.83.13.4913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=3088567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaL28XksFyqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4913-4917&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=Y.+C.+Tungauthor=M.+Quinlanauthor=H.+M.+Wisniewskiauthor=L.+I.+Binder&title=Abnormal+phosphorylation+of+the+microtubule-associated+protein+tau+%28tau%29+in+Alzheimer+cytoskeletal+pathology&doi=10.1073%2Fpnas.83.13.4913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology</span></div><div class="casAuthors">Grundke-Iqbal, Inge; Iqbal, Khalid; Tung, Yunn Chyn; Quinlan, Maureen; Wisniewski, Henryk M.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4913-17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A monoclonal antibody to the microtubule-assocd. protein τ (tau) labeled some neurofibrillary tangles and plaque neurites, the 2 major locations of paired-helical filaments (PHF), in Alzheimer disease brain.  The antibody also labeled isolated PHF that had been repeatedly washed with SDS.  Dephosphorylation of the tissue sections with alk. phosphatase prior to immunolabeling dramatically increased the no. of tangles and plaques recognized by the antibody.  The plaque core amyloid was not stained in either dephosphorylated or nondephosphorylated tissue sections.  On immunoblots PHF polypeptides were labeled readily only when dephosphorylated.  In contrast, a com. available monoclonal antibody to a phosphorylated epitope of neurofilaments that labeled the tangles and the plaque neurites in tissue did not label any PHF polypeptides on immunoblots.  The PHF polypeptides, labeled with the monoclonal antibody to τ, electrophoresed with those polypeptides recognized by antibodies to isolated PHF.  The antibody to τ labeled microtubules from normal human brains assembled in vitro but identically treated Alzheimer brain prepns. had to be dephosphorylated to be completely recognized by this antibody.  These findings suggest that τ in Alzheimer brain is an abnormally phosphorylated protein component of PHF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcyxbsq2aXprVg90H21EOLACvtfcHk0lgIbYIIa50MJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFyqtrg%253D&md5=3ac88b7002e26c53c54e71a3a91471ba</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.13.4913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.13.4913%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520tau%2520%2528tau%2529%2520in%2520Alzheimer%2520cytoskeletal%2520pathology%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D4913%26epage%3D4917%26doi%3D10.1073%2Fpnas.83.13.4913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span> </span><span class="NLM_article-title">Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=16914861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=219-242&author=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Discoveries+of+tau%2C+abnormally+hyperphosphorylated+tau+and+others+of+neurofibrillary+degeneration%3A+a+personal+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discoveries of Tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: A personal historical perspective</span></div><div class="casAuthors">Iqbal, Khalid; Grundke-Iqbal, Inge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">219-242</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease was described by Alois Alzheimer in 1907, but it was not until ∼60-70 years later that any new significant developments were reported on the pathol. of this disease.  The discoveries that laid down the foundation for the exciting research that has been carried out during the last ∼20 years and that have significantly enhanced our understanding of the disease are the ultrastructure of neurofibrillary tangles and neuritic (senile) plaques, the clin.-pathol. correlation of these lesions to the presence of dementia, and the bulk isolation and protein compn. of paired helical filaments and plaque amyloid.  We discovered tau as the major protein subunit of paired helical filaments/neurofibrillary tangles, the abnormal hyperphosphorylation of this protein in this lesion and in Alzheimer brain cytosol and the gain of toxic function by the cytosolic abnormally hyper-phosphorylated tau in Alzheimer brain.  Here we present a personal historical account of the work in our labs. that led, in 1986, to the discoveries of tau and its abnormal hyperphosphorylation in paired helical filaments and Alzheimer brain cytosol.  This article also describes several major findings which subsequently resulted from the abnormal hyperphosphorylation of tau and in a large part account for the current understanding of the role of this lesion in Alzheimer disease and other tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkB8SG1qCLkLVg90H21EOLACvtfcHk0lgIbYIIa50MJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKktL4%253D&md5=a337940cbdf40deb55ecfc7e1e3dfbb1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DDiscoveries%2520of%2520tau%252C%2520abnormally%2520hyperphosphorylated%2520tau%2520and%2520others%2520of%2520neurofibrillary%2520degeneration%253A%2520a%2520personal%2520historical%2520perspective%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D219%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Maixner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, H.-R.</span><span> </span><span class="NLM_article-title">The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">001</span><span class="refDoi"> DOI: 10.13188/2327-204X.1000001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.13188%2F2327-204X.1000001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADC%252BC2srnvVCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=001&author=D.+W.+Maixnerauthor=H.-R.+Weng&title=The+Role+of+Glycogen+Synthase+Kinase+3+Beta+in+Neuroinflammation+and+Pain&doi=10.13188%2F2327-204X.1000001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain</span></div><div class="casAuthors">Maixner Dylan Warren; Weng Han-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutics & pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">001</span>
        ISSN:<span class="NLM_cas:issn">2327-204X</span>.
    </div><div class="casAbstract">Neuroinflammation is a crucial mechanism related to many neurological diseases.  Extensive studies in recent years have indicated that dysregulation of Glycogen Synthase Kinase 3 Beta (GSK3β) contributes to the development and progression of these disorders through regulating the neuroinflammation processes.  Inhibitors of GSK3β have been shown to be beneficial in many neuroinflammatory disease models including Alzheimer's disease, multiple sclerosis and AIDS dem entia complex.  Glial activation and elevated pro-inflammation cytokines (signs of neuroinflammation) in the spinal cord have been widely recognized as a pivotal mechanism underlying the development and maintenance of many types of pathological pain.  The role of GSK3β in the pathogenesis of pain has recently emerged.  In this review, we will first review the GSK3β structure, regulation, and mechanisms by which GSK3βregulates inflammation.  We will then describe neuroinflammationin general and in specific types of neurological diseases and the potential beneficial effects induced by inhibiting GSK3β.  Finally, we will provide new evidence linking aberrant levels of GSK3β in the development of pathological pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsPOijTcCFn--MdeMhXAHkfW6udTcc2eZusk4HYM5Strntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srnvVCrsA%253D%253D&md5=41a449aa81d8562f26dc91f46281a269</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.13188%2F2327-204X.1000001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.13188%252F2327-204X.1000001%26sid%3Dliteratum%253Aachs%26aulast%3DMaixner%26aufirst%3DD.%2BW.%26aulast%3DWeng%26aufirst%3DH.-R.%26atitle%3DThe%2520Role%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%2520Beta%2520in%2520Neuroinflammation%2520and%2520Pain%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D1%26spage%3D001%26doi%3D10.13188%2F2327-204X.1000001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gomez-Sintes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="refDoi"> DOI: 10.3389/fnmol.2011.00045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3389%2Ffnmol.2011.00045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22110426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=45&author=R.+Gomez-Sintesauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Avila&title=GSK-3+Mouse+Models+to+Study+Neuronal+Apoptosis+and+Neurodegeneration&doi=10.3389%2Ffnmol.2011.00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 mouse models to study neuronal apoptosis and neurodegeneration</span></div><div class="casAuthors">Gomez-Sintes, Raquel; Hernandez, Felix; Lucas, Jose J.; Avila, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">45</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Increased GSK-3 activity is believed to contribute to the etiol. of chronic disorders like Alzheimer's disease (AD), schizophrenia, diabetes, and some types of cancer, thus supporting therapeutic potential of GSK-3 inhibitors.  Numerous mouse models with modified GSK-3 have been generated in order to study the physiol. of GSK-3, its implication in diverse pathologies and the potential effect of GSK-3 inhibitors.  In this review we have focused on the relevance of these mouse models for the study of the role of GSK-3 in apoptosis.  GSK-3 is involved in two apoptotic pathways, intrinsic and extrinsic pathways, and plays opposite roles depending on the apoptotic signaling process that is activated.  It promotes cell death when acting through intrinsic pathway and plays an anti-apoptotic role if the extrinsic pathway is occurring.  It is important to dissect this duality since, among the diseases in which GSK-3 is involved, excessive cell death is crucial in some illnesses like neurodegenerative diseases, while a deficient apoptosis is occurring in others such as cancer or autoimmune diseases.  The clin. application of a classical GSK-3 inhibitor, lithium, is limited by its toxic consequences, including motor side effects.  Recently, the mechanism leading to activation of apoptosis following chronic lithium administration has been described.  Understanding this mechanism could help to minimize side effects and to improve application of GSK-3 inhibitors to the treatment of AD and to extend the application to other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRtAFuwCjX7Vg90H21EOLACvtfcHk0lhYcEAsS0sy_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyr&md5=bc7c4970ddd7db63124c1a5fe7c38e26</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2011.00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2011.00045%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sintes%26aufirst%3DR.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DGSK-3%2520Mouse%2520Models%2520to%2520Study%2520Neuronal%2520Apoptosis%2520and%2520Neurodegeneration%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D4%26spage%3D45%26doi%3D10.3389%2Ffnmol.2011.00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">GSK-3β and memory formation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.3389/fnmol.2012.00047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3389%2Ffnmol.2012.00047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22536172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCqsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=47&author=A.+Takashima&title=GSK-3%CE%B2+and+memory+formation&doi=10.3389%2Ffnmol.2012.00047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3β and memory formation</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">April</span>),
    <span class="NLM_cas:pages">47</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In Alzheimer's disease (AD), tau hyperphosphorylation and neurofibrillary tangle (NFT) formation are strongly assocd. with dementia, a characteristic and early feature of this disease.  Glycogen synthase kinase 3β (GSK-3β) is a pivotal kinase in both the normal and pathol. phosphorylation of tau.  In the diseased state, hyperphosphorylated tau is deposited in NFTs, the formation of which, drive the disease process.  GSK-3β which is also involved in long-term depression induction, interacts with tau to inhibit synaptic long-term potentiation.  Strong lines of evidence suggest that the activation of GSK-3β is responsible for the memory deficits seen in both advanced age and AD.  In this review, we will focus on the role of GSK-3β in brain function, particularly in memory maintenance.  We will examine human and mouse studies which suggest a role for GSK-3β in memory maintenance and the eventual development of memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokF3Ge7EOqQrVg90H21EOLACvtfcHk0lhYcEAsS0sy_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCqsbnN&md5=b97aed5b0bb4841a5e2efd70571ab2ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2012.00047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2012.00047%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DGSK-3%25CE%25B2%2520and%2520memory%2520formation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2012%26volume%3D5%26spage%3D47%26doi%3D10.3389%2Ffnmol.2012.00047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Domínguez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span> </span><span class="NLM_article-title">Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3 by Tideglusib</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1074/jbc.M111.306472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1074%2Fjbc.M111.306472" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=893-904&issue=2&author=J.+M.+Dom%C3%ADnguezauthor=A.+Fuertesauthor=L.+Orozcoauthor=M.+del+Monte-Mill%C3%A1nauthor=E.+Delgadoauthor=M.+Medina&title=Evidence+for+Irreversible+Inhibition+of+Glycogen+Synthase+Kinase-3+by+Tideglusib&doi=10.1074%2Fjbc.M111.306472"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.306472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.306472%26sid%3Dliteratum%253Aachs%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DJ.%2BM.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DL.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DEvidence%2520for%2520Irreversible%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520by%2520Tideglusib%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D2%26spage%3D893%26epage%3D904%26doi%3D10.1074%2Fjbc.M111.306472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Del Ser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinwachs, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Carrillo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vericat, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, T.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease with the GSK-3 inhibitor tideglusib: A pilot study</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3233%2FJAD-2012-120805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22936007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGrurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=205-215&author=T.+Del+Serauthor=K.+C.+Steinwachsauthor=H.+J.+Gertzauthor=M.+V.+Andr%C3%A9sauthor=B.+G%C3%B3mez-Carrilloauthor=M.+Medinaauthor=J.+A.+Vericatauthor=P.+Redondoauthor=D.+Fleetauthor=T.+Leon&title=Treatment+of+Alzheimer%E2%80%99s+disease+with+the+GSK-3+inhibitor+tideglusib%3A+A+pilot+study&doi=10.3233%2FJAD-2012-120805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study</span></div><div class="casAuthors">del Ser, Teodoro; Steinwachs, Klaus C.; Gertz, Hermann J.; Andres, Maria V.; Gomez-Carrillo, Belen; Medina, Miguel; Vericat, Joan A.; Redondo, Pilar; Fleet, David; Leon, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-215</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">This pilot, double-blind, placebo-controlled, randomized, escalating dose trial explored the safety and efficacy of tideglusib, an inhibitor of glycogen synthase kinase-3, in Alzheimer's disease (AD) patients.  Thirty mild-moderate AD patients on cholinesterase inhibitor treatment were administered escalating doses (400, 600, 800, 1,000 mg) of tideglusib or placebo (ratio 2 : 1) for 4, 4, 6, and 6 wk, resp.  The primary objective was to evaluate the safety and tolerability of tideglusib with strict criteria for drug escalation or withdrawal.  Mini-Mental Status Examn. (MMSE), Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog+), word fluency, Geriatric Depression Scale (GDS), and a final Global Clin. Assessment (GCA) were assessed as secondary objectives.  Treatment was well tolerated.  Adverse events were as frequent in active and placebo groups, except for some moderate, asymptomatic, and fully reversible increases (>2.5 × ULN) of serum transaminases in 6 active cases (p = 0.001).  Tideglusib produced pos. trends in MMSE, ADAS-cog, GDS, and GCA without statistical significance in this small sample.  Responders in MMSE were significantly higher in the active group (p = 0.05).  Patients escalated up to 1000 mg/day had a benefit of 1.68 points in the MMSE and 4.72 points in the ADAS-cog+ when compared to placebo.  This small pilot study provides valuable safety and efficacy ests. for the treatment of AD patients with tideglusib, currently being confirmed in a larger clin. trial.  Due to escalating doses and the small sample size, this trial provides insufficient evidence to support or reject a benefit of tideglusib in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETLaPrOao1rVg90H21EOLACvtfcHk0li5Ro00NdpMrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGrurjE&md5=7a75de640f08ff234d4e3f50838c4967</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120805%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BSer%26aufirst%3DT.%26aulast%3DSteinwachs%26aufirst%3DK.%2BC.%26aulast%3DGertz%26aufirst%3DH.%2BJ.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DM.%2BV.%26aulast%3DG%25C3%25B3mez-Carrillo%26aufirst%3DB.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DVericat%26aufirst%3DJ.%2BA.%26aulast%3DRedondo%26aufirst%3DP.%26aulast%3DFleet%26aufirst%3DD.%26aulast%3DLeon%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520the%2520GSK-3%2520inhibitor%2520tideglusib%253A%2520A%2520pilot%2520study%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26spage%3D205%26epage%3D215%26doi%3D10.3233%2FJAD-2012-120805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rowe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D.-M.</span><span> </span><span class="NLM_article-title">GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">920</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2007.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.neubiorev.2007.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=920-931&author=M.+K.+Roweauthor=C.+Wiestauthor=D.-M.+Chuang&title=GSK-3+is+a+viable+potential+target+for+therapeutic+intervention+in+bipolar+disorder&doi=10.1016%2Fj.neubiorev.2007.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2007.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2007.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DM.%2BK.%26aulast%3DWiest%26aufirst%3DC.%26aulast%3DChuang%26aufirst%3DD.-M.%26atitle%3DGSK-3%2520is%2520a%2520viable%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520bipolar%2520disorder%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2007%26volume%3D31%26spage%3D920%26epage%3D931%26doi%3D10.1016%2Fj.neubiorev.2007.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teachey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Modulation of Muscle Insulin Resistance by Selective Inhibition of Glycogen Synthase Kinase-3 in Zucker Diabetic Fatty Rats</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">E892</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1152/ajpendo.00346.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1152%2Fajpendo.00346.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=E892-900&issue=5&author=E.+J.+Henriksenauthor=T.+R.+Kinnickauthor=M.+K.+Teacheyauthor=M.+P.+O%E2%80%99Keefeauthor=D.+Ringauthor=K.+W.+Johnsonauthor=S.+D.+Harrison&title=Modulation+of+Muscle+Insulin+Resistance+by+Selective+Inhibition+of+Glycogen+Synthase+Kinase-3+in+Zucker+Diabetic+Fatty+Rats&doi=10.1152%2Fajpendo.00346.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00346.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00346.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DTeachey%26aufirst%3DM.%2BK.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%2BP.%26aulast%3DRing%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DModulation%2520of%2520Muscle%2520Insulin%2520Resistance%2520by%2520Selective%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520in%2520Zucker%2520Diabetic%2520Fatty%2520Rats%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D284%26issue%3D5%26spage%3DE892%26epage%3D900%26doi%3D10.1152%2Fajpendo.00346.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Marsell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisask, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundgren-Andersson, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljunggren, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, K. B.</span><span> </span><span class="NLM_article-title">GSK-3 inhibition by an orally active small molecule increases bone mass in rats</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1016/j.bone.2011.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bone.2011.11.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=619-627&issue=3&author=R.+Marsellauthor=G.+Sisaskauthor=Y.+Nilssonauthor=A.+K.+Sundgren-Anderssonauthor=U.+Anderssonauthor=S.+Larssonauthor=O.+Nilssonauthor=O.+Ljunggrenauthor=K.+B.+Jonsson&title=GSK-3+inhibition+by+an+orally+active+small+molecule+increases+bone+mass+in+rats&doi=10.1016%2Fj.bone.2011.11.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DMarsell%26aufirst%3DR.%26aulast%3DSisask%26aufirst%3DG.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DSundgren-Andersson%26aufirst%3DA.%2BK.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DLjunggren%26aufirst%3DO.%26aulast%3DJonsson%26aufirst%3DK.%2BB.%26atitle%3DGSK-3%2520inhibition%2520by%2520an%2520orally%2520active%2520small%2520molecule%2520increases%2520bone%2520mass%2520in%2520rats%26jtitle%3DBone%26date%3D2012%26volume%3D50%26issue%3D3%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.bone.2011.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Doble, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">GSK-3: tricks of the trade for a multi-tasking kinase</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1242/jcs.00384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1242%2Fjcs.00384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=12615961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFWhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=1175-1186&author=B.+Dobleauthor=J.+R.+Woodgett&title=GSK-3%3A+tricks+of+the+trade+for+a+multi-tasking+kinase&doi=10.1242%2Fjcs.00384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3: Tricks of the trade for a multi-tasking kinase</span></div><div class="casAuthors">Doble, Bradley W.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) is a multifunctional serine/threonine kinase found in all eukaryotes.  The enzyme is a key regulator of numerous signaling pathways, including cellular responses to Wnt, receptor tyrosine kinases, and G-protein-coupled receptors and is involved in a wide range of cellular processes, ranging from glycogen metab. to cell cycle regulation and proliferation.  GSK-3 is unusual in that it is normally active in cells and is primarily regulated through inhibition of its activity.  Another peculiarity compared with other protein kinases is its preference for primed substrates, i.e., substrates previously phosphorylated by another kinase.  Several recent advances have improved the understanding of GSK-3 regulation in multiple pathways.  These include the soln. of the crystal structure of GSK-3, which has provided insight into GSK-3's penchant for primed substrates and the regulation of GSK-3 by serine phosphorylation, and findings related to the involvement of GSK-3 in the Wnt/β-catenin and Hedgehog pathways.  Finally, since increased GSK-3 activity may be linked to pathol. in diseases such as Alzheimer's disease and non-insulin-dependent diabetes mellitus, several new GSK-3 inhibitors, such as the aloisines, the paullones and the maleimides, have been developed.  Although they are just starting to be characterized in cell culture expts., these new inhibitors hold promise as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7SGJVebXiRLVg90H21EOLACvtfcHk0lhdo98B4OmCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFWhtbc%253D&md5=fb267e44a019d584b6cac5881e8ed1a9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00384%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGSK-3%253A%2520tricks%2520of%2520the%2520trade%2520for%2520a%2520multi-tasking%2520kinase%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D1175%26epage%3D1186%26doi%3D10.1242%2Fjcs.00384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kitano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishigaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minamoto, T.</span><span> </span><span class="NLM_article-title">Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">e55289</span><span class="refDoi"> DOI: 10.1371/journal.pone.0055289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1371%2Fjournal.pone.0055289" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e55289&issue=2&author=A.+Kitanoauthor=T.+Shimasakiauthor=Y.+Chikanoauthor=M.+Nakadaauthor=M.+Hiroseauthor=T.+Higashiauthor=Y.+Ishigakiauthor=Y.+Endoauthor=T.+Takinoauthor=H.+Satoauthor=Y.+Saiauthor=K.+Miyamotoauthor=Y.+Motooauthor=K.+Kawakamiauthor=T.+Minamoto&title=Aberrant+glycogen+synthase+kinase+3%CE%B2+is+involved+in+pancreatic+cancer+cell+invasion+and+resistance+to+therapy&doi=10.1371%2Fjournal.pone.0055289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0055289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0055289%26sid%3Dliteratum%253Aachs%26aulast%3DKitano%26aufirst%3DA.%26aulast%3DShimasaki%26aufirst%3DT.%26aulast%3DChikano%26aufirst%3DY.%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DT.%26aulast%3DIshigaki%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DK.%26aulast%3DMotoo%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DMinamoto%26aufirst%3DT.%26atitle%3DAberrant%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520is%2520involved%2520in%2520pancreatic%2520cancer%2520cell%2520invasion%2520and%2520resistance%2520to%2520therapy%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3De55289%26doi%3D10.1371%2Fjournal.pone.0055289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolosky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Assoro, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demidenko, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervello, M.</span><span> </span><span class="NLM_article-title">GSK-3 as potential target for therapeutic intervention in cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2881</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.18632/oncotarget.2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.18632%2Foncotarget.2037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2881-2911&issue=10&author=J.+A.+McCubreyauthor=L.+S.+Steelmanauthor=F.+E.+Bertrandauthor=N.+M.+Davisauthor=M.+Sokoloskyauthor=S.+L.+Abramsauthor=G.+Montaltoauthor=A.+B.+D%E2%80%99Assoroauthor=M.+Libraauthor=F.+Nicolettiauthor=R.+Maestroauthor=J.+Baseckeauthor=D.+Rakusauthor=A.+Gizakauthor=Z.+Demidenkoauthor=L.+Coccoauthor=A.+M.+Martelliauthor=M.+Cervello&title=GSK-3+as+potential+target+for+therapeutic+intervention+in+cancer&doi=10.18632%2Foncotarget.2037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2037%26sid%3Dliteratum%253Aachs%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DBertrand%26aufirst%3DF.%2BE.%26aulast%3DDavis%26aufirst%3DN.%2BM.%26aulast%3DSokolosky%26aufirst%3DM.%26aulast%3DAbrams%26aufirst%3DS.%2BL.%26aulast%3DMontalto%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Assoro%26aufirst%3DA.%2BB.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DMaestro%26aufirst%3DR.%26aulast%3DBasecke%26aufirst%3DJ.%26aulast%3DRakus%26aufirst%3DD.%26aulast%3DGizak%26aufirst%3DA.%26aulast%3DDemidenko%26aufirst%3DZ.%26aulast%3DCocco%26aufirst%3DL.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26aulast%3DCervello%26aufirst%3DM.%26atitle%3DGSK-3%2520as%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D10%26spage%3D2881%26epage%3D2911%26doi%3D10.18632%2Foncotarget.2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gray, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brail, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooksey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrington, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span> </span><span class="NLM_article-title">A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span><span class="refDoi"> DOI: 10.1007/s10637-015-0278-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1007%2Fs10637-015-0278-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=26403509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1187-1196&author=J.+E.+Grayauthor=J.+R.+Infanteauthor=L.+H.+Brailauthor=G.+R.+Simonauthor=J.+F.+Cookseyauthor=S.+F.+Jonesauthor=D.+L.+Farringtonauthor=A.+Yeoauthor=K.+A.+Jacksonauthor=K.+H.+Chowauthor=M.+J.+Zamek-Gliszczynskiauthor=H.+A.+Burris&title=A+first-in-human+phase+I+dose-escalation%2C+pharmacokinetic%2C+and+pharmacodynamic+evaluation+of+intravenous+LY2090314%2C+a+glycogen+synthase+kinase+3+inhibitor%2C+administered+in+combination+with+pemetrexed+and+carboplatin&doi=10.1007%2Fs10637-015-0278-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin</span></div><div class="casAuthors">Gray, Jhanelle E.; Infante, Jeffrey R.; Brail, Les H.; Simon, George R.; Cooksey, Jennifer F.; Jones, Suzanne F.; Farrington, Daphne L.; Yeo, Adeline; Jackson, Kimberley A.; Chow, Kay H.; Zamek-Gliszczynski, Maciej J.; Burris, Howard A., III</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1187-1196</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclin. efficacy in xenograft models when combined with platinum regimens.  A first-in-human phase 1 dose-escalation study evaluated the combination of LY with pemetrexed/carboplatin.  Forty-one patients with advanced solid tumors received single-dose LY monotherapy lead-in and 37 patients received LY (10-120 mg) plus pemetrexed/carboplatin (500 mg/m2 and 5-6 AUC, resp.) across 8 dose levels every 21 days.  Primary objective was max. tolerated dose (MTD) detn.; secondary endpoints included safety, antitumor activity, pharmacokinetics, and beta-catenin pharmacodynamics.  MTD of LY with pemetrexed/carboplatin was 40 mg.  Eleven dose-limiting toxicities (DLTs) occurred in ten patients.  DLTs during LY monotherapy occurred at ≥40 mg: grade 2 visual disturbance (n = 1) and grade 3/4 peri-infusional thoracic pain during or shortly post infusion (n = 4; chest, upper abdominal, and back pain).  Ranitidine was added after de-escalation to 80 mg LY to minimize peri-infusional thoracic pain.  Following LY with pemetrexed/carboplatin therapy, DLTs included grade 3/4 thrombocytopenia (n = 4) and grade 4 neutropenia (n = 1).  Best overall response by RECIST included 5 confirmed partial responses (non-small cell lung cancer [n = 3], mesothelioma, and breast cancer) and 19 patients having stable disease.  Systemic LY exposure was approx. linear over dose range studied.  Transient upregulation of beta-catenin measured in peripheral blood mononuclear cells (PBMCs) occurred at 40 mg LY.  The initial safety profile of LY2090314 was established.  MTD LY dose with pemetrexed/carboplatin is 40 mg IV every 3 wk plus ranitidine.  Efficacy of LY plus pemetrexed/carboplatin requires confirmation in randomized trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERZ5mBHdU37Vg90H21EOLACvtfcHk0ljmTqR4UvMCWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsr3P&md5=432e42751491fdd88a53688888d89909</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10637-015-0278-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-015-0278-7%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DJ.%2BE.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DBrail%26aufirst%3DL.%2BH.%26aulast%3DSimon%26aufirst%3DG.%2BR.%26aulast%3DCooksey%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DFarrington%26aufirst%3DD.%2BL.%26aulast%3DYeo%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26atitle%3DA%2520first-in-human%2520phase%2520I%2520dose-escalation%252C%2520pharmacokinetic%252C%2520and%2520pharmacodynamic%2520evaluation%2520of%2520intravenous%2520LY2090314%252C%2520a%2520glycogen%2520synthase%2520kinase%25203%2520inhibitor%252C%2520administered%2520in%2520combination%2520with%2520pemetrexed%2520and%2520carboplatin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2015%26volume%3D33%26spage%3D1187%26epage%3D1196%26doi%3D10.1007%2Fs10637-015-0278-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery of GSK-3 Inhibitors and a Perspective on their Utility for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0065-7743(09)04401-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0065-7743%2809%2904401-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3-26&author=R.+G.+Gentlesauthor=S.+Huauthor=G.+M.+Dubowchik&title=Recent+Advances+in+the+Discovery+of+GSK-3+Inhibitors+and+a+Perspective+on+their+Utility+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0065-7743%2809%2904401-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904401-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904401-7%26sid%3Dliteratum%253Aachs%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520of%2520GSK-3%2520Inhibitors%2520and%2520a%2520Perspective%2520on%2520their%2520Utility%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0065-7743%2809%2904401-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer’s Disease Models</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1155/2012/381029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1155%2F2012%2F381029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-32&author=T.+Kramerauthor=B.+Schmidtauthor=F.+Lo+Monte&title=Small-Molecule+Inhibitors+of+GSK-3%3A+Structural+Insights+and+Their+Application+to+Alzheimer%E2%80%99s+Disease+Models&doi=10.1155%2F2012%2F381029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2012%2F381029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F381029%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520GSK-3%253A%2520Structural%2520Insights%2520and%2520Their%2520Application%2520to%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Models%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D32%26doi%3D10.1155%2F2012%2F381029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Selenica, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helboe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotharius, J.</span><span> </span><span class="NLM_article-title">Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2Fsj.bjp.0707471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=17906685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=959-979&author=M.+L.+Selenicaauthor=H.+S.+Jensenauthor=A.+K.+Larsenauthor=M.+L.+Pedersenauthor=L.+Helboeauthor=M.+Leistauthor=J.+Lotharius&title=Efficacy+of+small-molecule+glycogen+synthase+kinase-3+inhibitors+in+the+postnatal+rat+model+of+tau+hyperphosphorylation&doi=10.1038%2Fsj.bjp.0707471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation</span></div><div class="casAuthors">Selenica, M.-L.; Jensen, H. S.; Larsen, A. K.; Pedersen, M. L.; Helboe, L.; Leist, M.; Lotharius, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-979</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) affects neuropathol. events assocd. with Alzheimer's disease (AD) such as hyperphosphorylation of the protein, tau.  GSK-3β expression, enzyme activity and tau phosphorylated at AD-relevant epitopes are elevated in juvenile rodent brains.  Here, we assess five GSK-3β inhibitors and lithium in lowering phosphorylated tau (p-tau) and GSK-3β enzyme activity levels in 12-day old postnatal rats.  Brain levels of inhibitors following treatment in vivo were optimized based on pharmacokinetic data.  At optimal doses, p-tau (Ser396) levels in brain tissue was measured by immunoblotting and correlated with GSK-3β enzyme activities in the same tissues.  Effects of GSK inhibitors on p-tau, GSK-3β activities and cell death were measured in a human neuronal cell line (LUHMES).  Lithium and CHIR98014 reduced tau phosphorylation (Ser396) in the cortex and hippocampus of postnatal rats, while Alsterpaullone and SB216763 were effective only in hippocampus.  AR-A014418 and Indirubin-3'-monoxime were ineffective in either brain region.  Inhibition of p-tau in brain required several-fold higher levels of GSK inhibitors than the IC50 values obtained in recombinant or cell-based GSK-3β enzyme activity assays.  The inhibitory effect on GSK-3 activity ex vivo correlated with protection against cell death and decrease of p-tau- in LUHMES cells, using low M inhibitor concns.  Selective small-mol. inhibitors of GSK-3β reduce tau phosphorylation in vivo.  These findings corroborate earlier suggestions that GSK-3 may be an attractive target for disease-modification in AD and related conditions where tau phosphorylation is believed to contribute to disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYyPbYO9nGNbVg90H21EOLACvtfcHk0liZmevj7Exihg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynt73E&md5=ace7b6b45cce7c07516e6572183f1e1a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707471%26sid%3Dliteratum%253Aachs%26aulast%3DSelenica%26aufirst%3DM.%2BL.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DPedersen%26aufirst%3DM.%2BL.%26aulast%3DHelboe%26aufirst%3DL.%26aulast%3DLeist%26aufirst%3DM.%26aulast%3DLotharius%26aufirst%3DJ.%26atitle%3DEfficacy%2520of%2520small-molecule%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%2520in%2520the%2520postnatal%2520rat%2520model%2520of%2520tau%2520hyperphosphorylation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D959%26epage%3D979%26doi%3D10.1038%2Fsj.bjp.0707471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Khodor, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramboz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhortova, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1021/cn200085z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200085z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-11&author=P.+C.+Chenauthor=I.+N.+Gaisinaauthor=B.+F.+El-Khodorauthor=S.+Rambozauthor=N.+R.+Makhortovaauthor=L.+L.+Rubinauthor=A.+P.+Kozikowski&title=Identification+of+a+Maleimide-Based+Glycogen+Synthase+Kinase-3+%28GSK-3%29+Inhibitor%2C+BIP-135%2C+That+Prolongs+the+Median+Survival+Time+of+%CE%947+SMA+KO+Mouse+Model+of+Spinal+Muscular+Atrophy&doi=10.1021%2Fcn200085z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span></div><div class="casAuthors">Chen, Po C.; Gaisina, Irina N.; El-Khodor, Bassem F.; Ramboz, Sylvie; Makhortova, Nina R.; Rubin, Lee L.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-11</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of upregulated glycogen synthase kinase-3 (GSK-3) in various pathol. conditions has led to the development of a host of chem. diverse small mol. GSK-3 inhibitors, such as BIP-135 (I).  GSK-3 inhibition emerged as an alternative therapeutic target for treating spinal muscular atrophy (SMA) when a no. of GSK-3 inhibitors were shown to elevate survival motor neuron (SMN) levels in vitro and to rescue motor neurons when their intrinsic SMN level was diminished by SMN-specific short hairpin RNA (shRNA).  Despite their cellular potency, the in vivo efficacy of GSK-3 inhibitors has yet to be evaluated in an animal model of SMA.  Herein, we disclose that a potent and reasonably selective GSK-3 inhibitor, namely BIP-135, was tested in a transgenic Δ7 SMA KO mouse model of SMA and found to prolong the median survival of these animals.  In addn., this compd. was shown to elevate the SMN protein level in SMA patient-derived fibroblast cells as detd. by Western blot, and was neuroprotective in a cell-based, SMA-related model of oxidative stress-induced neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcySOXJLoZx7Vg90H21EOLACvtfcHk0lhwgpxwrSyWDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL&md5=728c77967169f3fa99263b1a2622d084</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcn200085z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200085z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DEl-Khodor%26aufirst%3DB.%2BF.%26aulast%3DRamboz%26aufirst%3DS.%26aulast%3DMakhortova%26aufirst%3DN.%2BR.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520a%2520Maleimide-Based%2520Glycogen%2520Synthase%2520Kinase-3%2520%2528GSK-3%2529%2520Inhibitor%252C%2520BIP-135%252C%2520That%2520Prolongs%2520the%2520Median%2520Survival%2520Time%2520of%2520%25CE%25947%2520SMA%2520KO%2520Mouse%2520Model%2520of%2520Spinal%2520Muscular%2520Atrophy%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D11%26doi%3D10.1021%2Fcn200085z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Textor, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6270</span><span class="NLM_x">–</span> <span class="NLM_lpage">6286</span><span class="refDoi"> DOI: 10.1021/jm900647e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900647e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6270-6286&author=M.+Saitohauthor=J.+Kunitomoauthor=E.+Kimuraauthor=H.+Iwashitaauthor=Y.+Unoauthor=T.+Onishiauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=T.+Tanakaauthor=C.+D.+Molauthor=D.+R.+Douganauthor=G.+P.+Textorauthor=G.+P.+Snellauthor=M.+Takizawaauthor=F.+Itohauthor=M.+Kori&title=2-%7B3-%5B4-%28Alkylsulfinyl%29phenyl%5D-1-benzofuran-5-yl%7D-5-methyl-1%2C3%2C4-oxadiazole+Derivatives+as+Novel+Inhibitors+of+Glycogen+Synthase+Kinase-3%CE%B2+with+Good+Brain+Permeability&doi=10.1021%2Fjm900647e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900647e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900647e%26sid%3Dliteratum%253Aachs%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DOnishi%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DTextor%26aufirst%3DG.%2BP.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DTakizawa%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKori%26aufirst%3DM.%26atitle%3D2-%257B3-%255B4-%2528Alkylsulfinyl%2529phenyl%255D-1-benzofuran-5-yl%257D-5-methyl-1%252C3%252C4-oxadiazole%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%2520with%2520Good%2520Brain%2520Permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6270%26epage%3D6286%26doi%3D10.1021%2Fjm900647e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Onishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, M.</span><span> </span><span class="NLM_article-title">A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(<i>S</i>)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07532.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1111%2Fj.1471-4159.2011.07532.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21992552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GqtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=1330-1340&author=T.+Onishiauthor=H.+Iwashitaauthor=Y.+Unoauthor=J.+Kunitomoauthor=M.+Saitohauthor=E.+Kimuraauthor=H.+Fujitaauthor=N.+Uchiyamaauthor=M.+Koriauthor=M.+Takizawa&title=A+novel+glycogen+synthase+kinase-3+inhibitor+2-methyl-5-%283-%7B4-%5B%28S%29-methylsulfinyl%5Dphenyl%7D-1-benzofuran-5-yl%29-1%2C3%2C4-oxadiazole+decreases+tau+phosphorylation+and+ameliorates+cognitive+deficits+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07532.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease</span></div><div class="casAuthors">Onishi, Tomohiro; Iwashita, Hiroki; Uno, Yumiko; Kunitomo, Jun; Saitoh, Morihisa; Kimura, Eiji; Fujita, Hisashi; Uchiyama, Noriko; Kori, Masakuni; Takizawa, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">1330-1340</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder leading to a progressive loss of cognitive function and is pathol. characterized by senile plaques and neurofibrillary tangles.  Glycogen synthase kinase-3 (GSK-3) is involved in AD pathogenesis.  GSK-3 is reported not only to phosphorylate tau, a major component of neurofibrillary tangles, but also to regulate the prodn. of amyloid β, which is deposited in senile plaques.  Therefore, pharmacol. inhibition of GSK-3 is considered an attractive therapeutic approach.  In this study, we report the pharmacol. effects of a novel GSK-3 inhibitor, 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole (MMBO), which displays high selectivity for GSK-3 and brain penetration following oral administration.  MMBO inhibited tau phosphorylation in primary neural cell culture and also in normal mouse brain.  When administered to a transgenic mouse model of AD, MMBO significantly decreased hippocampal tau phosphorylation at GSK-3 sites.  Addnl., chronic MMBO administration suppressed tau pathol. as assessed by AT8-immunoreactivity without affecting amyloid β pathol.  Finally, in behavioral assessments, MMBO significantly improved memory and cognitive deficits in the Y-maze and in novel object recognition tests in the transgenic AD mouse model.  These results indicate that pharmacol. GSK-3 inhibition ameliorates behavioral dysfunction with suppression of tau phosphorylation in an AD mouse model, and that MMBO might be beneficial for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBzTlsWPk5ELVg90H21EOLACvtfcHk0ljBOv1pMvNUyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GqtbrM&md5=635985e46ba585e33dd54e7b4c705422</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07532.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07532.x%26sid%3Dliteratum%253Aachs%26aulast%3DOnishi%26aufirst%3DT.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKori%26aufirst%3DM.%26aulast%3DTakizawa%26aufirst%3DM.%26atitle%3DA%2520novel%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%25202-methyl-5-%25283-%257B4-%255B%2528S%2529-methylsulfinyl%255Dphenyl%257D-1-benzofuran-5-yl%2529-1%252C3%252C4-oxadiazole%2520decreases%2520tau%2520phosphorylation%2520and%2520ameliorates%2520cognitive%2520deficits%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D119%26spage%3D1330%26epage%3D1340%26doi%3D10.1111%2Fj.1471-4159.2011.07532.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, A.</span><span> </span><span class="NLM_article-title">Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl] carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1296</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.brainres.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19698704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyqsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1296&publication_year=2009&pages=148-163&author=Y.+Unoauthor=H.+Iwashitaauthor=T.+Tsukamotoauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=M.+Koriauthor=A.+Nakanishi&title=Efficacy+of+a+novel%2C+orally+active+GSK-3+inhibitor+6-Methyl-N-%5B3-%5B%5B3-%281-methylethoxy%29propyl%5D+carbamoyl%5D-1H-pyrazol-4-yl%5Dpyridine-3-carboxamide+in+tau+transgenic+mice&doi=10.1016%2Fj.brainres.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice</span></div><div class="casAuthors">Uno, Yumiko; Iwashita, Hiroki; Tsukamoto, Tetsuya; Uchiyama, Noriko; Kawamoto, Tomohiro; Kori, Masakuni; Nakanishi, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-163</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) composed of hyperphosphorylated and aggregated tau are common pathol. characteristics in Alzheimer's disease (AD) and other tauopathies.  Aberrant tau phosphorylation is an early and pivotal event in the pathogenesis of tauopathies, and since GSK-3 is a key factor implicated in aberrant tau phosphorylation, GSK-3 inhibition is expected to suppress tauopathy disease progression.  In the present study, we report the efficacy of a newly discovered small mol. GSK-3 inhibitor, 6-methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide (compd. A), to inhibit tau phosphorylation and to reduce the amt. of pathol. aggregated tau in JNPL3 mice that overexpress a mutant form of human tau.  Compd. A is a highly potent and selective inhibitor of GSK-3 with an IC50 of 2 nM, with at least 230-fold lower potency against 27 other kinases.  Oral administration of compd. A resulted in a significant redn. of tau phosphorylation at several GSK-3 directed sites.  Furthermore, chronic oral administration of compd. A markedly reduced aggregated tau in old JNPL3 mice.  These results suggest that a novel, orally active GSK-3 inhibitor, compd. A, has potency in the prevention of tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKJz-108FxgLVg90H21EOLACvtfcHk0ljgFv1kUMZZyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyqsbzM&md5=72aed3cddd38d774e1c70bf3530e4d9e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DY.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DKori%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520a%2520novel%252C%2520orally%2520active%2520GSK-3%2520inhibitor%25206-Methyl-N-%255B3-%255B%255B3-%25281-methylethoxy%2529propyl%255D%2520carbamoyl%255D-1H-pyrazol-4-yl%255Dpyridine-3-carboxamide%2520in%2520tau%2520transgenic%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1296%26spage%3D148%26epage%3D163%26doi%3D10.1016%2Fj.brainres.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lesuisse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiraboschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, P.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutruc-Rosset, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Châtreau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarteronet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgevin, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T.</span><span> </span><span class="NLM_article-title">Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2010.01.132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2344-2349&author=D.+Lesuisseauthor=G.+Tiraboschiauthor=A.+Krickauthor=P.-Y.+Abecassisauthor=G.+Dutruc-Rossetauthor=D.+Babinauthor=F.+Halleyauthor=F.+Ch%C3%A2treauauthor=S.+Lachaudauthor=A.+Chevalierauthor=D.+Quarteronetauthor=M.-C.+Burgevinauthor=C.+Amaraauthor=P.+Bertrandauthor=T.+Rooney&title=Design+of+potent+and+selective+GSK3%CE%B2+inhibitors+with+acceptable+safety+profile+and+pharmacokinetics&doi=10.1016%2Fj.bmcl.2010.01.132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.132%26sid%3Dliteratum%253Aachs%26aulast%3DLesuisse%26aufirst%3DD.%26aulast%3DTiraboschi%26aufirst%3DG.%26aulast%3DKrick%26aufirst%3DA.%26aulast%3DAbecassis%26aufirst%3DP.-Y.%26aulast%3DDutruc-Rosset%26aufirst%3DG.%26aulast%3DBabin%26aufirst%3DD.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DCh%25C3%25A2treau%26aufirst%3DF.%26aulast%3DLachaud%26aufirst%3DS.%26aulast%3DChevalier%26aufirst%3DA.%26aulast%3DQuarteronet%26aufirst%3DD.%26aulast%3DBurgevin%26aufirst%3DM.-C.%26aulast%3DAmara%26aufirst%3DC.%26aulast%3DBertrand%26aufirst%3DP.%26aulast%3DRooney%26aufirst%3DT.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520GSK3%25CE%25B2%2520inhibitors%2520with%2520acceptable%2520safety%2520profile%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2344%26epage%3D2349%26doi%3D10.1016%2Fj.bmcl.2010.01.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Coffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng-Lovering, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span> </span><span class="NLM_article-title">6-Amino-4-(pyrimidin-4-yl)pyridones: Novel glycogen synthase kinase-3β inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2011.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21295469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1429-1433&author=K.+Coffmanauthor=M.+Brodneyauthor=J.+Cookauthor=L.+Lanyonauthor=J.+Panditauthor=S.+Sakyaauthor=J.+Schachterauthor=E.+Tseng-Loveringauthor=M.+Wessel&title=6-Amino-4-%28pyrimidin-4-yl%29pyridones%3A+Novel+glycogen+synthase+kinase-3%CE%B2+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">6-Amino-4-(pyrimidin-4-yl)pyridones: Novel glycogen synthase kinase-3β inhibitors</span></div><div class="casAuthors">Coffman, Karen; Brodney, Michael; Cook, James; Lanyon, Lorraine; Pandit, Jayvardhan; Sakya, Subas; Schachter, Joel; Tseng-Lovering, Elaine; Wessel, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1429-1433</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships for a novel series of 6-amino-4-(pyrimidin-4-yl)pyridones e. g., I derived from a high throughput screening hit are discussed.  Optimization of lead matter afforded compds. with good potency, selectivity and central nervous system (CNS) exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwwTI16k0bW7Vg90H21EOLACvtfcHk0lgOnEQbeHhdPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gmurw%253D&md5=9ba1c30bc6714d2299dde007bf322708</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DK.%26aulast%3DBrodney%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSakya%26aufirst%3DS.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DTseng-Lovering%26aufirst%3DE.%26aulast%3DWessel%26aufirst%3DM.%26atitle%3D6-Amino-4-%2528pyrimidin-4-yl%2529pyridones%253A%2520Novel%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2011.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogdin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Alfredsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span> </span><span class="NLM_article-title">Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9107</span><span class="NLM_x">–</span> <span class="NLM_lpage">9119</span><span class="refDoi"> DOI: 10.1021/jm201724m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201724m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9107-9119&author=S.+Bergauthor=M.+Berghauthor=S.+Hellbergauthor=K.+Hogdinauthor=Y.+Lo-Alfredssonauthor=P.+Sodermanauthor=S.+von+Bergauthor=T.+Weigeltauthor=M.+Ormoauthor=Y.+Xueauthor=J.+Tuckerauthor=J.+Neelissenauthor=E.+Jerningauthor=Y.+Nilssonauthor=R.+Bhat&title=Discovery+of+Novel+Potent+and+Highly+Selective+Glycogen+Synthase+Kinase-3%CE%B2+%28GSK3%CE%B2%29+Inhibitors+for+Alzheimer%E2%80%99s+Disease%3A+Design%2C+Synthesis%2C+and+Characterization+of+Pyrazines&doi=10.1021%2Fjm201724m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer's Disease: Design, Synthesis, and Characterization of Pyrazines</span></div><div class="casAuthors">Berg, Stefan; Bergh, Margareta; Hellberg, Sven; Hoegdin, Katharina; Lo-Alfredsson, Yvonne; Soederman, Peter; von Berg, Stefan; Weigelt, Tatjana; Ormoe, Mats; Xue, Yafeng; Tucker, Julie; Neelissen, Jan; Jerning, Eva; Nilsson, Yvonne; Bhat, Ratan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9107-9119</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/threonine kinase which was originally identified due to its role in glycogen metab.  Active forms of GSK3β localize to pretangle pathol. including dystrophic neuritis and neurofibrillary tangles in Alzheimer's disease (AD) brain.  By using a high throughput screening (HTS) approach to search for new chem. series and cocrystn. of key analogs to guide the optimization and synthesis of our pyrazine series, we have developed highly potent and selective inhibitors showing cellular efficacy and blood-brain barrier penetration.  The inhibitors are suitable for in vivo efficacy testing and may serve as a new treatment strategy for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR4w7EMbaI7Vg90H21EOLACvtfcHk0lgOnEQbeHhdPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggtrc%253D&md5=f1475e38163a8e81e9ca9a24b271a0be</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201724m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201724m%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DHogdin%26aufirst%3DK.%26aulast%3DLo-Alfredsson%26aufirst%3DY.%26aulast%3DSoderman%26aufirst%3DP.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DWeigelt%26aufirst%3DT.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DTucker%26aufirst%3DJ.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Novel%2520Potent%2520and%2520Highly%2520Selective%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%2520%2528GSK3%25CE%25B2%2529%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Characterization%2520of%2520Pyrazines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9107%26epage%3D9119%26doi%3D10.1021%2Fjm201724m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaprakasam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civiello, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacutin-Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapiel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nophsker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2015.03.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1856-1863&author=X.+Hanauthor=P.+Sivaprakasamauthor=R.+L.+Civielloauthor=S.+Jacutin-Porteauthor=K.+Kishauthor=M.+Pokrossauthor=H.+A.+Lewisauthor=N.+Ahmedauthor=N.+Szapielauthor=J.+A.+Newittauthor=E.+T.+Baldwinauthor=H.+Xiaoauthor=C.+M.+Krauseauthor=H.+Parkauthor=M.+Nophskerauthor=J.+S.+Lippyauthor=C.+R.+Burtonauthor=D.+R.+Langleyauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+new+acylaminopyridines+as+GSK-3+inhibitors+by+a+structure+guided+in-depth+exploration+of+chemical+space+around+a+pyrrolopyridinone+core&doi=10.1016%2Fj.bmcl.2015.03.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DSivaprakasam%26aufirst%3DP.%26aulast%3DCiviello%26aufirst%3DR.%2BL.%26aulast%3DJacutin-Porte%26aufirst%3DS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DH.%2BA.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DSzapiel%26aufirst%3DN.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DKrause%26aufirst%3DC.%2BM.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520new%2520acylaminopyridines%2520as%2520GSK-3%2520inhibitors%2520by%2520a%2520structure%2520guided%2520in-depth%2520exploration%2520of%2520chemical%2520space%2520around%2520a%2520pyrrolopyridinone%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1856%26epage%3D1863%26doi%3D10.1016%2Fj.bmcl.2015.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Pd-catalyzed intermolecular amidation of aryl halides: the discovery that xantphos can be trans-chelating in a palladium complex</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">6043</span><span class="NLM_x">–</span> <span class="NLM_lpage">6048</span><span class="refDoi"> DOI: 10.1021/ja012610k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja012610k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=6043-6048&author=J.+Yinauthor=S.+L.+Buchwald&title=Pd-catalyzed+intermolecular+amidation+of+aryl+halides%3A+the+discovery+that+xantphos+can+be+trans-chelating+in+a+palladium+complex&doi=10.1021%2Fja012610k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed Intermolecular Amidation of Aryl Halides: The Discovery that Xantphos Can Be Trans-Chelating in a Palladium Complex</span></div><div class="casAuthors">Yin, Jingjun; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6043-6048</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the intermol. coupling of aryl halides and amides using a Xantphos/Pd catalyst is described.  This system displays good functional group compatibility, and the desired C-N bond forming process proceeds in good to excellent yields with 1-4 mol % of the Pd catalyst.  Addnl., the arylation of sulfonamides, oxazolidinones, and ureas is reported.  The efficiency of these transformations was found to be highly dependent on reaction concns. and catalyst loadings.  A Pd complex resulting from oxidative addn. of 4-bromobenzonitrile, (Xantphos)Pd(4-cyanophenyl)(Br), was prepd. in one step from Xantphos, Pd2(dba)3, and the aryl bromide.  The complex proved to be an active catalyst for the coupling between 4-bromobenzonitrile and benzamide.  X-ray crystallog. anal. revealed a rare trans-chelating bisphosphine-Pd(II) structure with a large bite angle of 150.7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqutPXg1bRArVg90H21EOLACvtfcHk0ljVB01h8pMJkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlGis7Y%253D&md5=94eef150b41a39e7ae60b4fbe5ee7f8b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja012610k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja012610k%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPd-catalyzed%2520intermolecular%2520amidation%2520of%2520aryl%2520halides%253A%2520the%2520discovery%2520that%2520xantphos%2520can%2520be%2520trans-chelating%2520in%2520a%2520palladium%2520complex%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D6043%26epage%3D6048%26doi%3D10.1021%2Fja012610k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv" class="ext-link">Supporting Information</a> for details. Compounds <b>4</b> and <b>7</b> had GSK-3β IC<sub>50</sub>’s of 1.5 and 3.8 nM, respectively, in our assay. Their Ambit profiles are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">The GSK-3β protein was expressed and purified as described in ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>. The X-ray crystal structures of compounds <b>15</b> and <b>18</b> were deposited in the Protein Data Bank with PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F94">5F94</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F95">5F95</a>. See the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span> </span><span class="NLM_article-title">Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1107/S090744490302938X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1107%2FS090744490302938X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=439-46&author=M.+Aokiauthor=T.+Yokotaauthor=I.+Sugiuraauthor=C.+Sasakiauthor=T.+Hasegawaauthor=C.+Okumuraauthor=K.+Ishiguroauthor=T.+Kohnoauthor=S.+Sugioauthor=T.+Matsuzaki&title=Structural+insight+into+nucleotide+recognition+in+tau-protein+kinase+I%2Fglycogen+synthase+kinase+3+beta&doi=10.1107%2FS090744490302938X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS090744490302938X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490302938X%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DSugiura%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DC.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DC.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DSugio%26aufirst%3DS.%26aulast%3DMatsuzaki%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520nucleotide%2520recognition%2520in%2520tau-protein%2520kinase%2520I%252Fglycogen%2520synthase%2520kinase%25203%2520beta%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D439%26epage%3D46%26doi%3D10.1107%2FS090744490302938X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>The PyMOL Molecular Graphics System, version 1.0r2; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+version+1.0r2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0liFaYXK86Ineg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="note"><p class="first last">The following kinases tested in-house for compound <b>15</b> all have IC<sub>50</sub>’s > 2 μM: Aurora-B, BTK, CDK2, CK2A2, IRAK4, JAK2, JNK1-R, LCK, LG921, and TYK2 887; the following kinases tested in-house for compound <b>15</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (4.8), CDK5/p25 (5.4), cKIT, IGF1R, mAurA, MK2, P38A, PDGRb, PIM1 (3.1), PKCth, RSK1, and SYK.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="note"><p class="first last">The following kinases tested in-house for compound <b>18</b> all have IC<sub>50</sub>’s > 2 μM: Aurora-B, BTK, CDK2, CK2A2, CK2A2B, CK1E, IKK2, IRAK4, JAK1 CAL, FMS, JAK1, JAK2, JAK3, JNK1-R, LCK, LG921, ROCK1, ROCK2mut, SRMS, TRKA CAL, TRKB CAL, TYK2, and TYK2 887; the following kinases tested in-house for compound <b>18</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (13), ACK, CDK5/p25, cKIT, IGF1R, mAurA, MK2, P38A, PDGRb (36), PIM1, PKCth, RSK1, and SYK. The following kinases tested in-house for compound <b>29</b> all have IC<sub>50</sub>’s > 2 μM except for those with numbers (μM) given in parenthesis: Aurora-B, BTK, CDK2, CK2A2, CK2A2B, CK1D, CK1E, FMS, IRAK4, JAK1 CAL, JAK2,, JAK3, LCK, LG921 (1.9), ROCK1, ROCK2mut, STK33AD, SRMS, TRKA CAL, TRKBCAL, TYK2, TYK2 887, and ZAP70; the following kinases tested in-house for compound <b>29</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (19), ACK, CDK5/p25 (42), cKIT, CSK, IGF1R, MK2, P38A, PDGRb, PKCth, and SYK. The following kinases tested in-house for compound <b>33</b> all have IC<sub>50</sub>’s > 2 μM except for those with numbers (μM) given in parenthesis: Aurora-B, BTK, BMX, CDK2, CK2A1, CK2A2, CK2A1B, CK2A2B, CK1D, CK1E, FMS, IRAK1 (1.6), IRAK4, ITK, JAK2, JAK3, JNK1-R, LCK, LG921, LYNA, ROCK1, ROCK2mut, STK33AD, TEC, TNIK, TRKA CAL, TRKB CAL, TYK2, TYK2 887, and ZAP70; the following kinases tested in-house for compound <b>33</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: CDK5/p25 (42), cKIT, CSK, FYN, IGF1R, mAurA, MK2, MARK1, MARK2, MARK3, MARK4, P38A, PDGRb, PIM1, PKCTH, RSK1, SYK (42), TTBK1, and TTBK2. The Ambit heat map values for compounds <b>18</b>, <b>29</b>, and <b>33</b> are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> as well.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span> <span class="citation_source-book">Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development</span>; <span class="NLM_contrib-group">Martínez, A.; Castro, A.; Medina, M.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1002%2F0470052171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Mart%C3%ADnez&author=A.+Castro&author=M.+Medina&title=Glycogen+Synthase+Kinase+3+%28GSK-3%29+and+Its+Inhibitors%3A+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F0470052171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470052171%26sid%3Dliteratum%253Aachs%26btitle%3DGlycogen%2520Synthase%2520Kinase%25203%2520%2528GSK-3%2529%2520and%2520Its%2520Inhibitors%253A%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26pub%3DWiley-Interscience%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metherate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbari, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1016/S0896-6273(03)00434-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0896-6273%2803%2900434-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=12895417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFOksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2003&pages=409-421&author=S.+Oddoauthor=A.+Caccamoauthor=J.+D.+Shepherdauthor=M.+P.+Murphyauthor=T.+E.+Goldeauthor=R.+Kayedauthor=R.+Metherateauthor=M.+P.+Mattsonauthor=Y.+Akbariauthor=F.+M.+LaFerla&title=Triple-transgenic+model+of+Alzheimer%E2%80%99s+disease+with+plaques+and+tangles%3A+intracellular+Abeta+and+synaptic+dysfunction&doi=10.1016%2FS0896-6273%2803%2900434-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction</span></div><div class="casAuthors">Oddo, Salvatore; Caccamo, Antonella; Shepherd, Jason D.; Murphy, M. Paul; Golde, Todd E.; Kayed, Rakez; Metherate, Raju; Mattson, Mark P.; Akbari, Yama; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The neuropathol. correlates of Alzheimer's disease (AD) include amyloid-β (Aβ) plaques and neurofibrillary tangles.  To study the interaction between Aβ and tau and their effect on synaptic function, we derived a triple-transgenic model (3×Tg-AD) harboring PS1M146V, APPSwe, and tauP301L transgenes.  Rather than crossing independent lines, we microinjected two transgenes into single-cell embryos from homozygous PS1M146V knockin mice, generating mice with the same genetic background.  3×Tg-AD mice progressively develop plaques and tangles.  Synaptic dysfunction, including LTP deficits, manifests in an age-related manner, but before plaque and tangle pathol.  Deficits in long-term synaptic plasticity correlate with the accumulation of intraneuronal Aβ.  These studies suggest a novel pathogenic role for intraneuronal Aβ with regards to synaptic plasticity.  The recapitulation of salient features of AD in these mice clarifies the relationships between Aβ, synaptic dysfunction, and tangles and provides a valuable model for evaluating potential AD therapeutics as the impact on both lesions can be assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw1IPrYvfU7Vg90H21EOLACvtfcHk0liFaYXK86Ineg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFOksro%253D&md5=4abc16e818125d976b34e1e68128130d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900434-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900434-3%26sid%3Dliteratum%253Aachs%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DShepherd%26aufirst%3DJ.%2BD.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DMetherate%26aufirst%3DR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAkbari%26aufirst%3DY.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DTriple-transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520plaques%2520and%2520tangles%253A%2520intracellular%2520Abeta%2520and%2520synaptic%2520dysfunction%26jtitle%3DNeuron%26date%3D2003%26volume%3D39%26spage%3D409%26epage%3D421%26doi%3D10.1016%2FS0896-6273%2803%2900434-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="note"><p class="first last">See the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> for detailed data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':[],'ref42':[],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':[],'ref47':[],'ref48':['cit48'],'ref49':['cit49'],'ref50':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuhua Zhong, Shaoxi Yang, Jianyu Cui, Jie Wang, Lin Li, Yilin Chen, Junjie Chen, Pengju Feng, Shun Huang, Hongsheng Li, Yanjian Han, Ganghua Tang, <span class="NLM_string-name hlFld-ContribAuthor">Kongzhen Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 18F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021,</strong> <em>18 </em>
                                    (3)
                                     , 1277-1284. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c01133" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c01133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c01133%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DNovel%252B18F-Labeled%252BIsonicotinamide-Based%252BRadioligands%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%26aulast%3DZhong%26aufirst%3DYuhua%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D18112020%26date%3D11012021%26date%3D09012021%26date%3D25012021%26volume%3D18%26issue%3D3%26spage%3D1277%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vadim Bernard-Gauthier, Andrew V. Mossine, Ashley Knight, Debasis Patnaik, Wen-Ning Zhao, Chialin Cheng, Hema S. Krishnan, Lucius L. Xuan, Peter S. Chindavong, Surya A. Reis, Jinshan Michael Chen, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Nicolas Salem, David Bonsall, Brenda Amaral, Cassis Varlow, Lisa Wells, Laurent Martarello, Shil Patel, Steven H. Liang, Ravi G. Kurumbail, Stephen J. Haggarty, Peter J. H. Scott, <span class="NLM_string-name hlFld-ContribAuthor">Neil Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9600-9617. <a href="https://doi.org/10.1021/acs.jmedchem.9b01030" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BBasis%252Bfor%252BAchieving%252BGSK-3%2525CE%2525B2%252BInhibition%252Bwith%252BHigh%252BPotency%25252C%252BSelectivity%25252C%252Band%252BBrain%252BExposure%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Band%252BDrug%252BDiscovery%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28062019%26date%3D21102019%26date%3D19092019%26volume%3D62%26issue%3D21%26spage%3D9600%26epage%3D9617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mei Ding, Johan Brengdahl, Madelene Lindqvist, Ulf Gehrmann, Elke Ericson, Stefan von Berg, Lena Ripa, <span class="NLM_string-name hlFld-ContribAuthor">Rajneesh Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , 543-553. <a href="https://doi.org/10.1021/acschembio.9b00075" title="DOI URL">https://doi.org/10.1021/acschembio.9b00075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00075%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BPhenotypic%252BScreening%252BApproach%252BUsing%252BHuman%252BTreg%252BCells%252BIdentified%252BRegulators%252Bof%252BForkhead%252BBox%252Bp3%252BExpression%26aulast%3DDing%26aufirst%3DMei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25012019%26date%3D25022019%26date%3D04032019%26date%3D26022019%26volume%3D14%26issue%3D3%26spage%3D543%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pradeep
K. Jaiswal, Vashundhra Sharma, Manas Mathur, <span class="NLM_string-name hlFld-ContribAuthor">Sandeep Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Modified Guareschi–Thorpe Type Regioselective Synthesis: A Unified Direct Access to 5,6,7,8-Tetrahydroquinolines and Other Alicyclic[b]-Fused Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (19)
                                     , 6059-6063. <a href="https://doi.org/10.1021/acs.orglett.8b02132" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02132%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOrganocatalytic%252BModified%252BGuareschi%2525E2%252580%252593Thorpe%252BType%252BRegioselective%252BSynthesis%25253A%252BA%252BUnified%252BDirect%252BAccess%252Bto%252B5%25252C6%25252C7%25252C8-Tetrahydroquinolines%252Band%252BOther%252BAlicyclic%25255Bb%25255D-Fused%252BPyridines%26aulast%3DJaiswal%26aufirst%3DPradeep%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01082018%26date%3D14092018%26volume%3D20%26issue%3D19%26spage%3D6059%26epage%3D6063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Yongje  Shin</span>, <span class="hlFld-ContribAuthor ">Jinhee  Kim</span>, and <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 9018-9034. <a href="https://doi.org/10.1021/acs.jmedchem.6b00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BFragment-Based%252Bde%252BNovo%252BDesign%252Bto%252Bthe%252BDiscovery%252Bof%252BSelective%252BPicomolar%252BInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase-3%252BBeta%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28062016%26date%3D30092016%26date%3D13102016%26date%3D27092016%26volume%3D59%26issue%3D19%26spage%3D9018%26epage%3D9034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florence F.  Wagner</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Bishop</span>, <span class="hlFld-ContribAuthor ">Jennifer P.  Gale</span>, <span class="hlFld-ContribAuthor ">Xi  Shi</span>, <span class="hlFld-ContribAuthor ">Michelle  Walk</span>, <span class="hlFld-ContribAuthor ">Joshua  Ketterman</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Doug  Barker</span>, <span class="hlFld-ContribAuthor ">Deepika  Walpita</span>, <span class="hlFld-ContribAuthor ">Arthur J.  Campbell</span>, <span class="hlFld-ContribAuthor ">Shannon  Nguyen</span>, <span class="hlFld-ContribAuthor ">Michael  Lewis</span>, <span class="hlFld-ContribAuthor ">Linda  Ross</span>, <span class="hlFld-ContribAuthor ">Michel  Weïwer</span>, <span class="hlFld-ContribAuthor ">W. Frank  An</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Germain</span>, <span class="hlFld-ContribAuthor ">Partha P.  Nag</span>, <span class="hlFld-ContribAuthor ">Shailesh  Metkar</span>, <span class="hlFld-ContribAuthor ">Taner  Kaya</span>, <span class="hlFld-ContribAuthor ">Sivaraman  Dandapani</span>, <span class="hlFld-ContribAuthor ">David E.  Olson</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Barbe</span>, <span class="hlFld-ContribAuthor ">Fanny  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Joshua R.  Sacher</span>, <span class="hlFld-ContribAuthor ">Jaime H.  Cheah</span>, <span class="hlFld-ContribAuthor ">David  Fei</span>, <span class="hlFld-ContribAuthor ">Jose  Perez</span>, <span class="hlFld-ContribAuthor ">Benito  Munoz</span>, <span class="hlFld-ContribAuthor ">Michelle  Palmer</span>, <span class="hlFld-ContribAuthor ">Kimberly  Stegmaier</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Schreiber</span>, <span class="hlFld-ContribAuthor ">Edward  Scolnick</span>, <span class="hlFld-ContribAuthor ">Yan-Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Edward B.  Holson</span>, and <span class="hlFld-ContribAuthor ">Jen Q.  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 1952-1963. <a href="https://doi.org/10.1021/acschembio.6b00306" title="DOI URL">https://doi.org/10.1021/acschembio.6b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase%252B3%252Bwith%252BExquisite%252BKinome-Wide%252BSelectivity%252Band%252BTheir%252BFunctional%252BEffects%26aulast%3DWagner%26aufirst%3DFlorence%2BF.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04042016%26date%3D29042016%26date%3D13052016%26date%3D15072016%26date%3D29042016%26volume%3D11%26issue%3D7%26spage%3D1952%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Manxing  Zou</span>, <span class="hlFld-ContribAuthor ">Huanfang  Xie</span>, <span class="hlFld-ContribAuthor ">Tailiang  Lin</span>, <span class="hlFld-ContribAuthor ">Weiping  Lyu</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113663. <a href="https://doi.org/10.1016/j.ejmech.2021.113663" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113663%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%252528cyclopropanecarboxamido%252529-N-%2525285-%252528%2525281-%2525284-fluorobenzyl%252529piperidin-4-yl%252529methoxy%252529pyridin-3-yl%252529isonicotinamide%252Bas%252Ba%252Bpotent%252Bdual%252BAChE%25252FGSK3%2525CE%2525B2%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BSignificantly%252Bincreasing%252Bthe%252Blevel%252Bof%252Bacetylcholine%252Bin%252Bthe%252Bbrain%252Bwithout%252Baffecting%252Bthat%252Bin%252Bintestine%26aulast%3DJiang%26aufirst%3DXueyang%26date%3D2021%26volume%3D223%26spage%3D113663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh R.  D’Mello</span>. </span><span class="cited-content_cbyCitation_article-title">When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5911. <a href="https://doi.org/10.3390/ijms22115911" title="DOI URL">https://doi.org/10.3390/ijms22115911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115911%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DWhen%252BGood%252BKinases%252BGo%252BRogue%25253A%252BGSK3%25252C%252Bp38%252BMAPK%252Band%252BCDKs%252Bas%252BTherapeutic%252BTargets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Band%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DSantosh%2BR.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irengbam Rocky  Mangangcha</span>, <span class="hlFld-ContribAuthor ">Raj Kumar  Brojen Singh</span>, <span class="hlFld-ContribAuthor ">Djamel  Lebeche</span>, <span class="hlFld-ContribAuthor ">Shakir  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Xanthone glucoside 2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3β and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>20 </em>, 1-17. <a href="https://doi.org/10.1080/07391102.2021.1902857" title="DOI URL">https://doi.org/10.1080/07391102.2021.1902857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1902857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1902857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DXanthone%252Bglucoside%252B2-%2525CE%2525B2-D-glucopyranosyl-1%25252C3%25252C6%25252C7-tetrahydroxy-9H-xanthen-9-one%252Bbinds%252Bto%252Bthe%252BATP-binding%252Bpocket%252Bof%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%252Band%252Binhibits%252Bits%252Bactivity%25253A%252Bimplications%252Bin%252Bprostate%252Bcancer%252Band%252Bassociated%252Bcardiovascular%252Bdisease%252Brisk%26aulast%3DMangangcha%26aufirst%3DIrengbam%2BRocky%26date%3D2021%26date%3D2021%26volume%3D20%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan-Kui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong-Xu  Xie</span>, <span class="hlFld-ContribAuthor ">Yong-Xi  Ge</span>, <span class="hlFld-ContribAuthor ">Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-Shi  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">An updated research of glycogen synthase kinase-3β inhibitors: a review. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 19-33. <a href="https://doi.org/10.1007/s00706-020-02718-y" title="DOI URL">https://doi.org/10.1007/s00706-020-02718-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02718-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02718-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DAn%252Bupdated%252Bresearch%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%25253A%252Ba%252Breview%26aulast%3DLiu%26aufirst%3DShan-Kui%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D19%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Tongtong  Liu</span>, <span class="hlFld-ContribAuthor ">Shiming  Chen</span>, <span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112874. <a href="https://doi.org/10.1016/j.ejmech.2020.112874" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112874%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B3-%2525284-pyridyl%252529-5-%2525284-sulfamido-phenyl%252529-1%25252C2%25252C4-oxadiazole%252Bderivatives%252Bas%252Bnovel%252BGSK-3%2525CE%2525B2%252Binhibitors%252Band%252Bevaluation%252Bof%252Btheir%252Bpotential%252Bas%252Bmultifunctional%252Banti-Alzheimer%252Bagents%26aulast%3DWang%26aufirst%3DMin%26date%3D2021%26volume%3D209%26spage%3D112874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Opeyemi  Iwaloye</span>, <span class="hlFld-ContribAuthor ">Olusola Olalekan  Elekofehinti</span>, <span class="hlFld-ContribAuthor ">Emmanuel Ayo  Oluwarotimi</span>, <span class="hlFld-ContribAuthor ">Babatom iwa  Kikiowo</span>, <span class="hlFld-ContribAuthor ">Toyin Mary  Fadipe</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies. </span><span class="cited-content_cbyCitation_journal-name">In Silico Pharmacology</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40203-020-00054-x" title="DOI URL">https://doi.org/10.1007/s40203-020-00054-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40203-020-00054-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40203-020-00054-x%26sid%3Dliteratum%253Aachs%26jtitle%3DIn%2520Silico%2520Pharmacology%26atitle%3DInsight%252Binto%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitory%252Bactivity%252Bof%252Bphyto-constituents%252Bfrom%252BMelissa%252Bofficinalis%25253A%252Bin%252Bsilico%252Bstudies%26aulast%3DIwaloye%26aufirst%3DOpeyemi%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Long  Shi</span>, <span class="hlFld-ContribAuthor ">Ning  Yan</span>, <span class="hlFld-ContribAuthor ">Ying-Jie  Cui</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 649. <a href="https://doi.org/10.3390/cells9030649" title="DOI URL">https://doi.org/10.3390/cells9030649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9030649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9030649%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DA%252BUnique%252BGSK-3%2525CE%2525B2%252Binhibitor%252BB10%252BHas%252Ba%252BDirect%252BEffect%252Bon%252BA%2525CE%2525B2%25252C%252BTargets%252BTau%252Band%252BMetal%252BDyshomeostasis%25252C%252Band%252BPromotes%252BNeuronal%252BNeurite%252BOutgrowth%26aulast%3DShi%26aufirst%3DXiao-Long%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D3%26spage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guy  Griebel</span>, <span class="hlFld-ContribAuthor ">Jeanne  Stemmelin</span>, <span class="hlFld-ContribAuthor ">Mati  Lopez-Grancha</span>, <span class="hlFld-ContribAuthor ">Denis  Boulay</span>, <span class="hlFld-ContribAuthor ">Gerald  Boquet</span>, <span class="hlFld-ContribAuthor ">Franck  Slowinski</span>, <span class="hlFld-ContribAuthor ">Philippe  Pichat</span>, <span class="hlFld-ContribAuthor ">Sandra  Beeské</span>, <span class="hlFld-ContribAuthor ">Shinji  Tanaka</span>, <span class="hlFld-ContribAuthor ">Akiko  Mori</span>, <span class="hlFld-ContribAuthor ">Masatake  Fujimura</span>, <span class="hlFld-ContribAuthor ">Junichi  Eguchi</span>. </span><span class="cited-content_cbyCitation_article-title">The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-54557-5" title="DOI URL">https://doi.org/10.1038/s41598-019-54557-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-54557-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-54557-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252Bselective%252BGSK3%252Binhibitor%25252C%252BSAR502250%25252C%252Bdisplays%252Bneuroprotective%252Bactivity%252Band%252Battenuates%252Bbehavioral%252Bimpairments%252Bin%252Bmodels%252Bof%252Bneuropsychiatric%252Bsymptoms%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bin%252Brodents%26aulast%3DGriebel%26aufirst%3DGuy%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdellah  El Aissouq</span>, <span class="hlFld-ContribAuthor ">Hamid  Toufik</span>, <span class="hlFld-ContribAuthor ">Fatima  Lamchouri</span>, <span class="hlFld-ContribAuthor ">Mourad  Stitou</span>, <span class="hlFld-ContribAuthor ">Abdelkrim  Ouammou</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR study of isonicotinamides derivatives as Alzheimr's disease inhibitors using PLS-R and ANN methods. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-7. <a href="https://doi.org/10.1109/ISACS48493.2019.9068919" title="DOI URL">https://doi.org/10.1109/ISACS48493.2019.9068919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/ISACS48493.2019.9068919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FISACS48493.2019.9068919%26sid%3Dliteratum%253Aachs%26atitle%3DQSAR%252Bstudy%252Bof%252Bisonicotinamides%252Bderivatives%252Bas%252BAlzheimr%252527s%252Bdisease%252Binhibitors%252Busing%252BPLS-R%252Band%252BANN%252Bmethods%26aulast%3DEl%2BAissouq%26aufirst%3DAbdellah%26date%3D2019%26spage%3D1%26epage%3D7%26pub%3DIEEE%26atitle%3D2019%252BInternational%252BConference%252Bon%252BIntelligent%252BSystems%252Band%252BAdvanced%252BComputing%252BSciences%252B%252528ISACS%252529%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue‐Gui  Liu</span>, <span class="hlFld-ContribAuthor ">Meng‐Chao  Lv</span>, <span class="hlFld-ContribAuthor ">Ming‐Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">Yu‐Qiu  Sun</span>, <span class="hlFld-ContribAuthor ">Pin‐Yi  Gao</span>, <span class="hlFld-ContribAuthor ">Dan‐Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A network pharmacology study on the triterpene saponins from
              Medicago sativa
              L. for the treatment of Neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Biochemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (8)
                                     <a href="https://doi.org/10.1111/jfbc.12955" title="DOI URL">https://doi.org/10.1111/jfbc.12955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jfbc.12955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjfbc.12955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Biochemistry%26atitle%3DA%252Bnetwork%252Bpharmacology%252Bstudy%252Bon%252Bthe%252Btriterpene%252Bsaponins%252Bfrom%252BMedicago%252Bsativa%252BL.%252Bfor%252Bthe%252Btreatment%252Bof%252BNeurodegenerative%252Bdiseases%26aulast%3DLiu%26aufirst%3DXue%25E2%2580%2590Gui%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Alaa A.  Osman</span>, <span class="hlFld-ContribAuthor ">Marwa A.  Zaater</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s00894-019-4032-5" title="DOI URL">https://doi.org/10.1007/s00894-019-4032-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-019-4032-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-019-4032-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DReceptor-based%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnovel%252BGSK-3%2525CE%2525B2%252Binhibitors%26aulast%3DEl%2BKerdawy%26aufirst%3DAhmed%2BM.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>, <span class="hlFld-ContribAuthor ">Anirudh  Sattiraju</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">J. John  Mann</span>, <span class="hlFld-ContribAuthor ">J.S. Dileep  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of [11C]CMP, a high affinity GSK3 ligand. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 778-781. <a href="https://doi.org/10.1016/j.bmcl.2019.01.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252B%25255B11C%25255DCMP%25252C%252Ba%252Bhigh%252Baffinity%252BGSK3%252Bligand%26aulast%3DPrabhakaran%26aufirst%3DJaya%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D778%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Xu</span>, <span class="hlFld-ContribAuthor ">S.L.  Wang</span>, <span class="hlFld-ContribAuthor ">L.  Zhu</span>, <span class="hlFld-ContribAuthor ">P.Y.  Wu</span>, <span class="hlFld-ContribAuthor ">W.B.  Dai</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 448-470. <a href="https://doi.org/10.1016/j.ejmech.2018.12.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252B%252528SAR%252529%252Bstudies%252Bof%252Bsynthetic%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%25253A%252BA%252Bcritical%252Breview%26aulast%3DXu%26aufirst%3DM.%26date%3D2019%26volume%3D164%26spage%3D448%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Triveni  Pardhi</span>, <span class="hlFld-ContribAuthor ">Kamala  Vasu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 177-194. <a href="https://doi.org/10.1080/07391102.2016.1270856" title="DOI URL">https://doi.org/10.1080/07391102.2016.1270856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1270856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1270856%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Bdual%252Bkinase%252Binhibitors%252Bof%252BCK2%252Band%252BGSK3%2525CE%2525B2%25253A%252Bcombined%252Bqualitative%252Band%252Bquantitative%252Bpharmacophore%252Bmodeling%252Bapproach%26aulast%3DPardhi%26aufirst%3DTriveni%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D1%26spage%3D177%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Prasanth  Saraswati</span>, <span class="hlFld-ContribAuthor ">S.M.  Ali Hussaini</span>, <span class="hlFld-ContribAuthor ">Namballa Hari  Krishna</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 843-858. <a href="https://doi.org/10.1016/j.ejmech.2017.11.103" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.103%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252Bsynthase%252Bkinase-3%252Band%252Bits%252Binhibitors%25253A%252BPotential%252Btarget%252Bfor%252Bvarious%252Btherapeutic%252Bconditions%26aulast%3DSaraswati%26aufirst%3DA.%2BPrasanth%26date%3D2018%26volume%3D144%26spage%3D843%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 657-666. <a href="https://doi.org/10.1080/13543776.2017.1259412" title="DOI URL">https://doi.org/10.1080/13543776.2017.1259412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1259412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1259412%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DGlycogen%252Bsynthase%252Bkinase%252B3%252B%252528GSK-3%252529%252Binhibitors%25253A%252Ba%252Bpatent%252Bupdate%252B%2525282014-2015%252529%26aulast%3DPalomo%26aufirst%3DValle%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D6%26spage%3D657%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 740-743. <a href="https://doi.org/10.1016/j.bmcl.2017.01.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bcarbon-11-labeled%252Bisonicotinamides%252Bas%252Bnew%252Bpotential%252BPET%252Bagents%252Bfor%252Bimaging%252Bof%252BGSK-3%252Benzyme%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGao%26aufirst%3DMingzhang%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D740%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven H.  Liang</span>, <span class="hlFld-ContribAuthor ">Jinshan Michael  Chen</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>, <span class="hlFld-ContribAuthor ">Jeanne S.  Chang</span>, <span class="hlFld-ContribAuthor ">George C.  Chang</span>, <span class="hlFld-ContribAuthor ">Christine K.  Taylor</span>, <span class="hlFld-ContribAuthor ">Patrick  Trapa</span>, <span class="hlFld-ContribAuthor ">Mark S.  Plummer</span>, <span class="hlFld-ContribAuthor ">Kimberly S.  Para</span>, <span class="hlFld-ContribAuthor ">Edward L.  Conn</span>, <span class="hlFld-ContribAuthor ">Lori  Lopresti‐Morrow</span>, <span class="hlFld-ContribAuthor ">Lorraine F.  Lanyon</span>, <span class="hlFld-ContribAuthor ">James M.  Cook</span>, <span class="hlFld-ContribAuthor ">Karl E. G.  Richter</span>, <span class="hlFld-ContribAuthor ">Charlie E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Joel B.  Schachter</span>, <span class="hlFld-ContribAuthor ">Fouad  Janat</span>, <span class="hlFld-ContribAuthor ">Ye  Che</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Lefker</span>, <span class="hlFld-ContribAuthor ">Bradley E.  Enerson</span>, <span class="hlFld-ContribAuthor ">Elijahu  Livni</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Nicolas J.  Guehl</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Florence F.  Wagner</span>, <span class="hlFld-ContribAuthor ">Roy  Perlis</span>, <span class="hlFld-ContribAuthor ">Edward B.  Holson</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Georges  El Fakhri</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (33)
                                     , 9601-9605. <a href="https://doi.org/10.1002/anie.201603797" title="DOI URL">https://doi.org/10.1002/anie.201603797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201603797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201603797%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%252BGlycogen%252BSynthase%252BKinase%2525E2%252580%2525903%252BInhibitor%252B%252528PF%2525E2%252580%25259004802367%252529%252BThat%252BModulates%252BTau%252BPhosphorylation%252Bin%252Bthe%252BBrain%25253A%252BTranslation%252Bfor%252BPET%252BNeuroimaging%26aulast%3DLiang%26aufirst%3DSteven%2BH.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D33%26spage%3D9601%26epage%3D9605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven H.  Liang</span>, <span class="hlFld-ContribAuthor ">Jinshan Michael  Chen</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>, <span class="hlFld-ContribAuthor ">Jeanne S.  Chang</span>, <span class="hlFld-ContribAuthor ">George C.  Chang</span>, <span class="hlFld-ContribAuthor ">Christine K.  Taylor</span>, <span class="hlFld-ContribAuthor ">Patrick  Trapa</span>, <span class="hlFld-ContribAuthor ">Mark S.  Plummer</span>, <span class="hlFld-ContribAuthor ">Kimberly S.  Para</span>, <span class="hlFld-ContribAuthor ">Edward L.  Conn</span>, <span class="hlFld-ContribAuthor ">Lori  Lopresti‐Morrow</span>, <span class="hlFld-ContribAuthor ">Lorraine F.  Lanyon</span>, <span class="hlFld-ContribAuthor ">James M.  Cook</span>, <span class="hlFld-ContribAuthor ">Karl E. G.  Richter</span>, <span class="hlFld-ContribAuthor ">Charlie E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Joel B.  Schachter</span>, <span class="hlFld-ContribAuthor ">Fouad  Janat</span>, <span class="hlFld-ContribAuthor ">Ye  Che</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Lefker</span>, <span class="hlFld-ContribAuthor ">Bradley E.  Enerson</span>, <span class="hlFld-ContribAuthor ">Elijahu  Livni</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Nicolas J.  Guehl</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Florence F.  Wagner</span>, <span class="hlFld-ContribAuthor ">Roy  Perlis</span>, <span class="hlFld-ContribAuthor ">Edward B.  Holson</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Georges  El Fakhri</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (33)
                                     , 9753-9757. <a href="https://doi.org/10.1002/ange.201603797" title="DOI URL">https://doi.org/10.1002/ange.201603797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201603797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201603797%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%252BGlycogen%252BSynthase%252BKinase%2525E2%252580%2525903%252BInhibitor%252B%252528PF%2525E2%252580%25259004802367%252529%252BThat%252BModulates%252BTau%252BPhosphorylation%252Bin%252Bthe%252BBrain%25253A%252BTranslation%252Bfor%252BPET%252BNeuroimaging%26aulast%3DLiang%26aufirst%3DSteven%2BH.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D33%26spage%3D9753%26epage%3D9757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected GSK-3 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the 3-pyridinyl isonicotinamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Pyridinyl Isonicotinamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, rt, 18 h; (b) cyclopropanecarboxyamide, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Xantphos, dioxane, 150 °C, 2 h; (c) cyclopropanecarbonyl chloride (2.1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, 0 °C, 1 h (88%); (d) LiOH (4 equiv), THF–MeOH (10:1), rt, 18 h (79%); (e) 3-aminopyridine, HATU, DMF, rt (or 85 °C), <i>i</i>-Pr<sub>2</sub>NEt, 18–48 h; (f) oxalyl chloride (1.2 equiv), DMF (cat.), rt, 30 min, then 3-aminopyridine, Et<sub>3</sub>N, rt, 2 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of compound <b>15</b> in the kinase domain of GSK-3β overlaid onto the X-ray structure of ADP bound GSK-3β complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1C">1J1C</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The ligands are rendered as a stick model in green carbons for ADP and magenta carbons for compound <b>15</b>. Image was prepared using PyMOL.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Alkoxy-pyridin-3-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alcohol/phenol, DMF, K<sub>2</sub>CO<sub>3</sub>, 65 °C, 18 h; (b) Pd/C/hydrogen (1 atm), MeOH; (c) <i>i</i>-PrOH, Ph<sub>3</sub>P, DIAD, rt, 5 h.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ambit radial graphs of compounds <b>8</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and <b>15</b>. This is a single-point assay panel with a control for each kinase. Each line represents remaining activity of a single kinase in the presence of 1 μM test compound. Starting from the center, the circles denote 83, 33, and 0% of control binding remaining.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The kinases are grouped into families differing by line color. As shown for <b>15</b>, the two teal lines at nearly 0% represent GSK-3α and β.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>27</b>–<b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride (1.2 equiv), DMF (cat.), 0 °C, 2 h, then 4-iodopyridin-3-amine, Et<sub>3</sub>N, 0 °C to rt; (b) aryl boronic acid, Na<sub>2</sub>CO<sub>3</sub> (2.0 M), Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 110 °C (microwave), 30 min.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ambit radial graphs for compounds <b>18</b>, <b>29</b>, and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Surface representation of compound <b>18</b> bound to the ATP-binding site of GSK-3β showing the 4-phenyl group of the 3-aminopyridine occupying the sugar pocket. The two conserved structural water molecules that were not detected in the X-ray structure of GSK-3β–compound <b>18</b> complex most likely due to the low resolution (3.0 Å) were modeled and are shown in the inset.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response (3, 10 mg/kg at 5 h) and time course (30 mg/kg) of <b>18</b> in the triple-transgenic mouse AD model.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The blue bar represents vehicle only, and the red bar shows maximum pTau reduction by LiCl (250 mg/kg ip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/medium/jm-2015-015502_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response of <b>33</b> at 1, 3, 10, and 30 mg/kg po and time course at both 10 and 30 mg/kg po in the mouse AD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01550/20160205/images/large/jm-2015-015502_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01550&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Facts and Figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.jalz.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.jalz.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=23507120" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=208-245&author=Alzheimer%E2%80%99s+Association&title=Alzheimer%E2%80%99s+Disease+Facts+and+Figures&doi=10.1016%2Fj.jalz.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D208%26epage%3D245%26doi%3D10.1016%2Fj.jalz.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=16914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=151-153&author=J.+Hardy&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis%3A+an+update+and+reappraisal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">151-153</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Here I recap the scientific and personal background of the delineation of the amyloid cascade hypothesis for Alzheimer's disease that I wrote with Gerry Higgins and the events leading to the writing of that influential review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9h63kZgivLVg90H21EOLACvtfcHk0lirv1ThOYjnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D&md5=9c91d6b0cf34cfdffbd2b0bb4b9429d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%253A%2520an%2520update%2520and%2520reappraisal%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D151%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zaghi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inayathullah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lossinsky, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoumi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avagyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa-Jeffrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiala, M.</span><span> </span><span class="NLM_article-title">Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1007/s00401-008-0481-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1007%2Fs00401-008-0481-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19139910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2009&pages=111-124&author=J.+Zaghiauthor=B.+Goldensonauthor=M.+Inayathullahauthor=A.+S.+Lossinskyauthor=A.+Masoumiauthor=H.+Avagyanauthor=M.+Mahanianauthor=M.+Bernasauthor=M.+Weinandauthor=M.+J.+Rosenthalauthor=A.+Espinosa-Jeffreyauthor=J.+de+Vellisauthor=D.+B.+Teplowauthor=M.+Fiala&title=Alzheimer+disease+macrophages+shuttle+amyloid-beta+from+neurons+to+vessels%2C+contributing+to+amyloid+angiopathy&doi=10.1007%2Fs00401-008-0481-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy</span></div><div class="casAuthors">Zaghi, Justin; Goldenson, Ben; Inayathullah, Mohammed; Lossinsky, Albert S.; Masoumi, Ava; Avagyan, Hripsime; Mahanian, Michelle; Bernas, Michael; Weinand, Martin; Rosenthal, Mark J.; Espinosa-Jeffrey, Araceli; Vellis, Jean; Teplow, David B.; Fiala, Milan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-124</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuronal accumulation of oligomeric amyloid-β (Αβ) is considered the proximal cause of neuronal demise in Alzheimer disease (AD) patients.  Blood-borne macrophages might reduce Aβ stress to neurons by immigration into the brain and phagocytosis of Αβ.  We tested migration and export across a blood-brain barrier model, and phagocytosis and clearance of Αβ by AD and normal subjects' macrophages.  Both AD and normal macrophages were inhibited in Αβ export across the blood-brain barrier due to adherence of Aβ-engorged macrophages to the endothelial layer.  In comparison to normal subjects' macrophages, AD macrophages ingested and cleared less Αβ, and underwent apoptosis upon exposure to sol., protofibrillar, or fibrillar Αβ.  Confocal microscopy of stained AD brain sections revealed oligomeric Aβ in neurons and apoptotic macrophages, which surrounded and infiltrated congophilic microvessels, and fibrillar Aβ in plaques and microvessel walls.  After incubation with AD brain sections, normal subjects' monocytes intruded into neurons and uploaded oligomeric Aβ.  In conclusion, in patients with AD, macrophages appear to shuttle Aβ from neurons to vessels where their apoptosis may release fibrillar Aβ, contributing to cerebral amyloid angiopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS6yLUNEq7Y7Vg90H21EOLACvtfcHk0li0xg6p-Dl5tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCltLk%253D&md5=db05736bca63e06a146188bd8f876631</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00401-008-0481-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-008-0481-0%26sid%3Dliteratum%253Aachs%26aulast%3DZaghi%26aufirst%3DJ.%26aulast%3DGoldenson%26aufirst%3DB.%26aulast%3DInayathullah%26aufirst%3DM.%26aulast%3DLossinsky%26aufirst%3DA.%2BS.%26aulast%3DMasoumi%26aufirst%3DA.%26aulast%3DAvagyan%26aufirst%3DH.%26aulast%3DMahanian%26aufirst%3DM.%26aulast%3DBernas%26aufirst%3DM.%26aulast%3DWeinand%26aufirst%3DM.%26aulast%3DRosenthal%26aufirst%3DM.%2BJ.%26aulast%3DEspinosa-Jeffrey%26aufirst%3DA.%26aulast%3Dde%2BVellis%26aufirst%3DJ.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DFiala%26aufirst%3DM.%26atitle%3DAlzheimer%2520disease%2520macrophages%2520shuttle%2520amyloid-beta%2520from%2520neurons%2520to%2520vessels%252C%2520contributing%2520to%2520amyloid%2520angiopathy%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D117%26spage%3D111%26epage%3D124%26doi%3D10.1007%2Fs00401-008-0481-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Grimes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">The multifaceted roles of glycogen synthase kinase 3β in cellular signaling</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/S0301-0082(01)00011-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0301-0082%2801%2900011-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=11527574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1yjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=391-426&author=C.+A.+Grimesauthor=R.+S.+Jope&title=The+multifaceted+roles+of+glycogen+synthase+kinase+3%CE%B2+in+cellular+signaling&doi=10.1016%2FS0301-0082%2801%2900011-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The multifaceted roles of glycogen synthase kinase 3β in cellular signaling</span></div><div class="casAuthors">Grimes, C. A.; Jope, R. S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-426</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Glycogen synthase kinase-3β (GSK3β) is a fascinating enzyme with an astoundingly diverse no. of actions in intracellular signaling systems.  GSK3β activity is regulated by serine (inhibitory) and tyrosine (stimulatory) phosphorylation, by protein complex formation, and by its intracellular localization.  GSK3β phosphorylates and thereby regulates the functions of many metabolic, signaling, and structural proteins.  Notable among the signaling proteins regulated by GSK3β are the many transcription factors, including activator protein-1, cAMP response element binding protein, heat shock factor-1, nuclear factor of activated T cells, Myc, β-catenin, CCAAT/enhancer binding protein, and NFκB.  Lithium, the primary therapeutic agent for bipolar mood disorder, is a selective inhibitor of GSK3β.  This raises the possibility that dysregulation of GSK3β and its inhibition by lithium may contribute to the disorder and its treatment, resp.  GSK3β has been linked to all of the primary abnormalities assocd. with Alzheimer's disease.  These include interactions between GSK3β and components of the plaque-producing amyloid system, the participation of GSK3β in phosphorylating the microtubule-binding protein tau that may contribute to the formation of neurofibrillary tangles, and interactions of GSK3β with presenilin and other Alzheimer's disease-assocd. proteins.  GSK3β also regulates cell survival, as it facilitates a variety of apoptotic mechanisms, and lithium provides protection from many insults.  Thus, GSK3β has a central role regulating neuronal plasticity, gene expression, and cell survival, and may be a key component of certain psychiatric and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFqZD3ZTv7LVg90H21EOLACvtfcHk0li0xg6p-Dl5tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1yjt7Y%253D&md5=1bcb96a552a0307c1be6e079b5b1bec0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2801%2900011-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252801%252900011-9%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BA.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DThe%2520multifaceted%2520roles%2520of%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520in%2520cellular%2520signaling%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D391%26epage%3D426%26doi%3D10.1016%2FS0301-0082%2801%2900011-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Molecular cloning and expression of glycogen synthase kinase-3/factor A</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2431</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1002%2Fj.1460-2075.1990.tb07419.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=2164470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK3MXis1Gr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1990&pages=2431-2438&author=J.+R.+Woodgett&title=Molecular+cloning+and+expression+of+glycogen+synthase+kinase-3%2Ffactor+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of glycogen synthase kinase-3/factor A</span></div><div class="casAuthors">Woodgett, James Robert</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2431-8</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a protein-serine kinase implicated in the hormonal control of several regulatory proteins, including glycogen synthase and transcription factor c-jun.  Two classes of rat brain cDNA for this enzyme were isolated (GSK-3α and GSK-3β).  The α-type encoded a 51-kDa polypeptide, the sequence of which included all of the tryptic peptides detd. by protein sequence anal. of purified skeletal muscle GSK-3.  The novel β-type cDNA had the potential to encode a 47-kDA protein with 85% amino acid identity to GSK-3α.  The 2 types of cDNA were the products of distinct genes as detd. by genomic organization and nucleic acid sequence anal.  Both α and β clones exhibited kinase activity when expressed in COS-1 cells and type-specific antibodies to GSK-3 α and β detect proteins of 51 and 47 kDa, resp., in a variety of rat tissue exts., with highest levels of both in brain.  Partial purifn. of GSK-3 activity from bovine resulted in the isolation of active α and β proteins.  The physiol. importance of these 2 proteins in cellular signal transduction is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm736N83asgLVg90H21EOLACvtfcHk0li0xg6p-Dl5tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXis1Gr&md5=3bacbf348b8ba673831fe9b9ca5cfde6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1990.tb07419.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1990.tb07419.x%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520cloning%2520and%2520expression%2520of%2520glycogen%2520synthase%2520kinase-3%252Ffactor%2520A%26jtitle%3DEMBO%2520J.%26date%3D1990%26volume%3D9%26spage%3D2431%26epage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span> </span><span class="NLM_article-title">Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1097/00005072-199701000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1097%2F00005072-199701000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=8990130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADyaK2s7ksVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=70-78&author=J.+J.+Peiauthor=T.+Tanakaauthor=Y.+C.+Tungauthor=E.+Braakauthor=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Distribution%2C+levels%2C+and+activity+of+glycogen+synthase+kinase-3+in+the+Alzheimer+disease+brain&doi=10.1097%2F00005072-199701000-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain</span></div><div class="casAuthors">Pei J J; Tanaka T; Tung Y C; Braak E; Iqbal K; Grundke-Iqbal I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">A number of studies have implicated a proline-directed protein kinase, glycogen synthase kinase-3 (GSK-3) in the hyperphosphorylation of tau in Alzheimer's disease (AD).  Toward understanding the role of GSK-3 in the abnormal hyperphosphorylation of tau in AD we have found that GSK-3 is prominently present in neuronal cell bodies and their processes and co-localizes with neurofibrillary changes in AD brain.  Furthermore, the levels of GSK-3 as determined by indirect ELISA are approximately 50% increased in the postsynaptosomal supernatant from AD brains as compared to the controls.  However, no increase in GSK-3 enzyme activity was detected.  In AD brain, with its reduced phosphatase activity, even normal levels of GSK-3 activity might be sufficient for the hyperphosphorylation of tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmu8m1y1XLJ0EgZCMqtRBifW6udTcc2eY7E5sjZYNnq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7ksVelsQ%253D%253D&md5=18b0957c0a36ecb25875aaa4e8c6bc91</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F00005072-199701000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199701000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DBraak%26aufirst%3DE.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DDistribution%252C%2520levels%252C%2520and%2520activity%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520the%2520Alzheimer%2520disease%2520brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1997%26volume%3D56%26spage%3D70%26epage%3D78%26doi%3D10.1097%2F00005072-199701000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1097/00005072-199909000-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1097%2F00005072-199909000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10499443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=1010-1019&author=J.+J.+Peiauthor=E.+Braakauthor=H.+Braakauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Distribution+of+active+glycogen+synthase+kinase+3beta+%28GSK-3beta%29+in+brains+staged+for+Alzheimer+disease+neurofibrillary+changes&doi=10.1097%2F00005072-199909000-00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes</span></div><div class="casAuthors">Pei, Jin-Jing; Braak, Eva; Braak, Heiko; Grundke-Iqbal, Inge; Iqbal, Khalid; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1010-1019</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">Accumulation of paired helical filaments (PHFs) in neurofibrillary tangles, neuropil threads, and dystrophic neurites is one of the major neuropathol. hallmarks of Alzheimer disease (AD).  The principal protein subunit of PHFs is the abnormally hyperphosphorylated tau.  Glycogen synthase kinase 3β (GSK-3β) is one of the candidate kinases involved in PHF-tau formation.  To play a role in PHF-tau formation, it would be expected that GSK-3β is active in tangle bearing neurons.  In the present study, the authors investigated the regional and intracellular distributions of active and inactive forms of GSK-3β in brains staged for neurofibrillary changes.  The authors found that neurons with tangle-like inclusions pos. for active, but not inactive, GSK-3β appear initially in the Pre-α layer of the entorhinal cortex and extend to other brain regions, coincident with the sequence of the development of neurofibrillary changes.  Active, but not inactive, GSK-3β was found to initially accumulate in the cytoplasm of pretangle neurons.  These data provide direct in situ evidence that is consistent with the involvement of GSK-3β in PHF-tau formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphCsw1UpeBWLVg90H21EOLACvtfcHk0lhi0C1a3hPykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOlsL4%253D&md5=3671085e971d742792dbf7f376c7d24f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00005072-199909000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199909000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DBraak%26aufirst%3DE.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DDistribution%2520of%2520active%2520glycogen%2520synthase%2520kinase%25203beta%2520%2528GSK-3beta%2529%2520in%2520brains%2520staged%2520for%2520Alzheimer%2520disease%2520neurofibrillary%2520changes%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1999%26volume%3D58%26spage%3D1010%26epage%3D1019%26doi%3D10.1097%2F00005072-199909000-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Leroy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J.-P.</span><span> </span><span class="NLM_article-title">Developmental expression and localization of glycogen synthase kinase-3β in rat brain</span> <span class="citation_source-journal">J. Chem. Neuroanat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/S0891-0618(99)00012-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0891-0618%2899%2900012-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10450875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVaht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=279-293&author=K.+Leroyauthor=J.-P.+Brion&title=Developmental+expression+and+localization+of+glycogen+synthase+kinase-3%CE%B2+in+rat+brain&doi=10.1016%2FS0891-0618%2899%2900012-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental expression and localization of glycogen synthase kinase-3β in rat brain</span></div><div class="casAuthors">Leroy, Karelle; Brion, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Neuroanatomy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">JCNAEE</span>;
        ISSN:<span class="NLM_cas:issn">0891-0618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase (GSK)-3β is a protein kinase in the wingless/wnt pathway and as such is involved in the regulation of growth and development of the neural tissue in Drosophila and in vertebrates.  GSK-3β is also abundantly expressed in mammalian adult brain, where it might play a role in the regulation of several substrates.  Here, the expression and the neuroanatomical distribution of GSK-3β immunoreactivity in the rat brain from embryonic up to adult stages was studied.  GSK-3β was expressed in the developing brain with the highest expression obsd. from 18 days of embryonic life up to 10 days of postnatal life.  Its expression decreased thereafter and was lowest in the adult.  GSK-3β was strongly expressed in developing neurons but only weakly expressed in layers contg. neuroblasts.  In the adult and during development, GSK-3β was detected in the perikarya and proximal part of dendrites.  In the embryo, an intense GSK-3β immunoreactivity was also obsd. in axonal tracts.  This axonal immunoreactivity had markedly decreased by 10 days of postnatal life and was absent at 20 days of postnatal life and in the adult.  No GSK-3β immunoreactivity was detected in astrocytes.  The GSK-3β immunoreactivity was found in most brain regions, although significant local variations of GSK-3β expression were obsd.  The developmental evolution of GSK-3β compartmentalization in neurons paralleled that of phosphorylated tau, a protein considered to be a physiol. substrate for the kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVvQKSfzSAdrVg90H21EOLACvtfcHk0lhi0C1a3hPykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVaht78%253D&md5=b15a111e176deefc04f86e51aed214fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0891-0618%2899%2900012-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-0618%252899%252900012-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DK.%26aulast%3DBrion%26aufirst%3DJ.-P.%26atitle%3DDevelopmental%2520expression%2520and%2520localization%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Chem.%2520Neuroanat.%26date%3D1999%26volume%3D16%26spage%3D279%26epage%3D293%26doi%3D10.1016%2FS0891-0618%2899%2900012-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sereno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Isla, T.</span><span> </span><span class="NLM_article-title">A novel GSK-3β inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1016/j.nbd.2009.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.nbd.2009.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19523516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=359-367&author=L.+Serenoauthor=M.+Comaauthor=M.+Rodriguezauthor=P.+Sanchez-Ferrerauthor=M.+B.+Sanchezauthor=I.+Gichauthor=J.+M.+Agulloauthor=M.+Perezauthor=J.+Avilaauthor=C.+Guardia-Laguartaauthor=J.+Clarimonauthor=A.+Lleoauthor=T.+G%C3%B3mez-Isla&title=A+novel+GSK-3%CE%B2+inhibitor+reduces+Alzheimer%E2%80%99s+pathology+and+rescues+neuronal+loss+in+vivo&doi=10.1016%2Fj.nbd.2009.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo</span></div><div class="casAuthors">Sereno, L.; Coma, M.; Rodriguez, M.; Sanchez-Ferrer, P.; Sanchez, M. B.; Gich, I.; Agullo, J. M.; Perez, M.; Avila, J.; Guardia-Laguarta, C.; Clarimon, J.; Lleo, A.; Gomez-Isla, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid deposits, neurofibrillary tangles, and neuronal cell death in selectively vulnerable brain regions are the chief hallmarks in Alzheimer's (AD) brains.  Glycogen synthase kinase-3 (GSK-3) is one of the key kinases required for AD-type abnormal hyperphosphorylation of tau, which is believed to be a crit. event in neurofibrillary tangle formation.  GSK-3 has also been recently implicated in amyloid precursor protein (APP) processing/Aβ prodn., apoptotic cell death, and learning and memory.  Thus, GSK-3 inhibition represents a very attractive drug target in AD and other neurodegenerative disorders.  To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non-ATP competitive GSK-3β inhibitor, NP12.  Treatment with this thiadiazolidinone compd. resulted in lower levels of tau phosphorylation, decreased amyloid deposition and plaque-assocd. astrocytic proliferation, protection of neurons in the entorhinal cortex and CA1 hippocampal subfield against cell death, and prevention of memory deficits in this transgenic mouse model.  These results show that this novel GSK-3 inhibitor has a dual impact on amyloid and tau alterations and, perhaps even more important, on neuronal survival in vivo further suggesting that GSK-3 is a relevant therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDbLMUp5zF7Vg90H21EOLACvtfcHk0lgDB2WZDLvZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D&md5=b3d6145f5662c989f22113bef022656e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSereno%26aufirst%3DL.%26aulast%3DComa%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSanchez-Ferrer%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DM.%2BB.%26aulast%3DGich%26aufirst%3DI.%26aulast%3DAgullo%26aufirst%3DJ.%2BM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DClarimon%26aufirst%3DJ.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Isla%26aufirst%3DT.%26atitle%3DA%2520novel%2520GSK-3%25CE%25B2%2520inhibitor%2520reduces%2520Alzheimer%25E2%2580%2599s%2520pathology%2520and%2520rescues%2520neuronal%2520loss%2520in%2520vivo%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26spage%3D359%26epage%3D367%26doi%3D10.1016%2Fj.nbd.2009.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Drug development targeting the glycogen synthase kinase-3β(GSK-3β)-mediated signal transduction pathway: role of GSK-3β in adult brain</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1254/jphs.08R29FM</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1254%2Fjphs.08R29FM" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19179803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFemtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=174-178&author=A.+Takashima&title=Drug+development+targeting+the+glycogen+synthase+kinase-3%CE%B2%28GSK-3%CE%B2%29-mediated+signal+transduction+pathway%3A+role+of+GSK-3%CE%B2+in+adult+brain&doi=10.1254%2Fjphs.08R29FM"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: role of GSK-3β in adult brain</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-178</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase.  Since its activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains, GSK-3β may be inhibited under normal conditions but activated under pathol. conditions.  Given its link to NFT formation, we sought to det. whether GSK-3β exists in the brain as a "pathol. time bomb" that promotes disease development.  To address this hypothesis, we analyzed GSK-3β heterozygote (GSK+/-) mice, which express GSK-3β at 50% wild-type levels.  When tested in the Morris water maze test, GSK+/- mice surprisingly exhibited retrograde amnesia.  Further anal. indicated that GSK+/- mice had impaired memory reconsolidation but normal memory consolidation.  Therefore, we concluded that GSK-3β activation is required for memory reconsolidation in the adult brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAd0ZTQ3NKLVg90H21EOLACvtfcHk0lgDB2WZDLvZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFemtLs%253D&md5=4102ddb90f55d8cdcbe63b510047d137</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1254%2Fjphs.08R29FM&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.08R29FM%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DDrug%2520development%2520targeting%2520the%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2528GSK-3%25CE%25B2%2529-mediated%2520signal%2520transduction%2520pathway%253A%2520role%2520of%2520GSK-3%25CE%25B2%2520in%2520adult%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D109%26spage%3D174%26epage%3D178%26doi%3D10.1254%2Fjphs.08R29FM" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Doble, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kockeritz, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.1016/j.devcel.2007.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.devcel.2007.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=957-971&author=B.+W.+Dobleauthor=S.+Patelauthor=G.+A.+Woodauthor=L.+K.+Kockeritzauthor=J.+R.+Woodgett&title=Functional+redundancy+of+GSK-3alpha+and+GSK-3beta+in+Wnt%2Fbeta-catenin+signaling+shown+by+using+an+allelic+series+of+embryonic+stem+cell+lines&doi=10.1016%2Fj.devcel.2007.04.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2007.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2007.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DG.%2BA.%26aulast%3DKockeritz%26aufirst%3DL.%2BK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DFunctional%2520redundancy%2520of%2520GSK-3alpha%2520and%2520GSK-3beta%2520in%2520Wnt%252Fbeta-catenin%2520signaling%2520shown%2520by%2520using%2520an%2520allelic%2520series%2520of%2520embryonic%2520stem%2520cell%2520lines%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D12%26spage%3D957%26epage%3D971%26doi%3D10.1016%2Fj.devcel.2007.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sutherland, C.</span><span> </span><span class="NLM_article-title">What Are the bona fide GSK3 Substrates?</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">505607</span><span class="refDoi"> DOI: 10.4061/2011/505607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.4061%2F2011%2F505607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21629754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADC%252BC3MrntVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=505607&author=C.+Sutherland&title=What+Are+the+bona+fide+GSK3+Substrates%3F&doi=10.4061%2F2011%2F505607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">What Are the bona fide GSK3 Substrates?</span></div><div class="casAuthors">Sutherland Calum</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">505607</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body.  However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo.  Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells.  In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQII8bXRBJjgDUE-swuRqsHfW6udTcc2eY9mikZHrCJorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrntVKqsA%253D%253D&md5=1539d25659573451e6d6f343ff03aa5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4061%2F2011%2F505607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F505607%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DWhat%2520Are%2520the%2520bona%2520fide%2520GSK3%2520Substrates%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D505607%26doi%3D10.4061%2F2011%2F505607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andjelkovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/378785a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2F378785a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=8524413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaK28XltFWj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=785-789&author=D.+A.+Crossauthor=D.+R.+Alessiauthor=P.+Cohenauthor=M.+Andjelkovichauthor=B.+A.+Hemmings&title=Inhibition+of+glycogen+synthase+kinase-3+by+insulin+mediated+by+protein+kinase+B&doi=10.1038%2F378785a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B</span></div><div class="casAuthors">Cross, Darren A. E.; Alessi, Dario R.; Cohen, Philip; Andjelkovich, Mirjana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6559</span>),
    <span class="NLM_cas:pages">785-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Agents which prevent the activation of both MAP kinase-activated protein kinase-1 and p70S6k by insulin in vivo do not block the phosphorylation and inhibition of glycogen synthase kinase-3 (GSK3) in L6 myotubes.  Another insulin-stimulated protein kinase inactivates GSK3 under these conditions, and the authors demonstrate that it is the product of the proto-oncogene protein kinase B (PKB, also known as Akt/RAC).  Like the inhibition of GSK3, the activation of PKB is prevented by inhibitors of phosphatidylinositol 3-kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKh6GNVgGhFbVg90H21EOLACvtfcHk0liE2Fmu0I1D0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFWj&md5=56723cab1f5412b4e55aca875989d1fa</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F378785a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378785a0%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAndjelkovich%26aufirst%3DM.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520by%2520insulin%2520mediated%2520by%2520protein%2520kinase%2520B%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D785%26epage%3D789%26doi%3D10.1038%2F378785a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NobLE, W.</span><span> </span><span class="NLM_article-title">Functional implications of glycogen synthase kinase-3-mediated Tau phosphorylation</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4061/2011/352805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.4061%2F2011%2F352805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=1-11&author=D.+P.+Hangerauthor=W.+NobLE&title=Functional+implications+of+glycogen+synthase+kinase-3-mediated+Tau+phosphorylation&doi=10.4061%2F2011%2F352805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4061%2F2011%2F352805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F352805%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DNobLE%26aufirst%3DW.%26atitle%3DFunctional%2520implications%2520of%2520glycogen%2520synthase%2520kinase-3-mediated%2520Tau%2520phosphorylation%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D1%26epage%3D11%26doi%3D10.4061%2F2011%2F352805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Stebbings, H.</span><span> </span><span class="NLM_article-title">Microtubule-based intracellular transport of organelles</span> <span class="citation_source-journal">Cytoskeleton</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/S1874-6020(06)80017-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS1874-6020%2806%2980017-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=113-140&author=H.+Stebbings&title=Microtubule-based+intracellular+transport+of+organelles&doi=10.1016%2FS1874-6020%2806%2980017-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1874-6020%2806%2980017-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1874-6020%252806%252980017-0%26sid%3Dliteratum%253Aachs%26aulast%3DStebbings%26aufirst%3DH.%26atitle%3DMicrotubule-based%2520intracellular%2520transport%2520of%2520organelles%26jtitle%3DCytoskeleton%26date%3D1995%26volume%3D2%26spage%3D113%26epage%3D140%26doi%3D10.1016%2FS1874-6020%2806%2980017-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau. A component of Alzheimer paired helical filaments</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">6084</span><span class="NLM_x">–</span> <span class="NLM_lpage">6089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=3084478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaL28XitVCqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=6084-6089&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=M.+Quinlanauthor=Y.+C.+Tungauthor=M.+S.+Zaidiauthor=H.+M.+Wisniewski&title=Microtubule-associated+protein+tau.+A+component+of+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-associated protein tau.  A component of Alzheimer paired helical filaments</span></div><div class="casAuthors">Grundke-Iqbal, Inge; Iqbal, Khalid; Quinlan, Maureen; Tung, Yunn Chyn; Zaidi, Masooma S.; Wisniewski, Henryk M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6084-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Microtubule-assocd. protein tau was purified from bovine brain microtubules by either (1) phosphocellulose chromatog., (2) heat treatment at pH 6.4 (3) heat treatment at pH 2.7, (4) heat treatment at pH 2.7 followed by extn. with perchloric acid and pptn. with glycerol, or (5) by pptn. with (NH4)2SO4 followed by extn. with perchloric acid.  All of these tau prepns. reacted specifically with antibodies to Alzheimer paired helical filaments.  Affinity purified antibodies to tau labeled both Alzheimer neurofibrillary tangles and plaque neurites but not amyloid in Alzheimer brain tissue sections and labeled paired helical filament polypeptides on Western blots.  Human brain tau and paired helical filament polypeptides comigrated on SDS-polyacrylamide gels.  Apparently, tau is a major component of Alzheimer paired helical filaments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6BKwstlhNy7Vg90H21EOLACvtfcHk0lhgQzqcCO8D2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVCqsb0%253D&md5=61cc3c14ac3cb3b7663d1ed7b6ffbf5c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DZaidi%26aufirst%3DM.%2BS.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26atitle%3DMicrotubule-associated%2520protein%2520tau.%2520A%2520component%2520of%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D6084%26epage%3D6089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4913</span><span class="NLM_x">–</span> <span class="NLM_lpage">4917</span><span class="refDoi"> DOI: 10.1073/pnas.83.13.4913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1073%2Fpnas.83.13.4913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=3088567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADyaL28XksFyqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4913-4917&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=Y.+C.+Tungauthor=M.+Quinlanauthor=H.+M.+Wisniewskiauthor=L.+I.+Binder&title=Abnormal+phosphorylation+of+the+microtubule-associated+protein+tau+%28tau%29+in+Alzheimer+cytoskeletal+pathology&doi=10.1073%2Fpnas.83.13.4913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology</span></div><div class="casAuthors">Grundke-Iqbal, Inge; Iqbal, Khalid; Tung, Yunn Chyn; Quinlan, Maureen; Wisniewski, Henryk M.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4913-17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A monoclonal antibody to the microtubule-assocd. protein τ (tau) labeled some neurofibrillary tangles and plaque neurites, the 2 major locations of paired-helical filaments (PHF), in Alzheimer disease brain.  The antibody also labeled isolated PHF that had been repeatedly washed with SDS.  Dephosphorylation of the tissue sections with alk. phosphatase prior to immunolabeling dramatically increased the no. of tangles and plaques recognized by the antibody.  The plaque core amyloid was not stained in either dephosphorylated or nondephosphorylated tissue sections.  On immunoblots PHF polypeptides were labeled readily only when dephosphorylated.  In contrast, a com. available monoclonal antibody to a phosphorylated epitope of neurofilaments that labeled the tangles and the plaque neurites in tissue did not label any PHF polypeptides on immunoblots.  The PHF polypeptides, labeled with the monoclonal antibody to τ, electrophoresed with those polypeptides recognized by antibodies to isolated PHF.  The antibody to τ labeled microtubules from normal human brains assembled in vitro but identically treated Alzheimer brain prepns. had to be dephosphorylated to be completely recognized by this antibody.  These findings suggest that τ in Alzheimer brain is an abnormally phosphorylated protein component of PHF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcyxbsq2aXprVg90H21EOLACvtfcHk0lhgQzqcCO8D2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFyqtrg%253D&md5=3ac88b7002e26c53c54e71a3a91471ba</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.13.4913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.13.4913%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520tau%2520%2528tau%2529%2520in%2520Alzheimer%2520cytoskeletal%2520pathology%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D4913%26epage%3D4917%26doi%3D10.1073%2Fpnas.83.13.4913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span> </span><span class="NLM_article-title">Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=16914861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=219-242&author=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Discoveries+of+tau%2C+abnormally+hyperphosphorylated+tau+and+others+of+neurofibrillary+degeneration%3A+a+personal+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discoveries of Tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: A personal historical perspective</span></div><div class="casAuthors">Iqbal, Khalid; Grundke-Iqbal, Inge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">219-242</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease was described by Alois Alzheimer in 1907, but it was not until ∼60-70 years later that any new significant developments were reported on the pathol. of this disease.  The discoveries that laid down the foundation for the exciting research that has been carried out during the last ∼20 years and that have significantly enhanced our understanding of the disease are the ultrastructure of neurofibrillary tangles and neuritic (senile) plaques, the clin.-pathol. correlation of these lesions to the presence of dementia, and the bulk isolation and protein compn. of paired helical filaments and plaque amyloid.  We discovered tau as the major protein subunit of paired helical filaments/neurofibrillary tangles, the abnormal hyperphosphorylation of this protein in this lesion and in Alzheimer brain cytosol and the gain of toxic function by the cytosolic abnormally hyper-phosphorylated tau in Alzheimer brain.  Here we present a personal historical account of the work in our labs. that led, in 1986, to the discoveries of tau and its abnormal hyperphosphorylation in paired helical filaments and Alzheimer brain cytosol.  This article also describes several major findings which subsequently resulted from the abnormal hyperphosphorylation of tau and in a large part account for the current understanding of the role of this lesion in Alzheimer disease and other tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkB8SG1qCLkLVg90H21EOLACvtfcHk0lhgQzqcCO8D2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKktL4%253D&md5=a337940cbdf40deb55ecfc7e1e3dfbb1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DDiscoveries%2520of%2520tau%252C%2520abnormally%2520hyperphosphorylated%2520tau%2520and%2520others%2520of%2520neurofibrillary%2520degeneration%253A%2520a%2520personal%2520historical%2520perspective%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D219%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Maixner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, H.-R.</span><span> </span><span class="NLM_article-title">The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">001</span><span class="refDoi"> DOI: 10.13188/2327-204X.1000001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.13188%2F2327-204X.1000001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A280%3ADC%252BC2srnvVCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=001&author=D.+W.+Maixnerauthor=H.-R.+Weng&title=The+Role+of+Glycogen+Synthase+Kinase+3+Beta+in+Neuroinflammation+and+Pain&doi=10.13188%2F2327-204X.1000001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain</span></div><div class="casAuthors">Maixner Dylan Warren; Weng Han-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutics & pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">001</span>
        ISSN:<span class="NLM_cas:issn">2327-204X</span>.
    </div><div class="casAbstract">Neuroinflammation is a crucial mechanism related to many neurological diseases.  Extensive studies in recent years have indicated that dysregulation of Glycogen Synthase Kinase 3 Beta (GSK3β) contributes to the development and progression of these disorders through regulating the neuroinflammation processes.  Inhibitors of GSK3β have been shown to be beneficial in many neuroinflammatory disease models including Alzheimer's disease, multiple sclerosis and AIDS dem entia complex.  Glial activation and elevated pro-inflammation cytokines (signs of neuroinflammation) in the spinal cord have been widely recognized as a pivotal mechanism underlying the development and maintenance of many types of pathological pain.  The role of GSK3β in the pathogenesis of pain has recently emerged.  In this review, we will first review the GSK3β structure, regulation, and mechanisms by which GSK3βregulates inflammation.  We will then describe neuroinflammationin general and in specific types of neurological diseases and the potential beneficial effects induced by inhibiting GSK3β.  Finally, we will provide new evidence linking aberrant levels of GSK3β in the development of pathological pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsPOijTcCFn--MdeMhXAHkfW6udTcc2ebZIH6c84lPB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srnvVCrsA%253D%253D&md5=41a449aa81d8562f26dc91f46281a269</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.13188%2F2327-204X.1000001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.13188%252F2327-204X.1000001%26sid%3Dliteratum%253Aachs%26aulast%3DMaixner%26aufirst%3DD.%2BW.%26aulast%3DWeng%26aufirst%3DH.-R.%26atitle%3DThe%2520Role%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%2520Beta%2520in%2520Neuroinflammation%2520and%2520Pain%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D1%26spage%3D001%26doi%3D10.13188%2F2327-204X.1000001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gomez-Sintes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="refDoi"> DOI: 10.3389/fnmol.2011.00045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3389%2Ffnmol.2011.00045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22110426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=45&author=R.+Gomez-Sintesauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Avila&title=GSK-3+Mouse+Models+to+Study+Neuronal+Apoptosis+and+Neurodegeneration&doi=10.3389%2Ffnmol.2011.00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 mouse models to study neuronal apoptosis and neurodegeneration</span></div><div class="casAuthors">Gomez-Sintes, Raquel; Hernandez, Felix; Lucas, Jose J.; Avila, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">45</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Increased GSK-3 activity is believed to contribute to the etiol. of chronic disorders like Alzheimer's disease (AD), schizophrenia, diabetes, and some types of cancer, thus supporting therapeutic potential of GSK-3 inhibitors.  Numerous mouse models with modified GSK-3 have been generated in order to study the physiol. of GSK-3, its implication in diverse pathologies and the potential effect of GSK-3 inhibitors.  In this review we have focused on the relevance of these mouse models for the study of the role of GSK-3 in apoptosis.  GSK-3 is involved in two apoptotic pathways, intrinsic and extrinsic pathways, and plays opposite roles depending on the apoptotic signaling process that is activated.  It promotes cell death when acting through intrinsic pathway and plays an anti-apoptotic role if the extrinsic pathway is occurring.  It is important to dissect this duality since, among the diseases in which GSK-3 is involved, excessive cell death is crucial in some illnesses like neurodegenerative diseases, while a deficient apoptosis is occurring in others such as cancer or autoimmune diseases.  The clin. application of a classical GSK-3 inhibitor, lithium, is limited by its toxic consequences, including motor side effects.  Recently, the mechanism leading to activation of apoptosis following chronic lithium administration has been described.  Understanding this mechanism could help to minimize side effects and to improve application of GSK-3 inhibitors to the treatment of AD and to extend the application to other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRtAFuwCjX7Vg90H21EOLACvtfcHk0ljpO_pBrevxCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyr&md5=bc7c4970ddd7db63124c1a5fe7c38e26</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2011.00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2011.00045%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sintes%26aufirst%3DR.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DGSK-3%2520Mouse%2520Models%2520to%2520Study%2520Neuronal%2520Apoptosis%2520and%2520Neurodegeneration%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D4%26spage%3D45%26doi%3D10.3389%2Ffnmol.2011.00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">GSK-3β and memory formation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.3389/fnmol.2012.00047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3389%2Ffnmol.2012.00047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22536172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCqsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=47&author=A.+Takashima&title=GSK-3%CE%B2+and+memory+formation&doi=10.3389%2Ffnmol.2012.00047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3β and memory formation</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">April</span>),
    <span class="NLM_cas:pages">47</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In Alzheimer's disease (AD), tau hyperphosphorylation and neurofibrillary tangle (NFT) formation are strongly assocd. with dementia, a characteristic and early feature of this disease.  Glycogen synthase kinase 3β (GSK-3β) is a pivotal kinase in both the normal and pathol. phosphorylation of tau.  In the diseased state, hyperphosphorylated tau is deposited in NFTs, the formation of which, drive the disease process.  GSK-3β which is also involved in long-term depression induction, interacts with tau to inhibit synaptic long-term potentiation.  Strong lines of evidence suggest that the activation of GSK-3β is responsible for the memory deficits seen in both advanced age and AD.  In this review, we will focus on the role of GSK-3β in brain function, particularly in memory maintenance.  We will examine human and mouse studies which suggest a role for GSK-3β in memory maintenance and the eventual development of memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokF3Ge7EOqQrVg90H21EOLACvtfcHk0ljpO_pBrevxCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCqsbnN&md5=b97aed5b0bb4841a5e2efd70571ab2ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2012.00047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2012.00047%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DGSK-3%25CE%25B2%2520and%2520memory%2520formation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2012%26volume%3D5%26spage%3D47%26doi%3D10.3389%2Ffnmol.2012.00047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Domínguez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span> </span><span class="NLM_article-title">Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3 by Tideglusib</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1074/jbc.M111.306472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1074%2Fjbc.M111.306472" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=893-904&issue=2&author=J.+M.+Dom%C3%ADnguezauthor=A.+Fuertesauthor=L.+Orozcoauthor=M.+del+Monte-Mill%C3%A1nauthor=E.+Delgadoauthor=M.+Medina&title=Evidence+for+Irreversible+Inhibition+of+Glycogen+Synthase+Kinase-3+by+Tideglusib&doi=10.1074%2Fjbc.M111.306472"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.306472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.306472%26sid%3Dliteratum%253Aachs%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DJ.%2BM.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DL.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DEvidence%2520for%2520Irreversible%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520by%2520Tideglusib%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D2%26spage%3D893%26epage%3D904%26doi%3D10.1074%2Fjbc.M111.306472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Del Ser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinwachs, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Carrillo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vericat, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, T.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease with the GSK-3 inhibitor tideglusib: A pilot study</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.3233%2FJAD-2012-120805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=22936007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGrurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=205-215&author=T.+Del+Serauthor=K.+C.+Steinwachsauthor=H.+J.+Gertzauthor=M.+V.+Andr%C3%A9sauthor=B.+G%C3%B3mez-Carrilloauthor=M.+Medinaauthor=J.+A.+Vericatauthor=P.+Redondoauthor=D.+Fleetauthor=T.+Leon&title=Treatment+of+Alzheimer%E2%80%99s+disease+with+the+GSK-3+inhibitor+tideglusib%3A+A+pilot+study&doi=10.3233%2FJAD-2012-120805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study</span></div><div class="casAuthors">del Ser, Teodoro; Steinwachs, Klaus C.; Gertz, Hermann J.; Andres, Maria V.; Gomez-Carrillo, Belen; Medina, Miguel; Vericat, Joan A.; Redondo, Pilar; Fleet, David; Leon, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-215</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">This pilot, double-blind, placebo-controlled, randomized, escalating dose trial explored the safety and efficacy of tideglusib, an inhibitor of glycogen synthase kinase-3, in Alzheimer's disease (AD) patients.  Thirty mild-moderate AD patients on cholinesterase inhibitor treatment were administered escalating doses (400, 600, 800, 1,000 mg) of tideglusib or placebo (ratio 2 : 1) for 4, 4, 6, and 6 wk, resp.  The primary objective was to evaluate the safety and tolerability of tideglusib with strict criteria for drug escalation or withdrawal.  Mini-Mental Status Examn. (MMSE), Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog+), word fluency, Geriatric Depression Scale (GDS), and a final Global Clin. Assessment (GCA) were assessed as secondary objectives.  Treatment was well tolerated.  Adverse events were as frequent in active and placebo groups, except for some moderate, asymptomatic, and fully reversible increases (>2.5 × ULN) of serum transaminases in 6 active cases (p = 0.001).  Tideglusib produced pos. trends in MMSE, ADAS-cog, GDS, and GCA without statistical significance in this small sample.  Responders in MMSE were significantly higher in the active group (p = 0.05).  Patients escalated up to 1000 mg/day had a benefit of 1.68 points in the MMSE and 4.72 points in the ADAS-cog+ when compared to placebo.  This small pilot study provides valuable safety and efficacy ests. for the treatment of AD patients with tideglusib, currently being confirmed in a larger clin. trial.  Due to escalating doses and the small sample size, this trial provides insufficient evidence to support or reject a benefit of tideglusib in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETLaPrOao1rVg90H21EOLACvtfcHk0lgAFLr2P8pcjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGrurjE&md5=7a75de640f08ff234d4e3f50838c4967</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120805%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BSer%26aufirst%3DT.%26aulast%3DSteinwachs%26aufirst%3DK.%2BC.%26aulast%3DGertz%26aufirst%3DH.%2BJ.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DM.%2BV.%26aulast%3DG%25C3%25B3mez-Carrillo%26aufirst%3DB.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DVericat%26aufirst%3DJ.%2BA.%26aulast%3DRedondo%26aufirst%3DP.%26aulast%3DFleet%26aufirst%3DD.%26aulast%3DLeon%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520the%2520GSK-3%2520inhibitor%2520tideglusib%253A%2520A%2520pilot%2520study%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26spage%3D205%26epage%3D215%26doi%3D10.3233%2FJAD-2012-120805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rowe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D.-M.</span><span> </span><span class="NLM_article-title">GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">920</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2007.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.neubiorev.2007.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=920-931&author=M.+K.+Roweauthor=C.+Wiestauthor=D.-M.+Chuang&title=GSK-3+is+a+viable+potential+target+for+therapeutic+intervention+in+bipolar+disorder&doi=10.1016%2Fj.neubiorev.2007.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2007.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2007.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DM.%2BK.%26aulast%3DWiest%26aufirst%3DC.%26aulast%3DChuang%26aufirst%3DD.-M.%26atitle%3DGSK-3%2520is%2520a%2520viable%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520bipolar%2520disorder%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2007%26volume%3D31%26spage%3D920%26epage%3D931%26doi%3D10.1016%2Fj.neubiorev.2007.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teachey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Modulation of Muscle Insulin Resistance by Selective Inhibition of Glycogen Synthase Kinase-3 in Zucker Diabetic Fatty Rats</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">E892</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1152/ajpendo.00346.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1152%2Fajpendo.00346.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=E892-900&issue=5&author=E.+J.+Henriksenauthor=T.+R.+Kinnickauthor=M.+K.+Teacheyauthor=M.+P.+O%E2%80%99Keefeauthor=D.+Ringauthor=K.+W.+Johnsonauthor=S.+D.+Harrison&title=Modulation+of+Muscle+Insulin+Resistance+by+Selective+Inhibition+of+Glycogen+Synthase+Kinase-3+in+Zucker+Diabetic+Fatty+Rats&doi=10.1152%2Fajpendo.00346.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00346.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00346.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DTeachey%26aufirst%3DM.%2BK.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%2BP.%26aulast%3DRing%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DModulation%2520of%2520Muscle%2520Insulin%2520Resistance%2520by%2520Selective%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520in%2520Zucker%2520Diabetic%2520Fatty%2520Rats%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D284%26issue%3D5%26spage%3DE892%26epage%3D900%26doi%3D10.1152%2Fajpendo.00346.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Marsell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisask, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundgren-Andersson, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljunggren, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, K. B.</span><span> </span><span class="NLM_article-title">GSK-3 inhibition by an orally active small molecule increases bone mass in rats</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1016/j.bone.2011.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bone.2011.11.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=619-627&issue=3&author=R.+Marsellauthor=G.+Sisaskauthor=Y.+Nilssonauthor=A.+K.+Sundgren-Anderssonauthor=U.+Anderssonauthor=S.+Larssonauthor=O.+Nilssonauthor=O.+Ljunggrenauthor=K.+B.+Jonsson&title=GSK-3+inhibition+by+an+orally+active+small+molecule+increases+bone+mass+in+rats&doi=10.1016%2Fj.bone.2011.11.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DMarsell%26aufirst%3DR.%26aulast%3DSisask%26aufirst%3DG.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DSundgren-Andersson%26aufirst%3DA.%2BK.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DLjunggren%26aufirst%3DO.%26aulast%3DJonsson%26aufirst%3DK.%2BB.%26atitle%3DGSK-3%2520inhibition%2520by%2520an%2520orally%2520active%2520small%2520molecule%2520increases%2520bone%2520mass%2520in%2520rats%26jtitle%3DBone%26date%3D2012%26volume%3D50%26issue%3D3%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.bone.2011.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Doble, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">GSK-3: tricks of the trade for a multi-tasking kinase</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1242/jcs.00384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1242%2Fjcs.00384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=12615961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFWhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=1175-1186&author=B.+Dobleauthor=J.+R.+Woodgett&title=GSK-3%3A+tricks+of+the+trade+for+a+multi-tasking+kinase&doi=10.1242%2Fjcs.00384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3: Tricks of the trade for a multi-tasking kinase</span></div><div class="casAuthors">Doble, Bradley W.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) is a multifunctional serine/threonine kinase found in all eukaryotes.  The enzyme is a key regulator of numerous signaling pathways, including cellular responses to Wnt, receptor tyrosine kinases, and G-protein-coupled receptors and is involved in a wide range of cellular processes, ranging from glycogen metab. to cell cycle regulation and proliferation.  GSK-3 is unusual in that it is normally active in cells and is primarily regulated through inhibition of its activity.  Another peculiarity compared with other protein kinases is its preference for primed substrates, i.e., substrates previously phosphorylated by another kinase.  Several recent advances have improved the understanding of GSK-3 regulation in multiple pathways.  These include the soln. of the crystal structure of GSK-3, which has provided insight into GSK-3's penchant for primed substrates and the regulation of GSK-3 by serine phosphorylation, and findings related to the involvement of GSK-3 in the Wnt/β-catenin and Hedgehog pathways.  Finally, since increased GSK-3 activity may be linked to pathol. in diseases such as Alzheimer's disease and non-insulin-dependent diabetes mellitus, several new GSK-3 inhibitors, such as the aloisines, the paullones and the maleimides, have been developed.  Although they are just starting to be characterized in cell culture expts., these new inhibitors hold promise as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7SGJVebXiRLVg90H21EOLACvtfcHk0ljauZjMQFJEhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFWhtbc%253D&md5=fb267e44a019d584b6cac5881e8ed1a9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00384%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGSK-3%253A%2520tricks%2520of%2520the%2520trade%2520for%2520a%2520multi-tasking%2520kinase%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D1175%26epage%3D1186%26doi%3D10.1242%2Fjcs.00384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kitano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishigaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minamoto, T.</span><span> </span><span class="NLM_article-title">Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">e55289</span><span class="refDoi"> DOI: 10.1371/journal.pone.0055289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1371%2Fjournal.pone.0055289" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e55289&issue=2&author=A.+Kitanoauthor=T.+Shimasakiauthor=Y.+Chikanoauthor=M.+Nakadaauthor=M.+Hiroseauthor=T.+Higashiauthor=Y.+Ishigakiauthor=Y.+Endoauthor=T.+Takinoauthor=H.+Satoauthor=Y.+Saiauthor=K.+Miyamotoauthor=Y.+Motooauthor=K.+Kawakamiauthor=T.+Minamoto&title=Aberrant+glycogen+synthase+kinase+3%CE%B2+is+involved+in+pancreatic+cancer+cell+invasion+and+resistance+to+therapy&doi=10.1371%2Fjournal.pone.0055289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0055289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0055289%26sid%3Dliteratum%253Aachs%26aulast%3DKitano%26aufirst%3DA.%26aulast%3DShimasaki%26aufirst%3DT.%26aulast%3DChikano%26aufirst%3DY.%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DT.%26aulast%3DIshigaki%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DK.%26aulast%3DMotoo%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DMinamoto%26aufirst%3DT.%26atitle%3DAberrant%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520is%2520involved%2520in%2520pancreatic%2520cancer%2520cell%2520invasion%2520and%2520resistance%2520to%2520therapy%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3De55289%26doi%3D10.1371%2Fjournal.pone.0055289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolosky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Assoro, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demidenko, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervello, M.</span><span> </span><span class="NLM_article-title">GSK-3 as potential target for therapeutic intervention in cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2881</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.18632/oncotarget.2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.18632%2Foncotarget.2037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2881-2911&issue=10&author=J.+A.+McCubreyauthor=L.+S.+Steelmanauthor=F.+E.+Bertrandauthor=N.+M.+Davisauthor=M.+Sokoloskyauthor=S.+L.+Abramsauthor=G.+Montaltoauthor=A.+B.+D%E2%80%99Assoroauthor=M.+Libraauthor=F.+Nicolettiauthor=R.+Maestroauthor=J.+Baseckeauthor=D.+Rakusauthor=A.+Gizakauthor=Z.+Demidenkoauthor=L.+Coccoauthor=A.+M.+Martelliauthor=M.+Cervello&title=GSK-3+as+potential+target+for+therapeutic+intervention+in+cancer&doi=10.18632%2Foncotarget.2037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2037%26sid%3Dliteratum%253Aachs%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DBertrand%26aufirst%3DF.%2BE.%26aulast%3DDavis%26aufirst%3DN.%2BM.%26aulast%3DSokolosky%26aufirst%3DM.%26aulast%3DAbrams%26aufirst%3DS.%2BL.%26aulast%3DMontalto%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Assoro%26aufirst%3DA.%2BB.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DMaestro%26aufirst%3DR.%26aulast%3DBasecke%26aufirst%3DJ.%26aulast%3DRakus%26aufirst%3DD.%26aulast%3DGizak%26aufirst%3DA.%26aulast%3DDemidenko%26aufirst%3DZ.%26aulast%3DCocco%26aufirst%3DL.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26aulast%3DCervello%26aufirst%3DM.%26atitle%3DGSK-3%2520as%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D10%26spage%3D2881%26epage%3D2911%26doi%3D10.18632%2Foncotarget.2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gray, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brail, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooksey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrington, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span> </span><span class="NLM_article-title">A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span><span class="refDoi"> DOI: 10.1007/s10637-015-0278-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1007%2Fs10637-015-0278-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=26403509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1187-1196&author=J.+E.+Grayauthor=J.+R.+Infanteauthor=L.+H.+Brailauthor=G.+R.+Simonauthor=J.+F.+Cookseyauthor=S.+F.+Jonesauthor=D.+L.+Farringtonauthor=A.+Yeoauthor=K.+A.+Jacksonauthor=K.+H.+Chowauthor=M.+J.+Zamek-Gliszczynskiauthor=H.+A.+Burris&title=A+first-in-human+phase+I+dose-escalation%2C+pharmacokinetic%2C+and+pharmacodynamic+evaluation+of+intravenous+LY2090314%2C+a+glycogen+synthase+kinase+3+inhibitor%2C+administered+in+combination+with+pemetrexed+and+carboplatin&doi=10.1007%2Fs10637-015-0278-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin</span></div><div class="casAuthors">Gray, Jhanelle E.; Infante, Jeffrey R.; Brail, Les H.; Simon, George R.; Cooksey, Jennifer F.; Jones, Suzanne F.; Farrington, Daphne L.; Yeo, Adeline; Jackson, Kimberley A.; Chow, Kay H.; Zamek-Gliszczynski, Maciej J.; Burris, Howard A., III</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1187-1196</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclin. efficacy in xenograft models when combined with platinum regimens.  A first-in-human phase 1 dose-escalation study evaluated the combination of LY with pemetrexed/carboplatin.  Forty-one patients with advanced solid tumors received single-dose LY monotherapy lead-in and 37 patients received LY (10-120 mg) plus pemetrexed/carboplatin (500 mg/m2 and 5-6 AUC, resp.) across 8 dose levels every 21 days.  Primary objective was max. tolerated dose (MTD) detn.; secondary endpoints included safety, antitumor activity, pharmacokinetics, and beta-catenin pharmacodynamics.  MTD of LY with pemetrexed/carboplatin was 40 mg.  Eleven dose-limiting toxicities (DLTs) occurred in ten patients.  DLTs during LY monotherapy occurred at ≥40 mg: grade 2 visual disturbance (n = 1) and grade 3/4 peri-infusional thoracic pain during or shortly post infusion (n = 4; chest, upper abdominal, and back pain).  Ranitidine was added after de-escalation to 80 mg LY to minimize peri-infusional thoracic pain.  Following LY with pemetrexed/carboplatin therapy, DLTs included grade 3/4 thrombocytopenia (n = 4) and grade 4 neutropenia (n = 1).  Best overall response by RECIST included 5 confirmed partial responses (non-small cell lung cancer [n = 3], mesothelioma, and breast cancer) and 19 patients having stable disease.  Systemic LY exposure was approx. linear over dose range studied.  Transient upregulation of beta-catenin measured in peripheral blood mononuclear cells (PBMCs) occurred at 40 mg LY.  The initial safety profile of LY2090314 was established.  MTD LY dose with pemetrexed/carboplatin is 40 mg IV every 3 wk plus ranitidine.  Efficacy of LY plus pemetrexed/carboplatin requires confirmation in randomized trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERZ5mBHdU37Vg90H21EOLACvtfcHk0lgTI5IPSR1eAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsr3P&md5=432e42751491fdd88a53688888d89909</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10637-015-0278-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-015-0278-7%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DJ.%2BE.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DBrail%26aufirst%3DL.%2BH.%26aulast%3DSimon%26aufirst%3DG.%2BR.%26aulast%3DCooksey%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DFarrington%26aufirst%3DD.%2BL.%26aulast%3DYeo%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26atitle%3DA%2520first-in-human%2520phase%2520I%2520dose-escalation%252C%2520pharmacokinetic%252C%2520and%2520pharmacodynamic%2520evaluation%2520of%2520intravenous%2520LY2090314%252C%2520a%2520glycogen%2520synthase%2520kinase%25203%2520inhibitor%252C%2520administered%2520in%2520combination%2520with%2520pemetrexed%2520and%2520carboplatin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2015%26volume%3D33%26spage%3D1187%26epage%3D1196%26doi%3D10.1007%2Fs10637-015-0278-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery of GSK-3 Inhibitors and a Perspective on their Utility for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0065-7743(09)04401-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0065-7743%2809%2904401-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3-26&author=R.+G.+Gentlesauthor=S.+Huauthor=G.+M.+Dubowchik&title=Recent+Advances+in+the+Discovery+of+GSK-3+Inhibitors+and+a+Perspective+on+their+Utility+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0065-7743%2809%2904401-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904401-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904401-7%26sid%3Dliteratum%253Aachs%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520of%2520GSK-3%2520Inhibitors%2520and%2520a%2520Perspective%2520on%2520their%2520Utility%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0065-7743%2809%2904401-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer’s Disease Models</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1155/2012/381029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1155%2F2012%2F381029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-32&author=T.+Kramerauthor=B.+Schmidtauthor=F.+Lo+Monte&title=Small-Molecule+Inhibitors+of+GSK-3%3A+Structural+Insights+and+Their+Application+to+Alzheimer%E2%80%99s+Disease+Models&doi=10.1155%2F2012%2F381029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2012%2F381029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F381029%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520GSK-3%253A%2520Structural%2520Insights%2520and%2520Their%2520Application%2520to%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Models%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D32%26doi%3D10.1155%2F2012%2F381029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Selenica, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helboe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotharius, J.</span><span> </span><span class="NLM_article-title">Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2Fsj.bjp.0707471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=17906685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=959-979&author=M.+L.+Selenicaauthor=H.+S.+Jensenauthor=A.+K.+Larsenauthor=M.+L.+Pedersenauthor=L.+Helboeauthor=M.+Leistauthor=J.+Lotharius&title=Efficacy+of+small-molecule+glycogen+synthase+kinase-3+inhibitors+in+the+postnatal+rat+model+of+tau+hyperphosphorylation&doi=10.1038%2Fsj.bjp.0707471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation</span></div><div class="casAuthors">Selenica, M.-L.; Jensen, H. S.; Larsen, A. K.; Pedersen, M. L.; Helboe, L.; Leist, M.; Lotharius, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-979</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) affects neuropathol. events assocd. with Alzheimer's disease (AD) such as hyperphosphorylation of the protein, tau.  GSK-3β expression, enzyme activity and tau phosphorylated at AD-relevant epitopes are elevated in juvenile rodent brains.  Here, we assess five GSK-3β inhibitors and lithium in lowering phosphorylated tau (p-tau) and GSK-3β enzyme activity levels in 12-day old postnatal rats.  Brain levels of inhibitors following treatment in vivo were optimized based on pharmacokinetic data.  At optimal doses, p-tau (Ser396) levels in brain tissue was measured by immunoblotting and correlated with GSK-3β enzyme activities in the same tissues.  Effects of GSK inhibitors on p-tau, GSK-3β activities and cell death were measured in a human neuronal cell line (LUHMES).  Lithium and CHIR98014 reduced tau phosphorylation (Ser396) in the cortex and hippocampus of postnatal rats, while Alsterpaullone and SB216763 were effective only in hippocampus.  AR-A014418 and Indirubin-3'-monoxime were ineffective in either brain region.  Inhibition of p-tau in brain required several-fold higher levels of GSK inhibitors than the IC50 values obtained in recombinant or cell-based GSK-3β enzyme activity assays.  The inhibitory effect on GSK-3 activity ex vivo correlated with protection against cell death and decrease of p-tau- in LUHMES cells, using low M inhibitor concns.  Selective small-mol. inhibitors of GSK-3β reduce tau phosphorylation in vivo.  These findings corroborate earlier suggestions that GSK-3 may be an attractive target for disease-modification in AD and related conditions where tau phosphorylation is believed to contribute to disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYyPbYO9nGNbVg90H21EOLACvtfcHk0lj9nGv1uoQz0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynt73E&md5=ace7b6b45cce7c07516e6572183f1e1a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707471%26sid%3Dliteratum%253Aachs%26aulast%3DSelenica%26aufirst%3DM.%2BL.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DPedersen%26aufirst%3DM.%2BL.%26aulast%3DHelboe%26aufirst%3DL.%26aulast%3DLeist%26aufirst%3DM.%26aulast%3DLotharius%26aufirst%3DJ.%26atitle%3DEfficacy%2520of%2520small-molecule%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%2520in%2520the%2520postnatal%2520rat%2520model%2520of%2520tau%2520hyperphosphorylation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D959%26epage%3D979%26doi%3D10.1038%2Fsj.bjp.0707471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Khodor, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramboz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhortova, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1021/cn200085z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200085z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-11&author=P.+C.+Chenauthor=I.+N.+Gaisinaauthor=B.+F.+El-Khodorauthor=S.+Rambozauthor=N.+R.+Makhortovaauthor=L.+L.+Rubinauthor=A.+P.+Kozikowski&title=Identification+of+a+Maleimide-Based+Glycogen+Synthase+Kinase-3+%28GSK-3%29+Inhibitor%2C+BIP-135%2C+That+Prolongs+the+Median+Survival+Time+of+%CE%947+SMA+KO+Mouse+Model+of+Spinal+Muscular+Atrophy&doi=10.1021%2Fcn200085z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span></div><div class="casAuthors">Chen, Po C.; Gaisina, Irina N.; El-Khodor, Bassem F.; Ramboz, Sylvie; Makhortova, Nina R.; Rubin, Lee L.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-11</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of upregulated glycogen synthase kinase-3 (GSK-3) in various pathol. conditions has led to the development of a host of chem. diverse small mol. GSK-3 inhibitors, such as BIP-135 (I).  GSK-3 inhibition emerged as an alternative therapeutic target for treating spinal muscular atrophy (SMA) when a no. of GSK-3 inhibitors were shown to elevate survival motor neuron (SMN) levels in vitro and to rescue motor neurons when their intrinsic SMN level was diminished by SMN-specific short hairpin RNA (shRNA).  Despite their cellular potency, the in vivo efficacy of GSK-3 inhibitors has yet to be evaluated in an animal model of SMA.  Herein, we disclose that a potent and reasonably selective GSK-3 inhibitor, namely BIP-135, was tested in a transgenic Δ7 SMA KO mouse model of SMA and found to prolong the median survival of these animals.  In addn., this compd. was shown to elevate the SMN protein level in SMA patient-derived fibroblast cells as detd. by Western blot, and was neuroprotective in a cell-based, SMA-related model of oxidative stress-induced neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcySOXJLoZx7Vg90H21EOLACvtfcHk0lj9nGv1uoQz0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL&md5=728c77967169f3fa99263b1a2622d084</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcn200085z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200085z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DEl-Khodor%26aufirst%3DB.%2BF.%26aulast%3DRamboz%26aufirst%3DS.%26aulast%3DMakhortova%26aufirst%3DN.%2BR.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520a%2520Maleimide-Based%2520Glycogen%2520Synthase%2520Kinase-3%2520%2528GSK-3%2529%2520Inhibitor%252C%2520BIP-135%252C%2520That%2520Prolongs%2520the%2520Median%2520Survival%2520Time%2520of%2520%25CE%25947%2520SMA%2520KO%2520Mouse%2520Model%2520of%2520Spinal%2520Muscular%2520Atrophy%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D11%26doi%3D10.1021%2Fcn200085z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Textor, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6270</span><span class="NLM_x">–</span> <span class="NLM_lpage">6286</span><span class="refDoi"> DOI: 10.1021/jm900647e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900647e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6270-6286&author=M.+Saitohauthor=J.+Kunitomoauthor=E.+Kimuraauthor=H.+Iwashitaauthor=Y.+Unoauthor=T.+Onishiauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=T.+Tanakaauthor=C.+D.+Molauthor=D.+R.+Douganauthor=G.+P.+Textorauthor=G.+P.+Snellauthor=M.+Takizawaauthor=F.+Itohauthor=M.+Kori&title=2-%7B3-%5B4-%28Alkylsulfinyl%29phenyl%5D-1-benzofuran-5-yl%7D-5-methyl-1%2C3%2C4-oxadiazole+Derivatives+as+Novel+Inhibitors+of+Glycogen+Synthase+Kinase-3%CE%B2+with+Good+Brain+Permeability&doi=10.1021%2Fjm900647e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900647e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900647e%26sid%3Dliteratum%253Aachs%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DOnishi%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DTextor%26aufirst%3DG.%2BP.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DTakizawa%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKori%26aufirst%3DM.%26atitle%3D2-%257B3-%255B4-%2528Alkylsulfinyl%2529phenyl%255D-1-benzofuran-5-yl%257D-5-methyl-1%252C3%252C4-oxadiazole%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%2520with%2520Good%2520Brain%2520Permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6270%26epage%3D6286%26doi%3D10.1021%2Fjm900647e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Onishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, M.</span><span> </span><span class="NLM_article-title">A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(<i>S</i>)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07532.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1111%2Fj.1471-4159.2011.07532.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21992552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GqtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=1330-1340&author=T.+Onishiauthor=H.+Iwashitaauthor=Y.+Unoauthor=J.+Kunitomoauthor=M.+Saitohauthor=E.+Kimuraauthor=H.+Fujitaauthor=N.+Uchiyamaauthor=M.+Koriauthor=M.+Takizawa&title=A+novel+glycogen+synthase+kinase-3+inhibitor+2-methyl-5-%283-%7B4-%5B%28S%29-methylsulfinyl%5Dphenyl%7D-1-benzofuran-5-yl%29-1%2C3%2C4-oxadiazole+decreases+tau+phosphorylation+and+ameliorates+cognitive+deficits+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07532.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease</span></div><div class="casAuthors">Onishi, Tomohiro; Iwashita, Hiroki; Uno, Yumiko; Kunitomo, Jun; Saitoh, Morihisa; Kimura, Eiji; Fujita, Hisashi; Uchiyama, Noriko; Kori, Masakuni; Takizawa, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">1330-1340</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder leading to a progressive loss of cognitive function and is pathol. characterized by senile plaques and neurofibrillary tangles.  Glycogen synthase kinase-3 (GSK-3) is involved in AD pathogenesis.  GSK-3 is reported not only to phosphorylate tau, a major component of neurofibrillary tangles, but also to regulate the prodn. of amyloid β, which is deposited in senile plaques.  Therefore, pharmacol. inhibition of GSK-3 is considered an attractive therapeutic approach.  In this study, we report the pharmacol. effects of a novel GSK-3 inhibitor, 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole (MMBO), which displays high selectivity for GSK-3 and brain penetration following oral administration.  MMBO inhibited tau phosphorylation in primary neural cell culture and also in normal mouse brain.  When administered to a transgenic mouse model of AD, MMBO significantly decreased hippocampal tau phosphorylation at GSK-3 sites.  Addnl., chronic MMBO administration suppressed tau pathol. as assessed by AT8-immunoreactivity without affecting amyloid β pathol.  Finally, in behavioral assessments, MMBO significantly improved memory and cognitive deficits in the Y-maze and in novel object recognition tests in the transgenic AD mouse model.  These results indicate that pharmacol. GSK-3 inhibition ameliorates behavioral dysfunction with suppression of tau phosphorylation in an AD mouse model, and that MMBO might be beneficial for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBzTlsWPk5ELVg90H21EOLACvtfcHk0lgtjRC5lhqr9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GqtbrM&md5=635985e46ba585e33dd54e7b4c705422</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07532.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07532.x%26sid%3Dliteratum%253Aachs%26aulast%3DOnishi%26aufirst%3DT.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKori%26aufirst%3DM.%26aulast%3DTakizawa%26aufirst%3DM.%26atitle%3DA%2520novel%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%25202-methyl-5-%25283-%257B4-%255B%2528S%2529-methylsulfinyl%255Dphenyl%257D-1-benzofuran-5-yl%2529-1%252C3%252C4-oxadiazole%2520decreases%2520tau%2520phosphorylation%2520and%2520ameliorates%2520cognitive%2520deficits%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D119%26spage%3D1330%26epage%3D1340%26doi%3D10.1111%2Fj.1471-4159.2011.07532.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, A.</span><span> </span><span class="NLM_article-title">Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl] carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1296</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.brainres.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=19698704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyqsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1296&publication_year=2009&pages=148-163&author=Y.+Unoauthor=H.+Iwashitaauthor=T.+Tsukamotoauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=M.+Koriauthor=A.+Nakanishi&title=Efficacy+of+a+novel%2C+orally+active+GSK-3+inhibitor+6-Methyl-N-%5B3-%5B%5B3-%281-methylethoxy%29propyl%5D+carbamoyl%5D-1H-pyrazol-4-yl%5Dpyridine-3-carboxamide+in+tau+transgenic+mice&doi=10.1016%2Fj.brainres.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice</span></div><div class="casAuthors">Uno, Yumiko; Iwashita, Hiroki; Tsukamoto, Tetsuya; Uchiyama, Noriko; Kawamoto, Tomohiro; Kori, Masakuni; Nakanishi, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-163</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) composed of hyperphosphorylated and aggregated tau are common pathol. characteristics in Alzheimer's disease (AD) and other tauopathies.  Aberrant tau phosphorylation is an early and pivotal event in the pathogenesis of tauopathies, and since GSK-3 is a key factor implicated in aberrant tau phosphorylation, GSK-3 inhibition is expected to suppress tauopathy disease progression.  In the present study, we report the efficacy of a newly discovered small mol. GSK-3 inhibitor, 6-methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide (compd. A), to inhibit tau phosphorylation and to reduce the amt. of pathol. aggregated tau in JNPL3 mice that overexpress a mutant form of human tau.  Compd. A is a highly potent and selective inhibitor of GSK-3 with an IC50 of 2 nM, with at least 230-fold lower potency against 27 other kinases.  Oral administration of compd. A resulted in a significant redn. of tau phosphorylation at several GSK-3 directed sites.  Furthermore, chronic oral administration of compd. A markedly reduced aggregated tau in old JNPL3 mice.  These results suggest that a novel, orally active GSK-3 inhibitor, compd. A, has potency in the prevention of tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKJz-108FxgLVg90H21EOLACvtfcHk0lhzeDwcO0SoBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyqsbzM&md5=72aed3cddd38d774e1c70bf3530e4d9e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DY.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DKori%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520a%2520novel%252C%2520orally%2520active%2520GSK-3%2520inhibitor%25206-Methyl-N-%255B3-%255B%255B3-%25281-methylethoxy%2529propyl%255D%2520carbamoyl%255D-1H-pyrazol-4-yl%255Dpyridine-3-carboxamide%2520in%2520tau%2520transgenic%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1296%26spage%3D148%26epage%3D163%26doi%3D10.1016%2Fj.brainres.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lesuisse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiraboschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, P.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutruc-Rosset, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Châtreau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarteronet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgevin, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T.</span><span> </span><span class="NLM_article-title">Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2010.01.132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2344-2349&author=D.+Lesuisseauthor=G.+Tiraboschiauthor=A.+Krickauthor=P.-Y.+Abecassisauthor=G.+Dutruc-Rossetauthor=D.+Babinauthor=F.+Halleyauthor=F.+Ch%C3%A2treauauthor=S.+Lachaudauthor=A.+Chevalierauthor=D.+Quarteronetauthor=M.-C.+Burgevinauthor=C.+Amaraauthor=P.+Bertrandauthor=T.+Rooney&title=Design+of+potent+and+selective+GSK3%CE%B2+inhibitors+with+acceptable+safety+profile+and+pharmacokinetics&doi=10.1016%2Fj.bmcl.2010.01.132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.132%26sid%3Dliteratum%253Aachs%26aulast%3DLesuisse%26aufirst%3DD.%26aulast%3DTiraboschi%26aufirst%3DG.%26aulast%3DKrick%26aufirst%3DA.%26aulast%3DAbecassis%26aufirst%3DP.-Y.%26aulast%3DDutruc-Rosset%26aufirst%3DG.%26aulast%3DBabin%26aufirst%3DD.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DCh%25C3%25A2treau%26aufirst%3DF.%26aulast%3DLachaud%26aufirst%3DS.%26aulast%3DChevalier%26aufirst%3DA.%26aulast%3DQuarteronet%26aufirst%3DD.%26aulast%3DBurgevin%26aufirst%3DM.-C.%26aulast%3DAmara%26aufirst%3DC.%26aulast%3DBertrand%26aufirst%3DP.%26aulast%3DRooney%26aufirst%3DT.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520GSK3%25CE%25B2%2520inhibitors%2520with%2520acceptable%2520safety%2520profile%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2344%26epage%3D2349%26doi%3D10.1016%2Fj.bmcl.2010.01.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Coffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng-Lovering, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span> </span><span class="NLM_article-title">6-Amino-4-(pyrimidin-4-yl)pyridones: Novel glycogen synthase kinase-3β inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2011.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=21295469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1429-1433&author=K.+Coffmanauthor=M.+Brodneyauthor=J.+Cookauthor=L.+Lanyonauthor=J.+Panditauthor=S.+Sakyaauthor=J.+Schachterauthor=E.+Tseng-Loveringauthor=M.+Wessel&title=6-Amino-4-%28pyrimidin-4-yl%29pyridones%3A+Novel+glycogen+synthase+kinase-3%CE%B2+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">6-Amino-4-(pyrimidin-4-yl)pyridones: Novel glycogen synthase kinase-3β inhibitors</span></div><div class="casAuthors">Coffman, Karen; Brodney, Michael; Cook, James; Lanyon, Lorraine; Pandit, Jayvardhan; Sakya, Subas; Schachter, Joel; Tseng-Lovering, Elaine; Wessel, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1429-1433</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships for a novel series of 6-amino-4-(pyrimidin-4-yl)pyridones e. g., I derived from a high throughput screening hit are discussed.  Optimization of lead matter afforded compds. with good potency, selectivity and central nervous system (CNS) exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwwTI16k0bW7Vg90H21EOLACvtfcHk0lj14WUypu0_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gmurw%253D&md5=9ba1c30bc6714d2299dde007bf322708</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DK.%26aulast%3DBrodney%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSakya%26aufirst%3DS.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DTseng-Lovering%26aufirst%3DE.%26aulast%3DWessel%26aufirst%3DM.%26atitle%3D6-Amino-4-%2528pyrimidin-4-yl%2529pyridones%253A%2520Novel%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2011.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogdin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Alfredsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span> </span><span class="NLM_article-title">Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9107</span><span class="NLM_x">–</span> <span class="NLM_lpage">9119</span><span class="refDoi"> DOI: 10.1021/jm201724m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201724m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9107-9119&author=S.+Bergauthor=M.+Berghauthor=S.+Hellbergauthor=K.+Hogdinauthor=Y.+Lo-Alfredssonauthor=P.+Sodermanauthor=S.+von+Bergauthor=T.+Weigeltauthor=M.+Ormoauthor=Y.+Xueauthor=J.+Tuckerauthor=J.+Neelissenauthor=E.+Jerningauthor=Y.+Nilssonauthor=R.+Bhat&title=Discovery+of+Novel+Potent+and+Highly+Selective+Glycogen+Synthase+Kinase-3%CE%B2+%28GSK3%CE%B2%29+Inhibitors+for+Alzheimer%E2%80%99s+Disease%3A+Design%2C+Synthesis%2C+and+Characterization+of+Pyrazines&doi=10.1021%2Fjm201724m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer's Disease: Design, Synthesis, and Characterization of Pyrazines</span></div><div class="casAuthors">Berg, Stefan; Bergh, Margareta; Hellberg, Sven; Hoegdin, Katharina; Lo-Alfredsson, Yvonne; Soederman, Peter; von Berg, Stefan; Weigelt, Tatjana; Ormoe, Mats; Xue, Yafeng; Tucker, Julie; Neelissen, Jan; Jerning, Eva; Nilsson, Yvonne; Bhat, Ratan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9107-9119</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/threonine kinase which was originally identified due to its role in glycogen metab.  Active forms of GSK3β localize to pretangle pathol. including dystrophic neuritis and neurofibrillary tangles in Alzheimer's disease (AD) brain.  By using a high throughput screening (HTS) approach to search for new chem. series and cocrystn. of key analogs to guide the optimization and synthesis of our pyrazine series, we have developed highly potent and selective inhibitors showing cellular efficacy and blood-brain barrier penetration.  The inhibitors are suitable for in vivo efficacy testing and may serve as a new treatment strategy for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR4w7EMbaI7Vg90H21EOLACvtfcHk0lj14WUypu0_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggtrc%253D&md5=f1475e38163a8e81e9ca9a24b271a0be</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201724m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201724m%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DHogdin%26aufirst%3DK.%26aulast%3DLo-Alfredsson%26aufirst%3DY.%26aulast%3DSoderman%26aufirst%3DP.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DWeigelt%26aufirst%3DT.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DTucker%26aufirst%3DJ.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Novel%2520Potent%2520and%2520Highly%2520Selective%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%2520%2528GSK3%25CE%25B2%2529%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Characterization%2520of%2520Pyrazines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9107%26epage%3D9119%26doi%3D10.1021%2Fjm201724m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaprakasam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civiello, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacutin-Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapiel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nophsker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2Fj.bmcl.2015.03.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1856-1863&author=X.+Hanauthor=P.+Sivaprakasamauthor=R.+L.+Civielloauthor=S.+Jacutin-Porteauthor=K.+Kishauthor=M.+Pokrossauthor=H.+A.+Lewisauthor=N.+Ahmedauthor=N.+Szapielauthor=J.+A.+Newittauthor=E.+T.+Baldwinauthor=H.+Xiaoauthor=C.+M.+Krauseauthor=H.+Parkauthor=M.+Nophskerauthor=J.+S.+Lippyauthor=C.+R.+Burtonauthor=D.+R.+Langleyauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+new+acylaminopyridines+as+GSK-3+inhibitors+by+a+structure+guided+in-depth+exploration+of+chemical+space+around+a+pyrrolopyridinone+core&doi=10.1016%2Fj.bmcl.2015.03.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DSivaprakasam%26aufirst%3DP.%26aulast%3DCiviello%26aufirst%3DR.%2BL.%26aulast%3DJacutin-Porte%26aufirst%3DS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DH.%2BA.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DSzapiel%26aufirst%3DN.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DKrause%26aufirst%3DC.%2BM.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520new%2520acylaminopyridines%2520as%2520GSK-3%2520inhibitors%2520by%2520a%2520structure%2520guided%2520in-depth%2520exploration%2520of%2520chemical%2520space%2520around%2520a%2520pyrrolopyridinone%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1856%26epage%3D1863%26doi%3D10.1016%2Fj.bmcl.2015.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Pd-catalyzed intermolecular amidation of aryl halides: the discovery that xantphos can be trans-chelating in a palladium complex</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">6043</span><span class="NLM_x">–</span> <span class="NLM_lpage">6048</span><span class="refDoi"> DOI: 10.1021/ja012610k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja012610k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=6043-6048&author=J.+Yinauthor=S.+L.+Buchwald&title=Pd-catalyzed+intermolecular+amidation+of+aryl+halides%3A+the+discovery+that+xantphos+can+be+trans-chelating+in+a+palladium+complex&doi=10.1021%2Fja012610k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed Intermolecular Amidation of Aryl Halides: The Discovery that Xantphos Can Be Trans-Chelating in a Palladium Complex</span></div><div class="casAuthors">Yin, Jingjun; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6043-6048</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the intermol. coupling of aryl halides and amides using a Xantphos/Pd catalyst is described.  This system displays good functional group compatibility, and the desired C-N bond forming process proceeds in good to excellent yields with 1-4 mol % of the Pd catalyst.  Addnl., the arylation of sulfonamides, oxazolidinones, and ureas is reported.  The efficiency of these transformations was found to be highly dependent on reaction concns. and catalyst loadings.  A Pd complex resulting from oxidative addn. of 4-bromobenzonitrile, (Xantphos)Pd(4-cyanophenyl)(Br), was prepd. in one step from Xantphos, Pd2(dba)3, and the aryl bromide.  The complex proved to be an active catalyst for the coupling between 4-bromobenzonitrile and benzamide.  X-ray crystallog. anal. revealed a rare trans-chelating bisphosphine-Pd(II) structure with a large bite angle of 150.7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqutPXg1bRArVg90H21EOLACvtfcHk0liLNyT_GsGXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlGis7Y%253D&md5=94eef150b41a39e7ae60b4fbe5ee7f8b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja012610k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja012610k%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPd-catalyzed%2520intermolecular%2520amidation%2520of%2520aryl%2520halides%253A%2520the%2520discovery%2520that%2520xantphos%2520can%2520be%2520trans-chelating%2520in%2520a%2520palladium%2520complex%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D6043%26epage%3D6048%26doi%3D10.1021%2Fja012610k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv" class="ext-link">Supporting Information</a> for details. Compounds <b>4</b> and <b>7</b> had GSK-3β IC<sub>50</sub>’s of 1.5 and 3.8 nM, respectively, in our assay. Their Ambit profiles are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">The GSK-3β protein was expressed and purified as described in ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>. The X-ray crystal structures of compounds <b>15</b> and <b>18</b> were deposited in the Protein Data Bank with PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F94">5F94</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F95">5F95</a>. See the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span> </span><span class="NLM_article-title">Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1107/S090744490302938X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1107%2FS090744490302938X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=439-46&author=M.+Aokiauthor=T.+Yokotaauthor=I.+Sugiuraauthor=C.+Sasakiauthor=T.+Hasegawaauthor=C.+Okumuraauthor=K.+Ishiguroauthor=T.+Kohnoauthor=S.+Sugioauthor=T.+Matsuzaki&title=Structural+insight+into+nucleotide+recognition+in+tau-protein+kinase+I%2Fglycogen+synthase+kinase+3+beta&doi=10.1107%2FS090744490302938X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS090744490302938X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490302938X%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DSugiura%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DC.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DC.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DSugio%26aufirst%3DS.%26aulast%3DMatsuzaki%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520nucleotide%2520recognition%2520in%2520tau-protein%2520kinase%2520I%252Fglycogen%2520synthase%2520kinase%25203%2520beta%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D439%26epage%3D46%26doi%3D10.1107%2FS090744490302938X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>The PyMOL Molecular Graphics System, version 1.0r2; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+version+1.0r2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhR716M_UBEoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="note"><p class="first last">The following kinases tested in-house for compound <b>15</b> all have IC<sub>50</sub>’s > 2 μM: Aurora-B, BTK, CDK2, CK2A2, IRAK4, JAK2, JNK1-R, LCK, LG921, and TYK2 887; the following kinases tested in-house for compound <b>15</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (4.8), CDK5/p25 (5.4), cKIT, IGF1R, mAurA, MK2, P38A, PDGRb, PIM1 (3.1), PKCth, RSK1, and SYK.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="note"><p class="first last">The following kinases tested in-house for compound <b>18</b> all have IC<sub>50</sub>’s > 2 μM: Aurora-B, BTK, CDK2, CK2A2, CK2A2B, CK1E, IKK2, IRAK4, JAK1 CAL, FMS, JAK1, JAK2, JAK3, JNK1-R, LCK, LG921, ROCK1, ROCK2mut, SRMS, TRKA CAL, TRKB CAL, TYK2, and TYK2 887; the following kinases tested in-house for compound <b>18</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (13), ACK, CDK5/p25, cKIT, IGF1R, mAurA, MK2, P38A, PDGRb (36), PIM1, PKCth, RSK1, and SYK. The following kinases tested in-house for compound <b>29</b> all have IC<sub>50</sub>’s > 2 μM except for those with numbers (μM) given in parenthesis: Aurora-B, BTK, CDK2, CK2A2, CK2A2B, CK1D, CK1E, FMS, IRAK4, JAK1 CAL, JAK2,, JAK3, LCK, LG921 (1.9), ROCK1, ROCK2mut, STK33AD, SRMS, TRKA CAL, TRKBCAL, TYK2, TYK2 887, and ZAP70; the following kinases tested in-house for compound <b>29</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: ABLWT (19), ACK, CDK5/p25 (42), cKIT, CSK, IGF1R, MK2, P38A, PDGRb, PKCth, and SYK. The following kinases tested in-house for compound <b>33</b> all have IC<sub>50</sub>’s > 2 μM except for those with numbers (μM) given in parenthesis: Aurora-B, BTK, BMX, CDK2, CK2A1, CK2A2, CK2A1B, CK2A2B, CK1D, CK1E, FMS, IRAK1 (1.6), IRAK4, ITK, JAK2, JAK3, JNK1-R, LCK, LG921, LYNA, ROCK1, ROCK2mut, STK33AD, TEC, TNIK, TRKA CAL, TRKB CAL, TYK2, TYK2 887, and ZAP70; the following kinases tested in-house for compound <b>33</b> all have IC<sub>50</sub>’s > 50 μM except for those with numbers (μM) given in parenthesis: CDK5/p25 (42), cKIT, CSK, FYN, IGF1R, mAurA, MK2, MARK1, MARK2, MARK3, MARK4, P38A, PDGRb, PIM1, PKCTH, RSK1, SYK (42), TTBK1, and TTBK2. The Ambit heat map values for compounds <b>18</b>, <b>29</b>, and <b>33</b> are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> as well.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span> <span class="citation_source-book">Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development</span>; <span class="NLM_contrib-group">Martínez, A.; Castro, A.; Medina, M.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1002%2F0470052171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Mart%C3%ADnez&author=A.+Castro&author=M.+Medina&title=Glycogen+Synthase+Kinase+3+%28GSK-3%29+and+Its+Inhibitors%3A+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F0470052171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470052171%26sid%3Dliteratum%253Aachs%26btitle%3DGlycogen%2520Synthase%2520Kinase%25203%2520%2528GSK-3%2529%2520and%2520Its%2520Inhibitors%253A%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26pub%3DWiley-Interscience%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metherate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbari, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1016/S0896-6273(03)00434-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=10.1016%2FS0896-6273%2803%2900434-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=12895417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFOksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2003&pages=409-421&author=S.+Oddoauthor=A.+Caccamoauthor=J.+D.+Shepherdauthor=M.+P.+Murphyauthor=T.+E.+Goldeauthor=R.+Kayedauthor=R.+Metherateauthor=M.+P.+Mattsonauthor=Y.+Akbariauthor=F.+M.+LaFerla&title=Triple-transgenic+model+of+Alzheimer%E2%80%99s+disease+with+plaques+and+tangles%3A+intracellular+Abeta+and+synaptic+dysfunction&doi=10.1016%2FS0896-6273%2803%2900434-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction</span></div><div class="casAuthors">Oddo, Salvatore; Caccamo, Antonella; Shepherd, Jason D.; Murphy, M. Paul; Golde, Todd E.; Kayed, Rakez; Metherate, Raju; Mattson, Mark P.; Akbari, Yama; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The neuropathol. correlates of Alzheimer's disease (AD) include amyloid-β (Aβ) plaques and neurofibrillary tangles.  To study the interaction between Aβ and tau and their effect on synaptic function, we derived a triple-transgenic model (3×Tg-AD) harboring PS1M146V, APPSwe, and tauP301L transgenes.  Rather than crossing independent lines, we microinjected two transgenes into single-cell embryos from homozygous PS1M146V knockin mice, generating mice with the same genetic background.  3×Tg-AD mice progressively develop plaques and tangles.  Synaptic dysfunction, including LTP deficits, manifests in an age-related manner, but before plaque and tangle pathol.  Deficits in long-term synaptic plasticity correlate with the accumulation of intraneuronal Aβ.  These studies suggest a novel pathogenic role for intraneuronal Aβ with regards to synaptic plasticity.  The recapitulation of salient features of AD in these mice clarifies the relationships between Aβ, synaptic dysfunction, and tangles and provides a valuable model for evaluating potential AD therapeutics as the impact on both lesions can be assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw1IPrYvfU7Vg90H21EOLACvtfcHk0livoIS8yuWXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFOksro%253D&md5=4abc16e818125d976b34e1e68128130d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900434-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900434-3%26sid%3Dliteratum%253Aachs%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DShepherd%26aufirst%3DJ.%2BD.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DMetherate%26aufirst%3DR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAkbari%26aufirst%3DY.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DTriple-transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520plaques%2520and%2520tangles%253A%2520intracellular%2520Abeta%2520and%2520synaptic%2520dysfunction%26jtitle%3DNeuron%26date%3D2003%26volume%3D39%26spage%3D409%26epage%3D421%26doi%3D10.1016%2FS0896-6273%2803%2900434-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="note"><p class="first last">See the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf" class="ext-link">Supporting Information</a> for detailed data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1C','PDB','1J1C'); return false;">PDB: 1J1C</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F94" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F94','PDB','5F94'); return false;">PDB: 5F94</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F95" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F95','PDB','5F95'); return false;">PDB: 5F95</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01550">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56248"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01550">10.1021/acs.jmedchem.5b01550</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES strings and GSK-3β/α and pTau IC<sub>50</sub> data for <b>11</b>–<b>45</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv">CSV</a>)</p></li><li><p class="inline">Synthesis and characterization of the aminopyridine intermediates from <a class="ref internalNav" href="#sch2">Scheme 2</a>; X-ray crystal studies of <b>15</b> and <b>18</b> bound to GSK-3β; biological assays; and related Ambit graphs (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_001.csv">jm5b01550_si_001.csv (2.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01550/suppl_file/jm5b01550_si_002.pdf">jm5b01550_si_002.pdf (1.28 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01550&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-3%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01550%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01550" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679921b61aaf3cee","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
